1. Cell Cycle/DNA Damage
    Cytoskeleton
    Antibody-drug Conjugate/ADC Related
  2. Microtubule/Tubulin
    ADC Cytotoxin

Paclitaxel 

Cat. No.: HY-B0015 Purity: 99.60%
Data Sheet SDS Handling Instructions

Paclitaxel is a potent anticancer agent known to promote microtubule (MT) assembly, inhibit MT depolymerization, and change MT dynamics required for mitosis and cell proliferation.

For research use only. We do not sell to patients.
Paclitaxel Chemical Structure

Paclitaxel Chemical Structure

CAS No. : 33069-62-4

Size Price Stock Quantity
Free Sample (0.5-1 mg)   Apply now  
10 mM * 1 mL in DMSO $55 In-stock
50 mg $50 In-stock
100 mg $80 In-stock
500 mg $120 In-stock
1 g   Get quote  
5 g   Get quote  

* Please select Quantity before adding items.

    Paclitaxel purchased from MCE. Usage Cited in: Am J Cancer Res. 2017 Apr 1;7(4):903-912.

    Synergistic inhibition of colony formation of ATC cells by Lenvatinib and Paclitaxel. Representative images of colony formation in C643 cells treated with vehicle control (DMSO) or Lenvatinib and Paclitaxel at the indicated concentrations, individually or in combination, are shown in left panel. Quantitative analysis of colony numbers is shown in right panel.
    • Biological Activity

    • Protocol

    • Technical Information

    • Purity & Documentation

    • References

    Description

    Paclitaxel is a potent anticancer agent known to promote microtubule (MT) assembly, inhibit MT depolymerization, and change MT dynamics required for mitosis and cell proliferation.

    IC50 & Target

    IC50: 4 nM (MT)

    In Vitro

    Paclitaxel at 0.1, 0.5, and 1 μM reduces the proliferation and survival of CCRF-HSB-2 cells in a dose-dependent fashion and that the IC50 value of taxol is about 0.25 μM[1]. Paclitaxel directly associates with the endoplasmic reticulum to stimulate the release of calcium into the cytosol, contributing to the induction of apoptosis[2].

    In Vivo

    In a SCID mouse xenograft model, low dose metronomic Paclitaxel treatment decreases lung dissemination of EGI-1 cells without significantly affecting their local tumor growth[3]. Low doses of paclitaxel promot liver metastasis in mouse xenografts, which correlats with changes in estrogen metabolism in the host liver[4]. Paclitaxel (2 mg/kg per treatment, black circles) induces mechanical hypersensitivity in the glabrous skin of the hindpaw[5].

    Clinical Trial
    NCT Number Sponsor Condition Start Date Phase
    NCT03096418 University of Wisconsin, Madison|National Cancer Institute (NCI) Breast Neoplasm Female March 13, 2017
    NCT02762981 Corcept Therapeutics Solid Tumors|Cellular Diagnosis, Ovarian Epithelial Cancer|Breast Cancer March 2016 Phase 1|Phase 2
    NCT00583349 Columbia University|Celgene Corporation Bladder Cancer December 2007 Phase 1|Phase 2
    NCT01746225 International Breast Cancer Study Group|Breast International Group Metastatic Breastcancer April 2013 Phase 2
    NCT02193633 Royal Marsden NHS Foundation Trust|Institute of Cancer Research, United Kingdom|AstraZeneca Advanced Cancer April 2013 Phase 1
    NCT01583426 German Breast Group|Celgene Corporation|Roche Pharma AG Tubular Breast Cancer Stage II|Mucinous Breast Cancer Stage II|Breast Cancer Female NOS|Invasive Ductal Breast Cancer|Tubular Breast Cancer Stage III|HER-2 Positive Breast Cancer|Inflammatory Breast Cancer Stage IV|Inflammatory Breast Cancer July 2012 Phase 3
    NCT01962103 Celgene Neuroblastoma|Rhabdomyosarcoma|Ewing's Sarcoma|Ewing's Tumor|Sarcoma, Ewing's|Sarcomas, Epitheliod|Sarcoma, Soft Tissue|Sarcoma, Spindle Cell|Melanoma|Malignant Melanoma|Clinical Oncology|Oncology, Medical|Pediatrics, Osteosarcoma|Osteogenic Sarcoma|Osteosarcoma Tumor|Sarcoma, Osteogenic|Tumors|Cancer|Neoplasia|Neoplasm|Histiocytoma|Fibrosarcoma|Dermatofibrosarcoma December 4, 2013 Phase 1|Phase 2
    NCT01442974 Grupo Hospital de Madrid Pancreatic Cancer January 2011
    NCT01969955 Chinese Academy of Medical Sciences Squamous Cell Carcinoma of Lung September 2013 Phase 2
    NCT02551432 Seoul National University Hospital Small Cell Lung Cancer September 2015 Phase 2
    NCT02389985 NewLink Genetics Corporation Ovarian Cancer July 2015 Phase 1|Phase 2
    NCT02033538 Zhejiang University Squamous Cell Carcinoma of Esophagus January 2014 Phase 2
    NCT00508326 M.D. Anderson Cancer Center Advanced Cancer October 2005 Phase 1
    NCT02157870 M.D. Anderson Cancer Center|National Institutes of Health (NIH)|National Cancer Institute (NCI) Ovarian Cancer December 2004 Phase 2
    NCT01994031 Nanjing Luye Sike Pharmaceutical Co.,Ltd. Solid Tumors August 2014 Phase 4
    NCT01497470 OncoGenex Technologies|Teva Pharmaceutical Industries Cancer April 2012 Phase 1
    NCT00102622 M.D. Anderson Cancer Center|National Institutes of Health (NIH)|National Cancer Institute (NCI) Ovarian Cancer December 2004 Phase 1
    NCT02262897 Tongji University Small Cell Lung Cancer September 2013 Phase 2
    NCT01431794 Sidney Kimmel Comprehensive Cancer Center|Novartis Resectable Pancreatic Adenocarcinoma September 2011 Phase 1|Phase 2
    NCT01973309 OncoMed Pharmaceuticals, Inc. Metastatic Breast Cancer September 2013 Phase 1
    NCT02415023 Hutchison Medipharma Limited Gastric Cancer September 2014 Phase 1|Phase 2
    NCT01209195 Merrimack Pharmaceuticals|Sanofi Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer,|Primary Peritoneal Cancer or Endometrial Cancer|Locally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer October 2010 Phase 1
    NCT02054884 Philogen S.p.A.|immatics Biotechnologies GmbH Merkel Cell Carcinoma October 2013 Phase 2
    NCT01954355 Swiss Group for Clinical Cancer Research Solid Tumor|Ovarian Cancer September 2013 Phase 1
    NCT02707159 Helse Stavanger HF Metastatic Pancreatic Cancer November 2014 Phase 2
    NCT00453076 Asan Medical Center Bile Duct Obstruction November 2006 Phase 3
    NCT00820170 Memorial Sloan Kettering Cancer Center|Bristol-Myers Squibb Breast Cancer January 2009 Phase 1|Phase 2
    NCT02076243 Icahn School of Medicine at Mount Sinai|Celgene Corporation Cutaneous Squamous Cell Carcinoma March 2014 Phase 2
    NCT01953445 Washington University School of Medicine Breast Neoplasms August 2014 Phase 2
    NCT01133912 Jungsil Ro|GlaxoSmithKline|CJ HealthCare Corporation|National Cancer Center, Korea Breast Cancer March 2009 Phase 1
    NCT01702844 UNC Lineberger Comprehensive Cancer Center|Celgene Non Small Cell Lung Cancer (NSCLC) October 2012 Phase 2
    NCT01698710 Massachusetts General Hospital Pancreatic Cysts November 2012
    NCT02788708 Floor Backes|Eisai Inc.|Ohio State University Comprehensive Cancer Center Fallopian Tube Carcinoma|Recurrent Ovarian Cancer|Primary Peritoneal Carcinoma|Recurrent Endometrial Cancer May 27, 2016 Phase 1
    NCT02684227 M.D. Anderson Cancer Center|Astellas Pharma Inc|Medivation, Inc.|National Comprehensive Cancer Network Endometrial Cancer August 2016 Phase 2
    NCT01107665 University of California, Irvine|GlaxoSmithKline Stage III Melanoma|Stage IV Melanoma|Unresectable Melanoma August 2010 Phase 2
    NCT00933374 Heinrich-Heine University, Duesseldorf Bladder Cancer July 2009 Phase 2
    NCT02280252 New York University School of Medicine Breast Cancer March 2005 Phase 2
    NCT02251951 Hellenic Oncology Research Group Stomach and Gastro-Esophageal Junction (GEJ) Cancer September 2012 Phase 2
    NCT00532285 National Cancer Center, Korea Breast Cancer September 2005 Phase 2
    NCT01992341 Amgen Advanced Solid Tumors July 2012 Phase 1
    NCT02279576 Spanish Oncology Genito-Urinary Group Penile Squamous Cell Carcinoma Stage IV January 2015 Phase 2
    NCT02555696 Celgene Metastatic Breast Cancer May 31, 2012
    NCT02023021 Xian-Jun Yu|Fudan University Stage IA Pancreatic Adenocarcinoma|Stage IB Pancreatic Adenocarcinoma|Stage IIA Pancreatic Adenocarcinoma|Stage IIB Pancreatic Adenocarcinoma January 2014 Phase 2
    NCT02273713 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Celgene Corporation Esophageal Cancer|Toxicity October 2014 Phase 1|Phase 2
    NCT02016209 Zhejiang University Non Small Cell Lung Cancer January 2014 Phase 2
    NCT02476955 ArQule Solid Tumors|Ovarian Cancer|Endometrial Cancer June 2015 Phase 1
    NCT00672295 AA Secord|Duke University Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer August 2007 Phase 1
    NCT02358161 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Novartis|Celgene Corporation Pancreatic Cancer September 2013 Phase 1|Phase 2
    NCT01016769 Memorial Sloan Kettering Cancer Center|NATL COMP CA NETWORK|Pfizer Squamous Cell Cancer|Head and Neck Cancer November 2009 Phase 1|Phase 2
    NCT01039844 M.D. Anderson Cancer Center|Luitpold Pharmaceuticals Melanoma December 2009 Phase 1
    NCT00487669 Dartmouth-Hitchcock Medical Center|CTI BioPharma Advanced Non-small Cell Lung Cancer October 2006 Phase 2
    NCT01444547 Chinese Academy of Medical Sciences|Beijing Municipal Science & Technology Commission Esophageal Cancer January 2007 Phase 2
    NCT00933426 M.D. Anderson Cancer Center|Celgene Corporation Prostate Cancer August 2009 Phase 1
    NCT01432223 Osaka Medical College Breast Cancer|HER-2 Positive Breast Cancer|Effects of Chemotherapy September 2011 Phase 2
    NCT02733250 Centre hospitalier de l'Université de Montréal (CHUM)|Centre de Recherche du Centre Hospitalier de l'Université de Montréal|Merck Canada Inc|Celgene Inc|Jewish General Hospital Lung Cancer March 13, 2017 Phase 1|Phase 2
    NCT02075021 New York University School of Medicine|Celgene Corporation Relapsed or Refractory Multiple Myeloma March 2014 Phase 1|Phase 2
    NCT01525706 Lawson Health Research Institute|University of Western Ontario, Canada Mucinous Cystic Tumor With Moderate Dysplasia|Mucinous Cystadenoma of Pancreas|Mucinous Cystadenocarcinoma of Pancreas|Benign Neoplasm of Pancreas September 2012 Phase 1
    NCT01134250 Philogen S.p.A. Solid Tumour,|Breast Cancer,|Metastatic Melanoma,|Non-small Cell Lung Cancer (NSCLC), June 2008 Phase 1|Phase 2
    NCT02230319 Medical Oncology & Hematology Associates of Northern Virginia|Inova Health System Breast Cancer October 2014 Phase 2
    NCT00833807 M.D. Anderson Cancer Center|Celgene Corporation Melanoma|Liver Metastasis February 2009 Phase 1
    NCT02887248 SCRI Development Innovations, LLC|Celgene Urothelial Carcinoma|Bladder Cancer|Transitional Cell Carcinoma January 12, 2017 Phase 2
    NCT00736619 Memorial Sloan Kettering Cancer Center|Celgene Corporation|National Comprehensive Cancer Network HEAD & NECK Cancer August 2008 Phase 1
    NCT00731861 Indiana University School of Medicine|Novartis|Indiana University Neoplasm Metastasis|Carcinoma May 2005 Phase 1
    NCT03166085 Memorial Sloan Kettering Cancer Center|Samus Therapeutics, Inc. Metastatic Breast Cancer May 23, 2017 Phase 1
    NCT02151149 Celgene Corporation Non-Small Cell Lung Cancer|Carcinoma|Squamous Cell Carcinoma|Adenocarcinoma|Carcinoma, Large Cell|Lung Neoplasm June 2014 Phase 4
    NCT00506779 M.D. Anderson Cancer Center Uterine Cancer December 2003 Phase 1|Phase 2
    NCT01303497 Centre Oscar Lambret|Groupe Sarcome Français|Groupe d’études des Tumeurs Osseuses Angiosarcoma September 2010 Phase 2
    NCT01822314 Fondazione Michelangelo Breast Cancer April 2013 Phase 3
    NCT02379416 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Solid Tumors February 20, 2015 Phase 1
    NCT01872403 The First Affiliated Hospital of Guangzhou Medical University Non-small Cell Lung Cancer October 2012 Phase 2
    NCT00970580 Biogen Non-Small Cell Lung Cancer October 2009 Phase 1
    NCT01764087 Hanmi Pharmaceutical Company Limited Unspecified Adult Solid Tumor, Protocol Specific|Gastric Cancer|Breast Cancer December 2012 Phase 1|Phase 2
    NCT01015222 M.D. Anderson Cancer Center Advanced Cancer November 2009 Phase 1
    NCT01258192 Zhejiang Cancer Hospital|Second Affiliated Hospital, School of Medicine, Zhejiang University Esophageal Squamous Cell Carcinoma January 2011 Phase 2
    NCT01253681 Amgen Carcinoma|Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cancer November 2010 Phase 1
    NCT01636622 M.D. Anderson Cancer Center Advanced Cancers July 2012 Phase 1
    NCT01667211 Chinese Academy of Medical Sciences Uterine Cervical Cancer November 2011 Phase 2
    NCT00900627 AstraZeneca Neoplasms|Breast Neoplasms|Breast Cancer June 2009 Phase 1|Phase 2
    NCT02530489 M.D. Anderson Cancer Center|Genentech, Inc. Breast Cancer February 4, 2016 Phase 2
    NCT02124317 Chinese PLA General Hospital Advanced Pancreatic Cancer April 2014 Phase 2
    NCT02545010 National University Hospital, Singapore Ovarian Cancer September 2015 Phase 1
    NCT02769832 Muhammad Furqan|Celgene Corporation|University of Iowa Small Cell Lung Cancer (SCLC) August 2016 Phase 2
    NCT01701349 Mateon Therapeutics Anaplastic Thyroid Cancer March 2015 Phase 3
    NCT02241551 University of Pittsburgh Borderline Resectable Pancreatic Cancer December 2014 Phase 2
    NCT01830244 Barwon Health Breast Cancer April 2013 Phase 2
    NCT01454778 Patrick Kelly|Sanford Health Peripheral Vascular Disease April 2011
    NCT01203267 Shanghai Jiao Tong University School of Medicine|Fudan University|Ruijin Hospital Breast Cancer December 2007 Phase 2
    NCT01757288 University of Texas Southwestern Medical Center|Celgene STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER March 2013 Phase 1|Phase 2
    NCT02776917 Barbara Parker, MD|University of California, San Diego Breast Neoplasms January 2018 Phase 1
    NCT02244502 NovoCure Ltd. Ovarian Carcinoma September 2014 Phase 1|Phase 2
    NCT02229045 Sun Yat-sen University Gastric Caner November 2010 Phase 2
    NCT01839487 Halozyme Therapeutics Metastatic Pancreatic Cancer April 2013 Phase 2
    NCT02017015 Celgene Corporation Pancreatic Neoplasms December 2013 Phase 2
    NCT02486601 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)|Celgene Corporation Cancer of Stomach June 2015 Phase 2
    NCT02051751 Novartis Pharmaceuticals|Novartis Neoplasms, Breast Neoplasms, Head and Neck Neoplasms March 5, 2014 Phase 1
    NCT02135822 Chinese PLA General Hospital Advanced Pancreatic Cancer May 2014 Phase 2
    NCT00322881 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Massachusetts General Hospital Ovarian Cancer|Primary Peritoneal Carcinoma|Fallopian Tube Cancer|Mixed Tumor, Mesodermal April 2006 Phase 2
    NCT00891605 Abbott|Genentech, Inc. Solid Tumors July 2009 Phase 1
    NCT00772798 Herlev Hospital|Odense University Hospital Ovarian Cancer June 2007 Phase 2
    NCT01113476 M.D. Anderson Cancer Center Advanced Cancer April 27, 2010 Phase 1
    NCT02501902 Pfizer|Celgene Metastatic Pancreatic Ductal Adenocarcinoma November 23, 2015 Phase 1
    NCT01374620 Centre Oscar Lambret Cancer June 2011 Phase 1
    NCT02064829 Sorrento Therapeutics, Inc. Metastatic Breast Cancer|Locally Recurrent Breast Cancer March 2014
    NCT02059876 Guangdong General Hospital Breast Cancer November 2013 Phase 2
    NCT00585052 University of Iowa Ovarian Cancer August 2003 Phase 2
    NCT02317991 SCRI Development Innovations, LLC|Celgene Gastroesophageal Cancer May 5, 2015 Phase 2
    NCT00961181 Biotronik AG In-stent Coronary Artery Restenosis August 2009
    NCT02405910 West Virginia University|Celgene Corporation Non-small Cell Lung Cancer Phase 2
    NCT01982448 Dana-Farber Cancer Institute|Myriad Genetics, Inc.|Translational Breast Cancer Research Consortium Triple Negative Breast Cancer February 2014 Phase 2
    NCT01814163 Spanish Lung Cancer Group Nonsquamous Nonsmall Cell Neoplasm of Lung February 2011
    NCT01240655 Novartis Pharmaceuticals|Novartis Solid Tumors April 2011 Phase 1
    NCT00807573 Memorial Sloan Kettering Cancer Center Lung Cancer December 2008 Phase 2
    NCT01070706 Jungsil Ro|Pfizer|CJ HealthCare Corporation|National Cancer Center, Korea Breast Cancer March 2009 Phase 1|Phase 2
    NCT01641783 Yanqiao Zhang|The Third Affiliated Hospital of Harbin Medical University Gastric Adenocarcinoma July 2012 Phase 2
    NCT02134067 Taiho Oncology, Inc. Advanced Solid Tumors August 2014 Phase 1
    NCT02181634 PrECOG, LLC.|Celgene Corporation Cholangiocarcinoma December 9, 2014 Phase 2
    NCT02383251 ARCAGY/ GINECO GROUP|Novartis Ovarian Cancer June 2015 Phase 2
    NCT02058667 University of Kentucky Breast Cancer July 2014 Phase 1
    NCT02752685 New York University School of Medicine Breast Cancer June 2016
    NCT02274012 Columbia University|Boehringer Ingelheim HER-2 Positive Gastric Cancer|Gastrooesophageal Cancer|Esophageal Cancer May 29, 2014 Phase 2
    NCT00666692 Abbott Non-small Cell Lung Cancer April 2008 Phase 1
    NCT02226757 VU University Medical Center NSCLC|HER2-expression|EGFR-mutation August 2014 Phase 2
    NCT01179269 Loyola University|GlaxoSmithKline Non-small Cell Lung Cancer March 2010 Phase 2
    NCT02272738 Osaka Medical Center for Cancer and Cardiovascular Diseases Pancreatic Cancer August 2013 Phase 1
    NCT00717340 AVEO Pharmaceuticals, Inc. Metastatic Breast Cancer February 2009 Phase 1
    NCT01515306 Eli Lilly and Company Malignant Solid Tumor July 2012 Phase 2
    NCT02730247 Liza Villaruz, MD|University of Pittsburgh Non-small Cell Lung Cancer April 2017 Phase 2
    NCT01306942 Spanish Breast Cancer Research Group|Bristol-Myers Squibb Breast Cancer July 2011 Phase 1|Phase 2
    NCT00840450 New York University School of Medicine|Novartis Ovarian Cancer April 2007 Phase 2
    NCT01333852 Lucas Vieira dos Santos|Fundação de Amparo à Pesquisa do Estado de São Paulo|University of Campinas, Brazil|Barretos Cancer Hospital Head and Neck Neoplasms|Squamous Cell Carcinoma February 2011 Phase 2
    NCT02594371 Kinex Pharmaceuticals Inc Metastatic Breast Cancer December 2015 Phase 3
    NCT02289456 Celgene Carcinoma, Non-Small-Cell Lung April 28, 2015 Phase 2
    NCT02788981 University of Chicago Breast Cancer March 28, 2017 Phase 2
    NCT00654758 Abbott Non-small Cell Lung Cancer December 2007 Phase 1
    NCT02215447 Barwon Health|Specialised Therapeutics Australia|Deakin University|Australasian Gastro-Intestinal Trials Group Gastrointestinal Neuroendocrine Carcinomas May 2015 Phase 2
    NCT03223376 Hutchison Medipharma Limited|Sun Yat-sen University Advanced Gastric Cancer September 2017 Phase 3
    NCT00289835 Laval University|Boston Scientific Corporation Coronary Artery Bypass Grafting February 2006 Phase 4
    NCT00096668 OncoGenex Technologies Breast Cancer October 2004 Phase 2
    NCT02338115 University of Michigan Cancer Center Breast Cancer May 2014
    NCT01405235 Institut fuer Frauengesundheit|GlaxoSmithKline|Schantl Pharma Service, Germany Recurrent, Persistent or Metastasized Cervical Cancer September 2006 Phase 3
    NCT02229058 Sun Yat-sen University Gastric Cancer November 2010 Phase 2
    NCT03085056 Memorial Sloan Kettering Cancer Center|Novartis Anaplastic Thyroid Cancer March 15, 2017 Early Phase 1
    NCT00254891 Pfizer Carcinoma, Non-Small-Cell Lung November 2005 Phase 3
    NCT02250326 Celgene Carcinoma, Non-Small-Cell Lung January 7, 2015 Phase 2
    NCT01171170 Dutch Society of Physicians for Pulmonology and Tuberculosis Non Small Cell Lung Cancer September 2010 Phase 2
    NCT00606515 Shandong Luye Pharmaceutical Co., Ltd.|Nanjing Sike Pharmaceutical Co., Ltd. Cancer February 2008 Phase 4
    NCT00622466 University of Texas Southwestern Medical Center Breast Cancer October 2007 Phase 2
    NCT00611962 Sanofi Neoplasms, Germ Cell and Embryonal December 2000 Phase 2
    NCT01011075 New Mexico Cancer Care Alliance|Fred Hutchinson Cancer Research Center|Novartis Non-small Cell Lung Cancer August 2009 Phase 2
    NCT00124943 Celgene Corporation|Celgene Coronary Restenosis July 2005 Phase 1|Phase 2
    NCT00268970 Agennix Non-small Cell Lung Cancer December 2005 Phase 2
    NCT02406170 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Esophageal Neoplasms|Stomach Neoplasms|Neoplasm Metastasis April 2015 Phase 1|Phase 2
    NCT00652119 M.D. Anderson Cancer Center|Genentech, Inc.|National Cancer Institute (NCI) Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer February 2008
    NCT02737709 Sun Yat-sen University Non-small Cell Lung Cancer March 2016 Phase 2
    NCT00531687 Rigshospitalet, Denmark Testicular Cancer September 2007 Phase 2
    NCT00350025 Fox Chase Cancer Center|Bristol-Myers Squibb Urologic Neoplasm August 2006 Phase 2
    NCT01778803 Verastem, Inc. Ovarian Cancer February 26, 2013 Phase 1
    NCT02005315 OncoMed Pharmaceuticals, Inc. Pancreatic Cancer|Stage IV Pancreatic Cancer September 2013 Phase 1
    NCT01522768 Memorial Sloan Kettering Cancer Center|Boehringer Ingelheim|University of Southern California|Dana-Farber Cancer Institute|United States Department of Defense Esophageal Cancer|Gastric Cancer March 2012 Phase 2
    NCT01617668 Novartis Pharmaceuticals|Novartis Breast Cancer August 2012 Phase 2
    NCT01091428 Millennium Pharmaceuticals, Inc.|Takeda Ovarian Carcinoma|Fallopian Tube Cancer|Peritoneal Cancer|Breast Carcinoma May 2010 Phase 2
    NCT01608009 Imperial College London|GlaxoSmithKline Ovarian Neoplasm July 2012 Phase 1
    NCT02267707 Celgene Corporation|Celgene Pancreatic Neoplasms|Cholestasis May 2015 Phase 1
    NCT02092363 OncoMed Pharmaceuticals, Inc. Ovarian Cancer January 2014 Phase 1
    NCT00670436 University of Ulm|B. Braun Melsungen AG Coronary Artery Disease|Chronic Total Occlusion|Native Coronary Artery February 2008 Phase 2
    NCT00502203 M.D. Anderson Cancer Center Mixed Tumor, Mullerian August 2001 Phase 2
    NCT02593175 M.D. Anderson Cancer Center|Amgen Breast Cancer August 2016 Phase 2
    NCT00511849 Pfizer Neoplasms November 2005 Phase 1
    NCT00020761 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) Esophageal Cancer|Gastric Cancer April 2000 Phase 2
    NCT01108055 Sandy Srinivas|GlaxoSmithKline|Stanford University Bladder Cancer|Bladder (Urothelial, Transitional Cell) Cancer|Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)|Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)|Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable April 2010 Phase 2
    NCT01739894 National University Hospital, Singapore Gastric Cancer January 2013 Phase 2
    NCT02187991 US Oncology Research|Millennium Pharmaceuticals, Inc. Breast Cancer|Breast Carcinoma|Breast Tumors|Malignant Neoplasm of Breast February 2015 Phase 2
    NCT01326767 Central European Society for Anticancer Drug Research|Saladax Biomedical, Inc.|Cantonal Hospital of St. Gallen|University Hospital, Basel, Switzerland|Assign Data Management and Biostatistics GmbH|Wake Forest University|University Hospital, Essen Carcinoma, Non-Small-Cell Lung March 2011 Phase 3
    NCT01023204 Bristol-Myers Squibb Breast Cancer October 2002 Phase 2
    NCT00768469 Puma Biotechnology, Inc. Advanced Malignant Solid Tumors October 2008 Phase 1
    NCT00738361 Ohio State University Comprehensive Cancer Center|National Comprehensive Cancer Network|Celgene Corporation Intraocular Melanoma August 2008 Phase 2
    NCT01572727 Novartis Pharmaceuticals|Novartis Breast Cancer August 2012 Phase 2|Phase 3
    NCT00881101 Nanjing Sike Pharmaceutical Co., Ltd. Solid Tumor April 2009 Phase 1
    NCT00971945 Bristol-Myers Squibb Breast Cancer June 2005 Phase 2
    NCT00971867 Bristol-Myers Squibb Head and Neck Cancer August 2006 Phase 2
    NCT02391662 Asociación de Oncología Médica del Hospital de Cruces Pancreatic Carcinoma Metastatic May 2015 Phase 2
    NCT01024062 Bristol-Myers Squibb Non-Small Cell Lung Cancer December 2002 Phase 2
    NCT01647828 OncoMed Pharmaceuticals, Inc. Stage IV Pancreatic Cancer October 2012 Phase 1|Phase 2
    NCT00313768 Pfizer Carcinoma, Non-Small-Cell Lung December 2005 Phase 2
    NCT02207361 Tianjin Medical University Cancer Institute and Hospital Metastatic Breast Cancer December 2013 Phase 4
    NCT01000896 AstraZeneca Cancer|Non Small Cell Lung Cancer|Epithelial Ovarian Cancer January 2010 Phase 1
    NCT01495247 Novartis Pharmaceuticals|Novartis Inoperable Locally Advanced Breast Cancer|Metastatic Breast Cancer (MBC) January 2012 Phase 1|Phase 2
    NCT02756013 Case Comprehensive Cancer Center Gynecologic Malignancies April 2016 Phase 2
    NCT01024101 Bristol-Myers Squibb Head and Neck Cancer January 2004 Phase 2
    NCT00855764 Bristol-Myers Squibb Head and Neck Cancer October 2005 Phase 2
    NCT02133612 Chinese Academy of Medical Sciences Esophageal Cancer December 2007 Phase 2
    NCT01248403 Krankenhaus Nordwest Advanced Gastric Cancer|Esophagogastric Junction Cancer October 2011 Phase 3
    NCT01196234 Asan Medical Center|AstraZeneca Non Small Cell Lung Cancer December 2009 Phase 2
    NCT00823186 Chang Gung Memorial Hospital|Sinphar Pharmaceutical Co., Ltd Cervical Cancer February 2009 Phase 1
    NCT00626561 M.D. Anderson Cancer Center|Genentech, Inc. Cervical Cancer|Uterine Cancer February 2008 Phase 2
    NCT00971841 Bristol-Myers Squibb Esophageal Cancer March 2008 Phase 2
    NCT01276041 Memorial Sloan Kettering Cancer Center|Genentech, Inc.|University of Pennsylvania Breast Cancer January 2011 Phase 2
    NCT01868984 Englewood Hospital and Medical Center|Spectranetics Corporation Fistula Stenosis May 2013 Phase 2
    NCT02923739 M.D. Anderson Cancer Center|Genentech, Inc. Malignant Neoplasms of Female Genital Organs May 5, 2017 Phase 2
    NCT01980277 Institut Paoli-Calmettes Breast Cancer January 2014 Phase 1|Phase 2
    NCT00034541 ImClone LLC|University of Colorado, Denver|Greenwich Hospital|IUPUI, Indianapolis, IN Carcinoma, Non-Small-Cell Lung December 2000 Phase 1|Phase 2
    NCT01014351 SCRI Development Innovations, LLC|Novartis Metastatic Melanoma February 2010 Phase 2
    NCT00556088 SCRI Development Innovations, LLC|Novartis Solid Tumors December 2007 Phase 1
    NCT02432365 Chang Gung Memorial Hospital|Asian Gynecologic Oncology Group|Taiwanese Gynecologic Oncology Group Cervical Cancer February 2015 Phase 2
    NCT02340117 SynerGene Therapeutics, Inc. Metastatic Pancreatic Cancer January 2015 Phase 2
    NCT01484080 Centro Nacional de Investigaciones Oncologicas CARLOS III|Hospital Universitario de Fuenlabrada|M.D. Anderson Cancer Center|Hospital Universitari de Bellvitge|Grupo Espanol de Investigacion del Cancer de Mama Breast Cancer October 2011 Phase 1|Phase 2
    NCT03083613 Chinese Academy of Medical Sciences Gastric Cancer|Gastroesophageal Junction Adenocarcinoma May 2015 Phase 2
    NCT00006227 Gynecologic Oncology Group|National Cancer Institute (NCI) Adult Type Ovarian Granulosa Cell Tumor|Ovarian Gynandroblastoma|Ovarian Sertoli-Leydig Cell Tumor|Ovarian Sex Cord Tumor With Annular Tubules|Ovarian Steroid Cell Tumor November 2000 Phase 2
    NCT01621243 Momenta Pharmaceuticals, Inc. Metastatic Pancreatic Cancer May 2012 Phase 1|Phase 2
    NCT01839773 Daehwa Pharmaceutical Co., Ltd. Stage IV Gastric Cancer March 2013 Phase 3
    NCT02436993 University of California, Irvine Breast Carcinoma April 2015 Phase 2
    NCT00465907 Sidney Kimmel Comprehensive Cancer Center Lung Cancer May 2003 Phase 2
    NCT02628132 King Faisal Specialist Hospital & Research Center|AstraZeneca Breast Cancer July 2016 Phase 1|Phase 2
    NCT00544648 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Lung Cancer November 2007 Phase 1|Phase 2
    NCT02138812 Bayer Medical Oncology May 9, 2014 Phase 1
    NCT00686322 Taipei Veterans General Hospital, Taiwan Non-small-cell Lung Cancer April 2008 Phase 4
    NCT00532857 Jungsil Ro|National Cancer Center, Korea Breast Cancer March 2007 Phase 2
    NCT02423603 Queen Mary University of London|AstraZeneca|Cancer Research UK Metastatic Breast Cancer May 2014 Phase 2
    NCT01224652 Korean Cancer Study Group|Boryung Pharmaceutical Co., Ltd Gastric Cancer Phase 3
    NCT03121352 Case Comprehensive Cancer Center Metastatic Triple Negative Breast Cancer May 19, 2017 Phase 2
    NCT01447706 Merrimack Pharmaceuticals|Sanofi Epithelial Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer October 2011 Phase 2
    NCT02300935 SCRI Development Innovations, LLC|Celgene Corporation|GlaxoSmithKline Melanoma January 2016 Phase 1
    NCT01407562 Rutgers, The State University of New Jersey|National Cancer Institute (NCI)|Rutgers Cancer Institute of New Jersey|GlaxoSmithKline Unspecified Adult Solid Tumor - Protocol Specific|Breast Cancer - Female August 2011 Phase 1
    NCT01548924 Centro Nacional de Investigaciones Oncologicas CARLOS III|Hospital Universitario de Fuenlabrada|M.D. Anderson Cancer Center|Hospital Universitari de Bellvitge Solid Tumors April 2012 Phase 1
    NCT00983424 Northwestern University|Avon Foundation Metastatic Breast Cancer February 2010 Phase 1
    NCT02301143 Celgene Pancreatic Neoplasms April 2015 Phase 2
    NCT00088829 Georgetown University|National Cancer Institute (NCI) Breast Cancer April 2001 Phase 2
    NCT01088815 Sidney Kimmel Comprehensive Cancer Center|Stand Up To Cancer|Genentech, Inc.|Celgene Corporation Metastatic Pancreatic Cancer September 2010 Phase 2
    NCT01565499 Spanish Breast Cancer Research Group|Celgene Corporation Breast Cancer June 2013 Phase 2
    NCT01962948 Fox Chase Cancer Center|National Cancer Institute (NCI) Recurrent Fallopian Tube Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Primary Peritoneal Cavity Cancer October 9, 2013 Phase 1|Phase 2
    NCT02040454 Englewood Hospital and Medical Center Arteriovenous Access Fistula Stenosis March 2014 Phase 2
    NCT00662311 University of Washington|National Cancer Institute (NCI) Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer March 2008 Phase 1|Phase 2
    NCT02058433 Caicun Zhou|Tongji University Non-Small Cell Lung Cancer January 2014 Phase 3
    NCT01325441 Boston Biomedical, Inc Cancer April 2011 Phase 1|Phase 2
    NCT02240212 Novartis Pharmaceuticals|Novartis Cancer October 2014 Phase 1
    NCT02672475 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Estrogen Receptor Negative|HER2/Neu Negative|Progesterone Receptor Negative|Recurrent Breast Carcinoma|Stage IV Breast Cancer|Triple-Negative Breast Carcinoma March 2016 Phase 1
    NCT00756847 Sanofi Cancer|Non-Small Cell Lung Cancer|Endometrial Carcinoma|Ovarian Carcinoma September 2008 Phase 1
    NCT02152137 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|Daiichi Sankyo Inc. Anaplastic Thyroid Cancer|Recurrent Thyroid Cancer September 2014 Phase 2
    NCT01756183 Zhejiang Cancer Hospital Surgically-Created Resection Cavity|Drug Safety September 2011 Phase 2
    NCT00085358 National Cancer Institute (NCI) Brenner Tumor|Fallopian Tube Cancer|Ovarian Carcinosarcoma|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mixed Epithelial Carcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Primary Peritoneal Cavity Cancer|Stage II Ovarian Epithelial Cancer|Stage III Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer May 2004 Phase 1
    NCT00030368 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific November 2001 Phase 1
    NCT02474173 National Cancer Institute (NCI) Estrogen Receptor Negative|HER2/Neu Negative|Progesterone Receptor Negative|Recurrent Breast Carcinoma|Stage III Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Triple-Negative Breast Carcinoma January 15, 2016 Phase 1
    NCT02174887 Institut Paoli-Calmettes Pancreatic Adenocarcinoma September 2014 Phase 1
    NCT00542451 Eric Winer, MD|Brigham and Women's Hospital|Beth Israel Deaconess Medical Center|Massachusetts General Hospital|Genentech, Inc.|Dana-Farber Cancer Institute Breast Cancer|Carcinoma of the Breast October 2007 Phase 2
    NCT02001974 Dompé Farmaceutici S.p.A|PRA Health Sciences Metastatic Breast Cancer January 2012 Phase 1
    NCT02993731 Boston Biomedical, Inc Carcinoma, Pancreatic Ductal December 2016 Phase 3
    NCT01200342 M.D. Anderson Cancer Center|Genta Incorporated Melanoma December 2010 Phase 2
    NCT00660218 State University of New York - Upstate Medical University|CTI BioPharma Carcinoma, Squamous Cell March 2008 Phase 1|Phase 2
    NCT02564146 AIO-Studien-gGmbH|ClinAssess GmbH|Celgene Corporation Metastatic Pancreatic Cancer|Adenocarcinoma of the Pancreas December 2016 Phase 2
    NCT00003092 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific September 1997 Phase 3
    NCT01770301 ARCAGY/ GINECO GROUP|Roche Pharma AG Ovarian Sex-cord Stromal Tumor February 2013 Phase 2
    NCT00499252 Gynecologic Oncology Group|National Cancer Institute (NCI) Fallopian Tube Carcinoma|Primary Peritoneal Carcinoma|Recurrent Ovarian Carcinoma June 2007 Phase 2
    NCT00814086 Gynecologic Oncology Group|National Cancer Institute (NCI) Chemotherapeutic Agent Toxicity|Endometrial Adenocarcinoma|Fallopian Tube Carcinoma|Gastrointestinal Complication|Malignant Ovarian Mixed Epithelial Tumor|Neurotoxicity Syndrome|Ovarian Brenner Tumor|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Primary Peritoneal Carcinoma|Stage II Ovarian Cancer|Stage III Ovarian Cancer|Stage IV Ovarian Cancer|Undifferentiated Ovarian Carcinoma February 2009 Phase 1
    NCT01700010 University of Michigan Cancer Center|GlaxoSmithKline Urothelial Cancer|Bladder Cancer November 2012 Phase 2
    NCT01416558 German Breast Group Metastatic Breast Cancer July 2011 Phase 2
    NCT01746771 Hanmi Pharmaceutical Company Limited|National OncoVenture HER-2 Positive Advanced Gastric Cancer November 2012 Phase 1|Phase 2
    NCT01297452 Memorial Sloan Kettering Cancer Center|Novartis Pharmaceuticals|Sai Life Sciences Solid Tumors February 15, 2011 Phase 1
    NCT02350517 Yuhong Li|Sun Yat-sen University Esophageal Squamous Cell Carcinoma January 2015 Phase 2
    NCT02425891 Hoffmann-La Roche Triple Negative Breast Cancer June 23, 2015 Phase 3
    NCT02834975 Marilyn Huang|Merck Sharp & Dohme Corp.|University of Miami Fallopian Tube Carcinoma|Peritoneal Carcinoma|Epithelial Ovarian Cancer December 22, 2016 Phase 2
    NCT00096343 University of Alabama at Birmingham|National Cancer Institute (NCI) Breast Cancer October 2002 Phase 2
    NCT00881816 Nanjing Sike Pharmaceutical Co., Ltd. Advanced Gastric Carcinoma April 2009 Phase 1
    NCT00057863 National Cancer Institute (NCI) Cervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Cervical Squamous Cell Carcinoma|Recurrent Cervical Carcinoma|Stage IVA Cervical Cancer|Stage IVB Cervical Cancer January 2003 Phase 2
    NCT01097746 M.D. Anderson Cancer Center|Genentech, Inc. Epithelial Ovarian Cancer|Primary Peritoneal Carcinoma|Fallopian Tube Cancer April 2010 Phase 2
    NCT00356811 GlaxoSmithKline Neoplasms, Breast May 2006 Phase 2
    NCT01421472 Merrimack Pharmaceuticals|Sanofi ER Positive, Her2 Negative Breast Cancer Patients|Triple Negative Breast Cancer Patients August 2011 Phase 2
    NCT00100139 INSYS Therapeutics Inc Neoplasm November 2004 Phase 1
    NCT00003130 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific November 1997 Phase 2
    NCT01934634 US Oncology Research|Novartis Pharmaceuticals|Delta Clinical Research, LLC Metastatic Pancreatic Cancer March 2014 Phase 1
    NCT00079430 National Cancer Institute (NCI) Brenner Tumor|Fallopian Tube Cancer|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mixed Epithelial Carcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Primary Peritoneal Cavity Cancer|Stage II Ovarian Epithelial Cancer|Stage III Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer June 2004 Phase 1
    NCT01964430 Celgene Pancreatic Neoplasms|Digestive System Neoplasms|Neoplasms by Site|Neoplasms|Endocrine Gland Neoplasms|Pancreatic Diseases|Digestive System Diseases|Endocrine System Diseases|Gemcitabine|Antimetabolites, Antineoplastic March 1, 2014 Phase 3
    NCT00300885 Bayer Carcinoma, Non-Small Cell Lung February 2006 Phase 3
    NCT00075270 GlaxoSmithKline Neoplasms, Breast January 2004 Phase 3
    NCT00486954 GlaxoSmithKline Neoplasms, Gastrointestinal Tract July 2007 Phase 3
    NCT01494688 Hoffmann-La Roche Advanced Solid Tumors December 2011 Phase 1
    NCT00217607 UNICANCER Sarcoma February 2005 Phase 2
    NCT00866528 GlaxoSmithKline Lung Cancer, Non-Small Cell July 2009 Phase 1
    NCT01161186 University of California, San Francisco|Celgene Corporation Pancreatic Neoplasms|Pancreatic Cancer|Adenocarcinoma July 2010 Phase 1
    NCT00005646 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer April 2000 Phase 2
    NCT03051373 Chinese PLA General Hospital Carcinoma, Transitional Cell April 1, 2017 Phase 2
    NCT01599078 Midwest Cardiovascular Research Foundation|Spectranetics Corporation Restenosis|Peripheral Arterial Disease January 2012
    NCT00003120 Southwest Oncology Group|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer November 1997 Phase 3
    NCT02615730 Yonsei University Advanced Gastric Adenocarcinoma February 2016 Phase 1|Phase 2
    NCT00653952 Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Sequus Pharmaceuticals|ALZA Ovarian Neoplasms May 1997 Phase 3
    NCT01263145 National Cancer Institute (NCI) Adult Solid Neoplasm|Recurrent Breast Carcinoma|Stage IV Breast Cancer January 5, 2011 Phase 1
    NCT02945800 H. Lee Moffitt Cancer Center and Research Institute|National Pediatric Cancer Foundation Osteosarcoma|Ewing Sarcoma|Rhabdomyosarcoma|Soft Tissue Sarcoma October 21, 2016 Phase 2
    NCT02077881 NewLink Genetics Corporation Metastatic Pancreatic Adenocarcinoma|Metastatic Pancreatic Cancer August 2014 Phase 1|Phase 2
    NCT00010257 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Thymoma|Thymic Carcinoma February 2001 Phase 2
    NCT00453167 National Cancer Center, Korea Lung Cancer December 2005 Phase 2
    NCT00540514 Celgene Non-Small Cell Lung Carcinoma November 2007 Phase 3
    NCT02382263 PH Research, S.L. Advanced Pancreatic Cancer April 2013 Phase 1|Phase 2
    NCT00031694 National Cancer Institute (NCI) Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer January 2002 Phase 2
    NCT00358163 Massachusetts General Hospital|Novartis Pharmaceuticals|Beth Israel Deaconess Medical Center|Brigham and Women's Hospital|Dana-Farber Cancer Institute Metastatic Non-hematologic Malignancies April 2006 Phase 1
    NCT01704690 Peking University Esophageal Cancer August 2012 Phase 2|Phase 3
    NCT02513563 H. Lee Moffitt Cancer Center and Research Institute Lung Cancer September 8, 2015 Phase 2
    NCT02569489 HUYA Bioscience International Breast Cancer December 2015 Phase 1
    NCT01423695 WiSP Wissenschaftlicher Service Pharma GmbH|Bristol-Myers Squibb|Roche Pharma AG Metastatic Breast Cancer February 2001 Phase 2
    NCT01199055 Daiichi Sankyo Co., Ltd.|ICON Clinical Research|Daiichi Sankyo Inc. Carcinoma, Non-Small-Cell Lung March 2010 Phase 1
    NCT02396108 National University Hospital, Singapore Breast Cancer March 2015 Phase 1|Phase 2
    NCT02379247 University of Kansas Medical Center|Novartis Pharmaceuticals Breast Cancer February 2015 Phase 1|Phase 2
    NCT02366949 Bayer Medical Oncology February 27, 2015 Phase 1
    NCT02826161 Boston Biomedical, Inc Carcinoma, Non-Small-Cell Lung November 2016 Phase 3
    NCT02630199 Samsung Medical Center Refractory Cancer December 2015 Phase 1
    NCT00059787 National Cancer Institute (NCI) Brenner Tumor|Fallopian Tube Cancer|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Stage III Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer April 2003 Phase 2
    NCT02312661 University Medical Center Groningen Epithelial Ovarian Cancer October 2015 Phase 1
    NCT01525602 Plexxikon Solid Tumors May 2012 Phase 1
    NCT02783222 Fondazione Sandro Pitigliani Breast Cancer November 2012 Phase 2
    NCT01235897 University of California, San Francisco|Merck Sharp & Dohme Corp. Advanced Solid Tumors|Tumors|Cancer March 2011 Phase 1
    NCT00544232 German Breast Group|Pharmacia|Amgen|Bristol-Myers Squibb Breast Cancer August 2002 Phase 3
    NCT02392637 M.D. Anderson Cancer Center|Celgene Biliary Tract Cancer April 2, 2015 Phase 2
    NCT01411410 Bayer Neoplasms August 2011 Phase 1
    NCT02501603 Yonsei University Gastric Cancer|Gastroesophageal Junction Cancer July 2016 Phase 2
    NCT02392507 Eli Lilly and Company|Celgene Carcinoma, Non-small-Cell Lung October 2015 Phase 2
    NCT02440425 H. Lee Moffitt Cancer Center and Research Institute|Merck Sharp & Dohme Corp. Ovarian Cancer August 12, 2015 Phase 2
    NCT02060253 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI)|Synta Pharmaceuticals Corp.|New York University Cancer Institute HER2-positive Breast Cancer|Male Breast Cancer|Recurrent Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer April 2014 Phase 1
    NCT02689427 M.D. Anderson Cancer Center|Astellas Pharma US, Inc. Breast Cancer September 2016 Phase 2
    NCT01851174 Western Regional Medical Center Pancreatic Carcinoma Non-resectable|Stage IV Pancreatic Cancer February 2013 Phase 2
    NCT01705483 Astellas Pharma Global Development, Inc.|Astellas Pharma Inc Pharmacokinetics of ASP9853|Non-hematologic Malignancies August 2012 Phase 1
    NCT00152477 UCB Pharma Carcinoma|Non-Squamous Non-Small-Cell Lung Cancer August 2005 Phase 2
    NCT00353717 Hadassah Medical Organization Breast Neoplasms November 2006 Phase 1|Phase 2
    NCT00991796 Daiichi Sankyo Inc. Non-small Cell Lung Cancer June 2009 Phase 2
    NCT02069158 Cristiana Sessa|Oncology Institute of Southern Switzerland Breast Cancer|NSCLC|Ovary Cancer|Endometrial Cancer|Small Cell Lung Cancer (SCLC)|Head and Neck (HNSCC) April 2014 Phase 1
    NCT01722968 Theodoros Foukakis|Karolinska University Hospital Breast Cancer November 2012 Phase 2
    NCT00888615 Gynecologic Oncology Group|National Cancer Institute (NCI) Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Tumor|Primary Peritoneal Serous Adenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recu December 2010 Phase 2
    NCT01852292 Novartis Pharmaceuticals|Novartis Head and Neck Squamous Cell Carcinoma October 1, 2013 Phase 2
    NCT00337532 Bristol-Myers Squibb Head and Neck Cancer May 2005 Phase 2|Phase 3
    NCT01174238 Adil Daud|University of California, San Francisco Melanoma July 2010 Phase 2
    NCT00937560 Hoffmann-La Roche Ovarian Cancer June 2009 Phase 2
    NCT02753998 Assistance Publique - Hôpitaux de Paris|Bard Peripheral Vascular (balloons provider) Angioplasty|Stenosis of Arteriovenous Fistula December 2016 Phase 3
    NCT02924909 Instituto Nacional de Cancer, Brazil Esophageal Cancer|Induction Chemotherapy November 2016 Phase 2
    NCT00753909 Hellenic Oncology Research Group Non Small Cell Lung Cancer November 2008 Phase 2
    NCT02276560 UNC Lineberger Comprehensive Cancer Center Stage IIIA Non-Small Cell Lung Cancer January 2015 Phase 2
    NCT00231868 Montefiore Medical Center Uterine Cancer December 2001 Phase 2
    NCT00507429 Mateon Therapeutics Anaplastic Thyroid Cancer August 2007 Phase 2|Phase 3
    NCT00603941 Daiichi Sankyo Inc. Anaplastic Thyroid Cancer January 2008 Phase 1|Phase 2
    NCT02163694 AbbVie Metastatic Breast Cancer July 2014 Phase 3
    NCT01858883 Incyte Corporation Metastatic Cancer|Metastatic Pancreatic Cancer June 2013 Phase 1|Phase 2
    NCT01493310 University of Chicago Male Breast Cancer|Recurrent Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer November 2011 Phase 1
    NCT02716038 Columbia University|Genentech, Inc.|Celgene Corporation Carcinoma, Non-Small-Cell Lung June 7, 2016 Phase 2
    NCT01677559 Washington University School of Medicine Adenocarcinoma|Pancreatic Neoplasms May 7, 2013 Phase 1
    NCT00887575 SCRI Development Innovations, LLC|Pfizer Breast Cancer June 2009 Phase 1|Phase 2
    NCT03193853 Baylor Research Institute|Takeda Triple Negative Breast Cancer July 5, 2017 Phase 2
    NCT01351350 Millennium Pharmaceuticals, Inc. Advanced Solid Malignancies|Hematologic Malignancies March 2011 Phase 1
    NCT00873119 Onxeo|Spectrum Pharmaceuticals, Inc Carcinoma of Unknown Primary February 2009 Phase 2
    NCT01055028 Stanford University|Genentech, Inc. Angiosarcomas|Soft Tissue Sarcoma February 2010 Phase 2
    NCT00825201 City of Hope Medical Center|National Cancer Institute (NCI)|National Comprehensive Cancer Network Ovarian Cancer|Peritoneal Cavity Cancer|Unspecified Adult Solid Tumor, Protocol Specific January 2009 Phase 1
    NCT00635050 University of Alabama at Birmingham|Ortho Biotech, Inc.|Genentech, Inc. Invasive Breast Cancer March 2008 Phase 2
    NCT00558636 Bayer Carcinoma, Non-Small-Cell Lung September 2007 Phase 3
    NCT00096291 Massachusetts General Hospital|National Cancer Institute (NCI) Breast Cancer February 2000 Phase 2
    NCT00006018 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific July 2000 Phase 1
    NCT02824575 Montefiore Medical Center|Deciphera Pharmaceuticals LLC|Albert Einstein College of Medicine, Inc. Breast Cancer|Breast Adenocarcinoma|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|Recurrent Breast Carcinoma|Stage IV Breast Cancer July 2016 Phase 1
    NCT02050178 OncoMed Pharmaceuticals, Inc. Pancreatic Cancer|Stage IV Pancreatic Cancer November 2013 Phase 1
    NCT01745367 AVEO Pharmaceuticals, Inc.|Astellas Pharma Inc Triple Negative Breast Cancer November 2012 Phase 2
    NCT02827201 Federation Francophone de Cancerologie Digestive|UNICANCER|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR) Metastatic Pancreatic Cancer November 2015 Phase 2
    NCT01160601 Peregrine Pharmaceuticals Non-Squamous Non-Small Cell Lung Cancer June 2010 Phase 2
    NCT02881125 University of Washington|National Cancer Institute (NCI) Small Cell Carcinoma November 3, 2016 Phase 1
    NCT02861690 Sun Yat-sen University Esophageal Carcinoma January 2010 Phase 2
    NCT01220154 David O'Malley|Genentech, Inc.|Ohio State University Comprehensive Cancer Center Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer|No Prior Chemotherapy October 2010 Phase 1
    NCT00561119 Samsung Medical Center|Korean Cancer Study Group Advanced Breast Cancer May 2007 Phase 3
    NCT01264328 Grupo Español de Tratamiento de Tumores de Cabeza y Cuello|Amgen|Trial Form Support S.L. Head and Neck Cancer December 2010 Phase 2
    NCT00313599 University of California, San Francisco|National Cancer Institute (NCI) Bladder Cancer|Brain and Central Nervous System Tumors|Breast Cancer|Esophageal Cancer|Extragonadal Germ Cell Tumor|Gastric Cancer|Lung Cancer|Ovarian Cancer|Prostate Cancer February 2006 Phase 1
    NCT00002913 National Cancer Institute (NCI) Brenner Tumor|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mixed Epithelial Carcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Stage III Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer December 1996 Phase 1
    NCT01007578 Bayer Peripheral Arterial Disease|Stenotic Femoro-popliteal Arteries|Occluded Femoro-popliteal Arteries|Atherosclerosis September 2007 Phase 1
    NCT02308553 Prof. Dr. med. Dirk Schadendorf|Boehringer Ingelheim|medac GmbH|Alcedis GmbH|University Hospital, Essen Cutaneous Malignant Melanoma January 2015 Phase 1|Phase 2
    NCT01249443 AIDS Malignancy Consortium|National Cancer Institute (NCI)|The EMMES Corporation|University of Arkansas HIV Infection|Recurrent Anal Cancer|Recurrent Breast Cancer|Recurrent Esophageal Cancer|Recurrent Gastric Cancer|Recurrent Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Non-small Cell Lung Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recur November 2013 Phase 1
    NCT02525653 Memorial Sloan Kettering Cancer Center|Celgene Corporation|Miami Cancer Institute Lung Cancer|Untreated Stage IV or Recurrent Squamous Cell Lung Cancers August 2015 Phase 2
    NCT00728845 University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Rutgers, The State University of New Jersey Lung Cancer June 16, 2008 Phase 1|Phase 2
    NCT01120158 Hellenic Oncology Research Group|University Hospital of Crete Breast Cancer September 2009 Phase 2
    NCT01433614 Thomas Hatschek|Karolinska University Hospital Metastatic Breast Cancer December 2002 Phase 3
    NCT02632305 AHS Cancer Control Alberta|Celgene Unresectable Biliary Tract Cancer July 2016 Phase 2
    NCT00702299 University of Arizona|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer September 2007 Phase 1
    NCT00317200 Hoosier Cancer Research Network|Genentech, Inc.|Walther Cancer Institute Small Cell Lung Cancer April 2006 Phase 2
    NCT00629499 SCRI Development Innovations, LLC|Celgene Corporation Breast Cancer April 2008 Phase 2
    NCT00022633 Southwest Oncology Group|National Cancer Institute (NCI) Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral Cancer July 2001 Phase 2
    NCT01223443 Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec|Boston Scientific Corporation|Canadian Institutes of Health Research (CIHR) Coronary Artery Bypass Grafting April 2010 Phase 4
    NCT01236716 Chinese Society of Lung Cancer Carcinoma, Non-Small-Cell Lung November 2010 Phase 2
    NCT00588237 Memorial Sloan Kettering Cancer Center|Genentech, Inc. Ovarian Cancer|Primary PERITONEUM|Fallopian Tube Cancer August 2006 Phase 2
    NCT01625286 AstraZeneca Advanced or Metastatic Breast Cancer|ER+ve Advanced or Metastatic Breast Cancer October 3, 2012 Phase 1|Phase 2
    NCT01924533 AstraZeneca Gastric Cancer September 2013 Phase 3
    NCT02767557 Herlev Hospital|Celgene Unresectable Pancreatic Carcinoma January 26, 2017 Phase 2
    NCT00154726 National Taiwan University Hospital Locally Advanced and Recurrent/Metastatic Gastric Cancer April 1997 Phase 2
    NCT02283372 Washington University School of Medicine Pancreatic Cancer January 21, 2015 Phase 1
    NCT02891018 Shandong Branden Med.Device Co.,Ltd|Fudan University In-stent Restenosis December 2015 Phase 3
    NCT00062010 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Lung Cancer February 2004 Phase 2
    NCT02311907 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Chemotherapeutic Agent Toxicity|Neuropathy|Neurotoxicity Syndrome|Pain|Stage IIIA Fallopian Tube Cancer|Stage IIIA Ovarian Cancer|Stage IIIA Primary Peritoneal Cancer|Stage IIIB Fallopian Tube Cancer|Stage IIIB Ovarian Cancer|Stage IIIB Primary Peritoneal Cancer|Stage IIIC Fallopian Tube Cancer|Stage IIIC Ovarian Cancer|Stage IIIC Primary Peritoneal Cancer|Stage IV Fallopian Tube Cancer|Stage IV Ovarian Cancer|Stage IV Primary Peritoneal Cancer December 2009 Phase 3
    NCT00617370 Memorial Sloan Kettering Cancer Center|Amgen|Pfizer Breast Cancer|Adenocarcinoma of the Breast November 2004
    NCT01728441 Provascular GmbH|William Cook Europe Peripheral Artery Disease October 2012
    NCT02911350 New York University School of Medicine Prostate Cancer May 2000 Phase 1
    NCT02799862 iOMEDICO AG|Celgene Corporation Carcinoma, Non-Small-Cell Lung August 2016
    NCT00178256 University of Rochester Carcinoma, Non-Small-Cell Lung June 1998 Phase 1|Phase 2
    NCT00687817 Peregrine Pharmaceuticals Non-small Cell Lung Cancer June 2008 Phase 2
    NCT01138046 GlaxoSmithKline Neoplasms, Breast April 2010 Phase 2
    NCT02999477 Dana-Farber Cancer Institute|Merck Sharp & Dohme Corp. Breast Cancer February 23, 2017 Phase 2
    NCT02016287 Shen Lin|Peking University Esophageal Squamous Cell Cancer|Elderly Patients December 2013 Phase 2
    NCT01034189 National Taiwan University Hospital Esophageal Cancer October 2008 Phase 2
    NCT00238420 National Cancer Institute (NCI) Bladder Urothelial Carcinoma|Stage I Bladder Cancer|Stage II Bladder Cancer|Stage III Bladder Cancer July 2005 Phase 1|Phase 2
    NCT01136031 Seoul National University Hospital Advanced Gastric Cancer January 2008 Phase 1|Phase 2
    NCT02370238 Dompé Farmaceutici S.p.A|PRA Health Sciences Metastatic Breast Cancer June 2015 Phase 2
    NCT01839890 Francisco Javier Goicolea|Effice Servicios Para la Investigacion S.L.|Fundación Médica para la Investigación y Desarrollo en el Area Cardiovascular Acute Myocardial Infarction April 2012 Phase 3
    NCT02651727 Verastem, Inc. Pancreatic Cancer September 2015 Phase 1
    NCT01336062 Peking University Gastric Adenocarcinoma April 2011 Phase 1|Phase 2
    NCT01146795 Jason D. Wright|Genentech, Inc.|Columbia University Epithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer May 2010 Phase 2
    NCT01255956 Medical University of Warsaw|KCRI In-Stent Restenosis December 2010 Phase 3
    NCT01402271 European Organisation for Research and Treatment of Cancer - EORTC Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer July 2012 Phase 1|Phase 2
    NCT03048942 University Hospitals Bristol NHS Foundation Trust HER2 Negative Metastatic Breast Cancer November 2014 Phase 2
    NCT02614833 Immutep S.A.|Prima BioMed Ltd Adenocarcinoma Breast Stage IV December 2015 Phase 2
    NCT02976909 Yuhong Li|Sun Yat-sen University Esophageal Squamous Cell Carcinoma November 2016 Phase 2
    NCT02698891 Dana-Farber Cancer Institute Early Stage Breast Cancer April 2016 Phase 2
    NCT00513786 David O'Malley|Genentech, Inc.|Ohio State University Comprehensive Cancer Center Endometrial Cancer August 2007 Phase 2
    NCT00494182 M.D. Anderson Cancer Center|Bayer Head and Neck Cancer|Squamous Cell Carcinoma April 2007 Phase 2
    NCT01367002 Yale University|Genentech, Inc. Endometrial Cancer June 2011 Phase 2
    NCT01057342 Swiss Group for Clinical Cancer Research Lung Cancer January 2010 Phase 2
    NCT01485848 Esperance Pharmaceuticals Inc Ovarian Cancer Recurrent February 2012 Phase 2
    NCT02758847 University of Pittsburgh Ischemia September 2016
    NCT02559674 Altor Bioscience Corporation Advanced Pancreatic Cancer July 2016 Phase 1|Phase 2
    NCT00251095 OncoGenex Technologies Breast Neoplasm September 2005 Phase 3
    NCT00491855 M.D. Anderson Cancer Center Peritoneal Cancer June 2007 Phase 1
    NCT03064126 Boston Scientific Corporation Peripheral Artery Disease|Atherosclerosis|Artery Diseases, Peripheral|Plaque, Atherosclerotic|Occlusive Arterial Disease March 2, 2017 Phase 3
    NCT00054028 National Cancer Institute (NCI) Recurrent Breast Cancer|Stage IIIB Breast Cancer|Stage IV Breast Cancer December 2002 Phase 1|Phase 2
    NCT01295502 Gynecologic Oncology Group|National Cancer Institute (NCI) Cervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Cervical Squamous Cell Carcinoma, Not Otherwise Specified|Stage IB Cervical Cancer|Stage IIA Cervical Cancer|Stage IIB Cervical Cancer|Stage IIIA Cervical Cancer|Stage IIIB Cervical Cancer|Stage IVA Cervical Cancer April 2011 Phase 1
    NCT00062179 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI)|Pharmacia Lung Cancer March 2003 Phase 2
    NCT01199263 National Cancer Institute (NCI) Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma December 6, 2010 Phase 2
    NCT03219762 Gruppo Oncologico Italiano di Ricerca Clinica|Temas srl|Clirest s.r.l.|Mipharm S.p.A.|Istituto Toscano Tumori - Centro per il Coordinamento delle Sperimentazioni Cliniche Small Cell Lung Cancer February 7, 2017 Phase 2
    NCT01834235 Precision Biologics, Inc Pancreatic Cancer, Adult April 2013 Phase 1|Phase 2
    NCT01625429 Shanghai Cancer Hospital, China Breast Cancer June 2012 Phase 2
    NCT02608229 Washington University School of Medicine|BioMed Valley Discoveries, Inc Pancreatic Cancer|Cancer of Pancreas|Cancer of the Pancreas|Pancreas Cancer June 6, 2016 Phase 1
    NCT01276769 Chinese Academy of Medical Sciences Triple Negative Breast Cancer January 2008 Phase 2
    NCT02043730 Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente|Unità Sperimentazioni cliniche|Istituto Nazionale Tumori di Napoli Pancreatic Cancer Stage II January 2014 Phase 2
    NCT01893801 Gayle Jameson|Translational Genomics Research Institute|Translational Drug Development|Virgina G. Piper Cancer Center - Clinical Trials|Pancreatic Cancer Research Team Stage IV Pancreatic Cancer May 2013 Phase 1|Phase 2
    NCT00398086 Celgene Corporation Metastatic Pancreatic Cancer November 2006 Phase 1|Phase 2
    NCT00028990 Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|North Central Cancer Treatment Group|NCIC Clinical Trials Group|NSABP Foundation Inc Breast Cancer December 2001 Phase 3
    NCT02124707 UNC Lineberger Comprehensive Cancer Center Head and Neck Cancer|Squamous Cell Carcinoma of the Head and Neck April 2014 Phase 2
    NCT02514551 Eli Lilly and Company Gastric Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma October 2015 Phase 2
    NCT01646762 Mayo Clinic|National Cancer Institute (NCI) Refractory Plasma Cell Myeloma November 2012 Phase 2
    NCT01579578 AstraZeneca Metastatic, Gastric or Gastro-oesophageal Junction, Cancer April 2012 Phase 2
    NCT01525966 City of Hope Medical Center|National Cancer Institute (NCI) Inflammatory Breast Cancer|Stage IIA Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Triple-negative Breast Cancer|Stage IIB Breast Cancer|Estrogen Receptor Negative|Progesterone Receptor Negative|HER2/Neu Negative February 15, 2012 Phase 2
    NCT02540018 Jena University Hospital|iVascular S.L.U.|KKS Netzwerk Peripheral Arterial Disease September 2015
    NCT02341456 AstraZeneca Advanced Solid Tumours January 16, 2015 Phase 1
    NCT03201861 RenJi Hospital Tubular Breast Cancer|Mucinous Breast Cancer|Invasive Duct Carcinoma of Breast July 20, 2017 Phase 2
    NCT00110084 Mayo Clinic|National Cancer Institute (NCI) Breast Cancer August 2005 Phase 2
    NCT02038647 Millennium Pharmaceuticals, Inc.|Takeda Small Cell Lung Cancer (SCLC) February 2014 Phase 2
    NCT00707707 AstraZeneca Breast Cancer|Triple Negative Breast Cancer|Metastatic Breast Cancer September 15, 2008 Phase 1
    NCT02047513 AIO-Studien-gGmbH|Celgene|ClinAssess GmbH Resectable Pancreatic Cancer|Ductal Adenocarcinoma of the Pancreas April 2015 Phase 2
    NCT00100789 Southwest Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer January 2005 Phase 2
    NCT01256762 Geron Corporation Locally Recurrent or Metastatic Breast Cancer November 2010 Phase 2
    NCT00174434 Pfizer Breast Neoplasms September 2005 Phase 1
    NCT01170663 Eli Lilly and Company Gastric Cancer December 2010 Phase 3
    NCT02586753 Mianyang Central Hospital Esophageal Squamous Cell Carcinoma December 2015 Phase 2
    NCT02891005 Shandong Branden Med.Device Co.,Ltd Small Vessel Lesion December 2015 Phase 3
    NCT02016274 Shen Lin|Peking University Esophageal Squamous Cell Cancer December 2013 Phase 2
    NCT00702572 Milton S. Hershey Medical Center Non-small Cell Lung Cancer April 2008 Phase 1
    NCT02929576 Medivation, Inc.|Astellas Pharma Inc Breast Cancer September 2016 Phase 3
    NCT00003644 Gynecologic Oncology Group|National Cancer Institute (NCI)|Southwest Oncology Group Ovarian Cancer October 1998 Phase 3
    NCT01366144 National Cancer Institute (NCI)|Abbott Breast Carcinoma|Carcinoma of Unknown Primary Origin|Endometrial Carcinoma|Esophageal Carcinoma|Lung Carcinoma|Malignant Head and Neck Neoplasm|Melanoma|Ovarian Carcinoma|Renal Pelvis and Ureter Urothelial Carcinoma|Testicular Lymphoma June 20, 2011 Phase 1
    NCT02301988 Genentech, Inc.|SOLTI Breast Cancer Research Group Breast Cancer February 17, 2015 Phase 2
    NCT01042925 Sanofi Breast Cancer|Breast Neoplasms February 2010 Phase 1|Phase 2
    NCT03125902 Hoffmann-La Roche Triple-Negative Breast Cancer August 3, 2017 Phase 3
    NCT02109341 Gruppo Oncologico Italiano di Ricerca Clinica Metastatic Pancreatic Cancer February 2014 Phase 1|Phase 2
    NCT00683059 Sunnybrook Health Sciences Centre|Celgene Corporation Transitional Cell Carcinoma March 2008 Phase 2
    NCT01238133 National Cancer Institute (NCI) Estrogen Receptor Negative|HER2/Neu Negative|Progesterone Receptor Negative|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Triple-Negative Breast Carcinoma December 2010 Phase 1
    NCT02467907 Hoffmann-La Roche Cervical Cancer July 28, 2015 Phase 2
    NCT02581982 Wake Forest University Health Sciences|National Cancer Institute (NCI) Transitional Cell Carcinoma March 2016 Phase 2
    NCT03116152 Innovent Biologics (Suzhou) Co. Ltd. Efficacy and Safety April 2017 Phase 2
    NCT02162719 Genentech, Inc. Breast Neoplasms September 2014 Phase 2
    NCT01971281 NovoCure Ltd. Pancreatic Adenocarcinoma November 2013 Phase 1|Phase 2
    NCT01616888 University Health Network, Toronto In-stent Arterial Restenosis June 2012
    NCT01558492 Weill Medical College of Cornell University Prostate Cancer March 2011 Phase 2
    NCT02640053 Academic and Community Cancer Research United|National Cancer Institute (NCI) Breast Carcinoma December 2015
    NCT02367352 Millennium Pharmaceuticals, Inc.|Takeda Advanced Solid Tumors|Ovarian Cancer|Small Cell Lung Cancer March 25, 2015 Phase 1
    NCT01821833 New Mexico Cancer Care Alliance|Alliance Healthcare Foundation Breast Cancer|Ovarian Neoplasm|Pain February 2013
    NCT02437812 Gynecologic Oncology Associates|University of North Carolina, Chapel Hill Epithelial Ovarian Carcinoma January 2014 Phase 2
    NCT01463072 City of Hope Medical Center|National Cancer Institute (NCI) Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer|Estrogen Receptor-negative Breast Cancer|Estrogen Receptor-positive Breast Cancer|HER2-negative Breast Cancer|HER2-positive Breast Cancer|Progesterone Receptor-negative Breast Cancer|Progesterone Receptor-positive Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Triple-negative Breast Cancer June 2012 Phase 2
    NCT01268059 MedImmune LLC Non-small Cell Lung Cancer December 2010 Phase 1|Phase 2
    NCT00390611 SCRI Development Innovations, LLC|Bayer Ovarian Cancer October 2006 Phase 2
    NCT02996318 University Hospital, Saarland|InnoRa GmbH DES In-stent Stenosis May 2016 Phase 2|Phase 3
    NCT03193918 Arog Pharmaceuticals, Inc. Esophagogastric Adenocarcinoma April 14, 2017 Phase 1
    NCT01287624 Fudan University|307 Hospital of PLA|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences|Sun Yat-sen University|Tianjin Medical University Cancer Institute and Hospital|Zhejiang Cancer Hospital|Changhai Hospital Breast Cancer January 2011 Phase 3
    NCT01236547 National Cancer Institute (NCI) Thyroid Gland Undifferentiated (Anaplastic) Carcinoma October 28, 2010 Phase 2
    NCT02178436 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Stage IV Pancreatic Cancer October 2014 Phase 1|Phase 2
    NCT01881230 Celgene Breast Tumor|Breast Cancer|Cancer of the Breast|Estrogen Receptor- Negative Breast Cancer|HER2- Negative Breast Cancer|Progesterone Receptor- Negative Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer|Triple-negative Breast Cancer|Triple-negative Metastatic Breast Cancer|Metastatic Breast Cancer September 26, 2013 Phase 2|Phase 3
    NCT00352300 Gynecologic Oncology Group|National Cancer Institute (NCI) Fallopian Tube Carcinoma|Infectious Disorder|Neutropenia|Ovarian Carcinosarcoma|Primary Peritoneal Carcinoma|Stage III Ovarian Cancer|Stage IV Ovarian Cancer June 2006 Phase 1
    NCT01779479 German Breast Group Primary Breast Cancer February 2013 Phase 2
    NCT02718742 Mayo Clinic|National Cancer Institute (NCI) Recurrent Bladder Urothelial Carcinoma|Stage IV Bladder Urothelial Carcinoma June 2016 Phase 2
    NCT01831089 PharmaMar Breast Cancer|Ovarian Cancer|Gynecological Cancer|Head and Neck Carcinoma|Non-small Cell Lung Cancer|Small Cell Lung Cancer|Non-squamous Cell Lung Cancer September 2013 Phase 1
    NCT01309607 National University Hospital, Singapore|National Cancer Centre, Singapore ErbB2-Positive Stage I-III Breast Cancer April 2011 Phase 2
    NCT02204345 Hoffmann-La Roche Squamous Non-Small Cell Lung Cancer October 2014 Phase 1|Phase 2
    NCT00954174 Gynecologic Oncology Group|National Cancer Institute (NCI) Ovarian Carcinosarcoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Recurrent Uterine Corpus Sarcoma|Stage I Ovarian Cancer|Stage IA Fallopian Tube Cancer|Stage IA Ovarian Cancer|Stage IA Uterine Sarcoma|Stage IB Fallopian Tube Cancer|Stage IB Ovarian Cancer|Stage IB Uterine Sarcoma|Stage IC Fallopian Tube Cancer|Stage IC Ovarian Cancer|Stage IC Uterine Sarcoma|Stage II Ovarian Cancer|Stage IIA Fallopian Tube Cancer|Stage IIA Ovarian Cance August 2009 Phase 3
    NCT01653912 Accenture Recurrent Platinum-resistant Ovarian Cancer December 2012 Phase 1|Phase 2
    NCT01159418 Southern Europe New Drug Organization|Novartis Advanced Solid Tumors June 2008 Phase 1
    NCT00288041 National Cancer Institute (NCI) Ciliary Body and Choroid Melanoma, Medium/Large Size|Extraocular Extension Melanoma|Iris Melanoma|Recurrent Intraocular Melanoma|Recurrent Melanoma|Stage IV Melanoma October 2005 Phase 2
    NCT00112489 Gynecologic Oncology Group|National Cancer Institute (NCI) Sarcoma May 2005 Phase 2
    NCT00818090 Korean Cancer Study Group Thymoma|Thymic Carcinoma September 2008 Phase 2
    NCT01620190 University of Washington|National Cancer Institute (NCI) Recurrent Non-Small Cell Lung Carcinoma|Stage IV Non-Small Cell Lung Cancer November 6, 2012 Phase 2
    NCT02562898 Margaret Tempero|University of California, San Francisco Metastatic Pancreatic Adenocarcinoma October 2015 Phase 1|Phase 2
    NCT02309177 Celgene Breast Neoplasms|Pancreatic Neoplasms January 14, 2015 Phase 1
    NCT00894569 Heidelberg University|Merck KGaA Neoplasms, Unknown Primary|Carcinoma July 2009 Phase 2
    NCT02001272 Hospices Civils de Lyon Ovarian Cancer December 2013 Phase 2
    NCT00360360 SCRI Development Innovations, LLC|Genentech, Inc. Neoplasm, Unknown Primary July 2006 Phase 2
    NCT01169870 National Cancer Center, Korea Breast Cancer July 2007 Phase 2
    NCT00918203 Eli Lilly and Company Non-Small Cell Lung Cancer January 2010 Phase 2
    NCT02481635 University Health Network, Toronto Pancreatic Cancer July 2016 Phase 1|Phase 2
    NCT01745757 UNICANCER Metastatic|Breast Cancer June 2012
    NCT01650376 Swedish Medical Center|AstraZeneca Stage III Ovarian Cancer|Stage IV Ovarian Cancer|Uterine Cancer August 2012 Phase 1|Phase 2
    NCT01063517 AstraZeneca Gastric Cancer February 2, 2010 Phase 2
    NCT00093145 Celgene Corporation|Celgene Breast Cancer June 2004 Phase 2
    NCT00575952 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Adenosquamous Carcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Mixed Adenocarcinoma|Endometrial Serous Adenocarcinoma|Endometrial Squamous Cell Carcinoma|Endometrial Undifferentiated Carcinoma|Recurrent Uterine Corpus Carcinoma|Stage IIIA Uterine Corpus Cancer|Stage IIIC Uterine Corpus Cancer|Stage IVA Uterine Corpus Cancer|Stage IVB Uterine Corpus Cancer January 2008 Phase 1
    NCT00004859 National Cancer Institute (NCI) Lung Cancer January 2000 Phase 3
    NCT00174356 Pfizer Carcinoma, Non-Small Cell Lung December 2002 Phase 1
    NCT01506856 Gynecologic Oncology Trial & Investigation Consortium|Japanese Gynecologic Oncology Group Epithelial Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Carcinoma May 2010 Phase 2|Phase 3
    NCT01142388 National Cancer Institute (NCI) Adenocarcinoma of the Gastroesophageal Junction|Esophageal Adenocarcinoma|Esophageal Squamous Cell Carcinoma|Recurrent Esophageal Carcinoma|Stage IV Esophageal Cancer September 2010 Phase 2
    NCT00002939 University of Chicago|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific November 1996 Phase 1
    NCT01763671 Intergroupe Francophone de Cancerologie Thoracique Non-squamous Non-small Cell Lung Cancer May 2013 Phase 3
    NCT02529878 The First Affiliated Hospital of Zhejiang Chinese Medical University|Jiangsu HengRui Medicine Co., Ltd. Gastric Cancer August 2015 Phase 2
    NCT00005647 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Head and Neck Cancer May 2000 Phase 1
    NCT00087217 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific May 2004 Phase 1
    NCT02399137 Merrimack Pharmaceuticals Pancreatic Cancer May 2015 Phase 2
    NCT02459457 Fudan University|Fudan University Shanghai Cancer Center Minhang Branch|Huadong Hospital|Wuxi No. 4 People's Hospital|Jiangsu Cancer Institute & Hospital|The First Affiliated Hospital of Xiamen University|Jiangxi Provincial Cancer Hospital|Shanxi Province Cancer Hospital|Gansu Cancer Hospital Stage III Esophageal Squamous Cell Carcinoma July 2015 Phase 3
    NCT03018080 Antoinette Tan|Merck Sharp & Dohme Corp.|Carolinas Healthcare System Breast - Female|Male Breast Cancer June 12, 2017 Phase 2
    NCT01276496 National Cancer Institute (NCI) Adult Solid Neoplasm|Estrogen Receptor Negative|HER2/Neu Negative|Male Breast Carcinoma|Progesterone Receptor Negative|Recurrent Breast Carcinoma|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Triple-Negative Breast Carcinoma December 2010 Phase 1
    NCT00639522 Nanjing Sike Pharmaceutical Co., Ltd. Gastric Carcinoma May 2008 Phase 1
    NCT02890511 Daehwa Pharmaceutical Co., Ltd. Solid Tumor|Stage IV Gastric Cancer August 2010 Phase 1|Phase 2
    NCT00516724 AstraZeneca Triple Negative Metastatic Breast Cancer|Advanced Ovarian Cancer|Carboplatin|Paclitaxel June 29, 2007 Phase 1
    NCT01485068 MINVASYS|European Cardiovascular Research Center In-stent Coronary Artery Restenosis March 2012
    NCT02013154 Leap Therapeutics, Inc. Esophageal Neoplasms|Adenocarcinoma of the Gastroesophageal Junction|Gastroesophageal Cancer|Squamous Cell Carcinoma|Gastric Adenocarcinoma January 2014 Phase 1
    NCT01317615 Novartis Pharmaceuticals|Novartis Carcinoma, Large Cell|Neuroendocrine Tumors April 2011 Phase 4
    NCT00459121 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Lung Cancer July 2007 Phase 2
    NCT00005059 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer January 2000 Phase 2
    NCT00821028 University of Oklahoma Atherosclerosis|Angioplasty|Peripheral Arterial Disease January 2009
    NCT02574663 TG Therapeutics, Inc.|SCRI Development Innovations, LLC Pancreatic Cancer|Colorectal Cancer|Rectal Cancer|Gastric Cancer|Esophageal Cancer|Gastrointestinal Stromal Tumor (GIST) October 2015 Phase 1
    NCT01386385 National Cancer Institute (NCI) Large Cell Lung Carcinoma|Lung Adenocarcinoma|Lung Adenocarcinoma, Mixed Subtype|Minimally Invasive Lung Adenocarcinoma|Squamous Cell Lung Carcinoma|Stage III Non-Small Cell Lung Cancer AJCC v7|Stage IIIA Non-Small Cell Lung Cancer AJCC v7|Stage IIIB Non-Small Cell Lung Cancer AJCC v7 June 20, 2011 Phase 1|Phase 2
    NCT01357161 Merck Sharp & Dohme Corp. Ovarian Cancer July 2011 Phase 2
    NCT01491204 Hanmi Pharmaceutical Company Limited Advanced Solid Tumors August 2006 Phase 1
    NCT02210559 FibroGen Pancreatic Cancer (Unresectable) July 2014 Phase 1|Phase 2
    NCT00181701 Massachusetts General Hospital|Dana-Farber Cancer Institute|Brigham and Women's Hospital Ovarian Carcinoma October 2004 Phase 2
    NCT00735696 Eli Lilly and Company Non Small Cell Lung Cancer January 2009 Phase 2
    NCT00522834 Synta Pharmaceuticals Corp. Melanoma August 2007 Phase 3
    NCT00368875 National Cancer Institute (NCI) Male Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer July 2006 Phase 1|Phase 2
    NCT02047500 EMD Serono|Threshold Pharmaceuticals Pancreatic Cancer January 2014 Phase 1
    NCT02835586 Hospices Civils de Lyon Critical Ischemia May 2013 Phase 3
    NCT02163291 Peking University Advanced Gastric Carcinoma December 2013 Phase 2
    NCT00915018 Puma Biotechnology, Inc. Breast Cancer August 2009 Phase 2
    NCT00138151 University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Rutgers, The State University of New Jersey Cervical Cancer March 2001 Phase 2
    NCT00462631 Heart Centre Rotenburg|B. Braun Medical SA Coronary Stenosis|Diabetes Mellitus May 2007 Phase 2|Phase 3
    NCT00667641 University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Rutgers, The State University of New Jersey Breast Cancer|Colorectal Cancer|Head and Neck Cancer|Lung Cancer|Melanoma (Skin)|Ovarian Cancer|Pancreatic Cancer|Prostate Cancer|Unspecified Adult Solid Tumor, Protocol Specific March 2007 Phase 1
    NCT01632371 Deutsches Herzzentrum Muenchen|Biotronik AG Restenosis|Stable Angina Pectoris|Acute Coronary Syndrome June 2012 Phase 4
    NCT00331422 Masonic Cancer Center, University of Minnesota Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer October 2005 Phase 2
    NCT01716715 National Cancer Institute (NCI) Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma November 2012 Phase 2
    NCT02290470 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Nausea|Vomiting April 2014 Phase 2
    NCT01827163 Memorial Sloan Kettering Cancer Center|GlaxoSmithKline HER2-Positive Early Stage Breast Cancer April 2013 Phase 2
    NCT00344552 Bristol-Myers Squibb Esophageal Cancer June 2006 Phase 2
    NCT01457846 AstraZeneca Gastro-oesophageal Junction Cancer|Gastric Cancer November 2011 Phase 2
    NCT02985333 Sun Yat-sen University Relapse/Refractory Multiple Myeloma January 2014 Phase 2
    NCT00291850 Central European Cooperative Oncology Group Non-Small Cell Lung Cancer June 2005 Phase 2
    NCT01485081 MINVASYS|European Cardiovascular Research Center Coronary Disease May 2012
    NCT02182232 Boehringer Ingelheim Carcinoma, Non-Small-Cell Lung June 2005 Phase 1
    NCT02344095 Seoul National University Hospital Epithelial Ovarian Carcinoma|Fallopian Tube Carcinoma|Primary Peritoneal Carcinoma December 2014 Phase 1
    NCT02318095 Duke University Resectable Pancreatic Cancers January 2015
    NCT01468909 National Cancer Institute (NCI) Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma December 2011 Phase 2
    NCT01721525 Memorial Sloan Kettering Cancer Center|National Comprehensive Cancer Network|Boehringer Ingelheim Head and Neck Cancer|Squamous Cell Cancer November 2012 Phase 1
    NCT00691379 Hellenic Oncology Research Group|University Hospital of Crete Breast Cancer April 2008 Phase 1|Phase 2
    NCT00602797 University of Nebraska|National Cancer Institute (NCI) Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer December 2007 Phase 2
    NCT02573493 Washington University School of Medicine|Celgene Corporation Squamous Cell Carcinoma of the Head and Neck|Carcinoma, Squamous Cell of the Head and Neck|Cancer of Head and Neck|Cancer of the Head and Neck|Head and Neck Cancer|Neoplasms, Head and Neck April 13, 2016 Phase 2
    NCT02279732 Bristol-Myers Squibb Lung Cancer (NSCLC) October 13, 2014 Phase 3
    NCT00309959 Gynecologic Oncology Group|National Cancer Institute (NCI) Cervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Cervical Small Cell Carcinoma|Cervical Squamous Cell Carcinoma|Recurrent Cervical Carcinoma November 2006 Phase 2
    NCT02632071 Kevin Kalinsky|Acetylon Pharmaceuticals Incorporated|National Cancer Institute (NCI)|Columbia University Metastatic Breast Cancer|Breast Carcinoma February 2016 Phase 1
    NCT00691912 Claudia Lorenz-Schlüter|University of Magdeburg Metastatic Breast Cancer December 2006 Phase 2
    NCT00006256 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer June 2000 Phase 2
    NCT03047265 Sun Yat-sen University Nasopharyngeal Carcinoma February 4, 2017 Phase 2
    NCT02138383 H. Lee Moffitt Cancer Center and Research Institute|Astellas Pharma Inc Pancreatic Cancer May 22, 2014 Phase 1
    NCT01285609 Bristol-Myers Squibb Lung Cancer - Non Small Cell (Squamous) August 2011 Phase 3
    NCT01740336 Genentech, Inc. Breast Cancer February 6, 2013 Phase 2
    NCT01764022 Biocad Human Epithelial Receptor (HER)-2 Positive Breast Cancer October 2012 Phase 3
    NCT02464501 Horizons International Peripheral Group|Advanced Catheter Therapies, Inc. Peripheral Arterial Disease|Cardiovascular Disease|Peripheral Vascular Disease May 20, 2015
    NCT01204320 Ospedale San Donato Stable Angina|Unstable Angina January 2008 Phase 4
    NCT00408460 University of Washington|National Cancer Institute (NCI) Malignant Pleural Effusion|Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer February 2006 Phase 2
    NCT02054338 Pierre Fabre Medicament Advanced Breast Cancer June 2006 Phase 3
    NCT00786110 University of Turin, Italy Adrenocortical Carcinoma April 2008 Phase 2
    NCT00966914 BioNumerik Pharmaceuticals, Inc. Non-small Cell Lung Cancer April 2010 Phase 3
    NCT00732953 University of Ulm|B. Braun Melsungen AG|OrbusNeich Coronary Artery Disease February 2009 Phase 2|Phase 3
    NCT02920450 University of Florida|Pfizer Non-Small Cell Lung Cancer July 30, 2017 Phase 1|Phase 2
    NCT02382406 Nisha Mohindra, MD|Hoosier Cancer Research Network|Merck Sharp & Dohme Corp.|Celgene Corporation Non-Small Cell Lung Cancer June 2015 Phase 1|Phase 2
    NCT02145065 Balton Sp.zo.o.|American Heart of Poland Peripheral Artery Disease|Femoropopliteal Artery Disease September 2014
    NCT00607438 Veeda Oncology|Bayer|Celgene Corporation Breast Cancer September 2007 Phase 2
    NCT01321775 Hospital Universitario Madrid Sanchinarro Breast Cancer August 2009 Phase 2
    NCT02412722 Millennium Pharmaceuticals, Inc.|Takeda Non-Hematologic Malignancy March 12, 2015 Phase 1
    NCT02628951 Samsung Medical Center Gastric Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma May 26, 2016 Phase 2
    NCT00709761 Novartis Pharmaceuticals|Novartis Neoplasms, Breast July 2008 Phase 2
    NCT03149913 Prof. Dr. med. Gunnar Tepe|InnoRa GmbH|Klinikum Rosenheim Stenosis|Occlusion|Restenosis December 15, 2016
    NCT02514031 University of Texas Southwestern Medical Center Pancreatic Cancer October 2015 Phase 1
    NCT01413750 National Cancer Institute (NCI) Stage IIIA Non-Small Cell Lung Cancer|Stage IIIB Non-Small Cell Lung Cancer|Stage IV Non-Small Cell Lung Cancer November 2010 Phase 1|Phase 2
    NCT01770171 Catholic University of the Sacred Heart Stage III-IV or Recurrent Endometrial Cancer April 2012 Phase 2
    NCT00003591 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Pancreatic Cancer November 1998 Phase 2
    NCT00945191 Daiichi Sankyo Inc. Ovarian Cancer September 2009 Phase 2
    NCT02549209 Daniela Matei, MD|Merck Sharp & Dohme Corp.|Hoosier Cancer Research Network|Big Ten Cancer Research Consortium Endometrial Cancer|Endometrial Adenocarcinoma July 2017 Phase 2
    NCT03019588 Merck Sharp & Dohme Corp. Gastric Neoplasms|Gastroesophageal Junction Adenocarcinoma February 16, 2017 Phase 3
    NCT00388076 GlaxoSmithKline Solid Tumor Cancer|Neoplasms, Breast April 2006 Phase 1
    NCT01158144 Zhejiang Cancer Hospital Non-small Cell Lung Cancer October 2009 Phase 2
    NCT02199418 RenJi Hospital Tubular Breast Cancer|Mucinous Breast Cancer|Invasive Ductal Breast Cancer|Inflammatory Breast Cancer January 2013 Phase 2
    NCT00307255 UNC Lineberger Comprehensive Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific August 2006 Phase 1
    NCT01186991 Genentech, Inc.|Hoffmann-La Roche Breast Cancer March 2011 Phase 2
    NCT02033993 Canadian Cancer Trials Group|Australian and New Zealand Urogenital and Prostate Cancer Trials Group|Celgene Urothelial Cancer January 27, 2014 Phase 2
    NCT01041027 Albert Einstein College of Medicine, Inc.|National Cancer Institute (NCI) Endometrial Adenocarcinoma|Stage IA Uterine Corpus Cancer|Stage IB Uterine Corpus Cancer|Stage II Uterine Corpus Cancer|Stage IIIA Uterine Corpus Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIC Uterine Corpus Cancer|Stage IVA Uterine Corpus Cancer|Stage IVB Uterine Corpus Cancer September 2008 Phase 2
    NCT01280058 National Cancer Institute (NCI) Pancreatic Acinar Cell Carcinoma|Pancreatic Ductal Adenocarcinoma|Recurrent Pancreatic Carcinoma|Stage IV Pancreatic Cancer December 2010 Phase 2
    NCT03030287 OncoMed Pharmaceuticals, Inc. Cancer Ovaries|Cancer Peritoneal|Cancer, Fallopian Tube December 2016 Phase 1
    NCT02106884 Universitaire Ziekenhuizen Leuven|Celgene Corporation Pancreatic Cancer April 2014 Phase 2
    NCT02050009 Fox Chase Cancer Center|National Cancer Institute (NCI) Ovarian Papillary Serous Carcinoma|Ovarian Serous Cystadenocarcinoma|Recurrent Fallopian Tube Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Ovarian Germ Cell Tumor|Recurrent Primary Peritoneal Cavity Cancer Phase 1
    NCT02270814 Washington University School of Medicine|Celgene Corporation Head and Neck Cancer|Head and Neck Squamous Cell Carcinoma|Cancer of the Head and Neck February 2, 2015 Phase 2
    NCT02607202 Fondazione del Piemonte per l'Oncologia Unknown Primary Tumors March 2015 Phase 2
    NCT01816594 Novartis Pharmaceuticals|Breast International Group|German Breast Group (GBG)|SOLTI Breast Cancer Research Group|Novartis HER2-positive, Newly Diagnosed, Primary Breast Cancer, Neoadjuvant Therapy, Trastuzumab September 2013 Phase 2
    NCT00919880 Tao OUYANG|Peking University Breast Cancer July 2009 Phase 2
    NCT01106898 University of Nebraska|National Cancer Institute (NCI) Stage I Breast Cancer|Stage II Breast Cancer March 2010 Phase 2
    NCT01398033 Herz-Zentrums Bad Krozingen|Heart Center Bad Krozingen In-stent Stenosis of Infrapopliteal Arteries April 2012 Phase 3
    NCT00329641 National Cancer Institute (NCI) Ciliary Body and Choroid Melanoma, Medium/Large Size|Extraocular Extension Melanoma|Iris Melanoma|Metastatic Intraocular Melanoma|Recurrent Intraocular Melanoma February 2011 Phase 2
    NCT01204125 Sanofi|SOLTI Breast Cancer Research Group Breast Cancer Female September 2010 Phase 2
    NCT03154294 Avera McKennan Hospital & University Health Center Advanced Solid Tumor July 2017 Phase 1
    NCT01281150 National Cancer Institute (NCI) Adult Solid Neoplasm|Estrogen Receptor Negative|Estrogen Receptor Positive|HER2/Neu Negative|Male Breast Carcinoma|Progesterone Receptor Negative|Recurrent Breast Carcinoma|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Triple-Negative Breast Carcinoma January 2011 Phase 1
    NCT01003158 AstraZeneca Neoplasms|Metastatic Cancer|Breast Cancer October 2009 Phase 1
    NCT02667743 Shanghai Yizhong Biotechnology Co., Ltd. Non-Small Cell Lung Cancer(NSCLC) March 2015 Phase 3
    NCT02503358 OHSU Knight Cancer Institute|National Cancer Institute (NCI) Stage IIIB Non-Small Cell Lung Cancer|Stage IV Non-Small Cell Lung Cancer July 2016 Phase 1
    NCT02812992 AIO-Studien-gGmbH Adenocarcinoma Pancreas June 2016 Phase 4
    NCT02367794 Hoffmann-La Roche Squamous Non-Small Cell Lung Cancer June 11, 2015 Phase 3
    NCT02048943 Roswell Park Cancer Institute|National Cancer Institute (NCI)|Novartis Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific March 2015 Phase 1
    NCT01644825 National Cancer Institute, Naples Ovarian Cancer December 2010 Phase 2
    NCT00661193 Southwest Oncology Group|National Cancer Institute (NCI) Lung Cancer December 2008 Phase 2
    NCT00255762 National Cancer Institute (NCI) Recurrent Melanoma|Stage IV Melanoma December 2005 Phase 2
    NCT02530437 M.D. Anderson Cancer Center|National Cancer Institute (NCI)|Ignyta, Inc. Esophageal Cancer March 7, 2017 Phase 1|Phase 2
    NCT02620800 Celgene Metastatic Pancreas Adenocarcinoma January 18, 2016 Phase 1|Phase 2
    NCT01196741 University College, London|AstraZeneca|Cancer Research UK Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer March 2011 Phase 2|Phase 3
    NCT02762474 Tianjin Medical University Cancer Institute and Hospital Esophageal Cancer July 2014 Phase 1|Phase 2
    NCT02367781 Hoffmann-La Roche Non-Small Cell Lung Cancer April 30, 2015 Phase 3
    NCT01506609 AbbVie (prior sponsor, Abbott)|AbbVie Metastatic Breast Cancer January 24, 2012 Phase 2
    NCT00368992 National Cancer Institute (NCI) Adenocarcinoma of the Lung|Adenosquamous Cell Lung Cancer|Bronchoalveolar Cell Lung Cancer|Large Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer August 2006 Phase 2
    NCT00129389 Spanish Breast Cancer Research Group|Bristol-Myers Squibb Breast Cancer September 2003 Phase 3
    NCT00373620 Korean Gynecologic Oncology Group Endometrial Cancer January 2006 Phase 2
    NCT00788931 Novartis Pharmaceuticals|Novartis HER-2 Positive Breast Cancer|Metastatic Breast Cancer December 2008 Phase 1
    NCT00107341 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Esophageal Cancer August 2005 Phase 2
    NCT02732938 Pfizer Metastatic Pancreatic Ductal Adenocarcinoma May 2016 Phase 2
    NCT01428414 Zhimin Shao|Roche Pharma AG|Fudan University HER-2 Positive Breast Cancer August 2011 Phase 2
    NCT00002189 Baker Norton Pharmaceuticals|NIH AIDS Clinical Trials Information Service Sarcoma, Kaposi|HIV Infections Phase 2
    NCT01281852 National Cancer Institute (NCI) Cervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Cervical Squamous Cell Carcinoma, Not Otherwise Specified|Recurrent Cervical Carcinoma|Stage IVB Cervical Cancer March 2011 Phase 1|Phase 2
    NCT00786552 University of Schleswig-Holstein Thyroid Cancer November 2008 Phase 2
    NCT02617849 Wilson Miller|Jewish General Hospital Metastatic Malignant Melanoma March 2016 Phase 2
    NCT01069796 ARCAGY/ GINECO GROUP Triple Negative Metastatic Breast Cancer April 2010 Phase 2
    NCT02654119 University of Nebraska|National Cancer Institute (NCI) HER2 Positive Breast Carcinoma|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer December 2015 Phase 2
    NCT02677597 Fudan University Esophageal Squamous Cell Carcinoma January 2016 Phase 3
    NCT02178956 Boston Biomedical, Inc Gastric Cancer|Gastroesophageal Junction Cancer August 2014 Phase 3
    NCT00832819 Eisai Co., Ltd.|Eisai Inc. Non-small-cell Lung Cancer February 2009 Phase 1
    NCT02629848 Takeda Carcinoma, Non-Small-Cell Lung July 2012 Phase 3
    NCT00478361 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Distal Urethral Cancer|Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter|Proximal Urethral Cancer|Recurrent Bladder Cancer|Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter|Recurrent Urethral Cancer|Regional Transitional Cell Cancer of the Renal Pelvis and Ureter|Stage III Bladder Cancer|Stage IV Bladder Cancer|Transitional Cell Carcinoma of the Bladder|Urethral Cancer Associated With Invasive Bladder Cancer April 2007 Phase 2
    NCT02725268 Millennium Pharmaceuticals, Inc.|European Network of Translational Research in Ovarian Cancer - EUTROC|European Network of Individualized Treatment in Endometrial Cancer - ENITEC|Takeda Endometrial Neoplasms April 1, 2016 Phase 2
    NCT00408655 National Cancer Institute (NCI) Ovarian Sarcoma|Ovarian Stromal Cancer|Recurrent Endometrial Carcinoma|Recurrent Ovarian Epithelial Cancer|Recurrent Ovarian Germ Cell Tumor|Stage III Endometrial Carcinoma|Stage III Ovarian Epithelial Cancer|Stage III Ovarian Germ Cell Tumor|Stage IV Endometrial Carcinoma|Stage IV Ovarian Epithelial Cancer|Stage IV Ovarian Germ Cell Tumor|Unspecified Adult Solid Tumor, Protocol Specific February 2007 Phase 1
    NCT01730833 City of Hope Medical Center|National Cancer Institute (NCI) HER2-positive Breast Cancer|Recurrent Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Breast Adenocarcinoma|Inflammatory Breast Carcinoma July 17, 2013 Phase 2
    NCT01204749 Amgen Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cancer November 2010 Phase 3
    NCT00131963 Duke University|National Cancer Institute (NCI) Breast Cancer October 2003
    NCT00003281 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer April 1998 Phase 2
    NCT02442063 Bayer Neoplasms|Bone Diseases August 2015 Phase 1
    NCT02151812 Hemoteq AG Coronary Artery Disease|Coronary Restenosis|Coronary Atherosclerosis|Coronary Arteriosclerosis August 2014
    NCT02628613 Fudan University Breast Cancer April 2015 Phase 3
    NCT01239732 Hoffmann-La Roche Ovarian Cancer December 2010 Phase 3
    NCT02560038 The University of Texas Health Science Center, Houston Urinary Bladder Neoplasms October 2015 Phase 2
    NCT01618136 Eisai Limited|Eisai Inc. Malignant Solid Tumour|Ovarian Cancer|Triple Negative Breast Cancer|Advanced Melanoma|B-cell Malignancy, Low-grade January 2012 Phase 1|Phase 2
    NCT01440998 National Cancer Institute (NCI) Endometrial Adenocarcinoma|Endometrial Adenosquamous Carcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Mucinous Adenocarcinoma|Endometrial Serous Adenocarcinoma|Endometrial Transitional Cell Carcinoma|Endometrial Undifferentiated Carcinoma|Endometrioid Adenocarcinoma|Recurrent Uterine Corpus Carcinoma|Stage III Uterine Corpus Cancer|Stage IIIA Uterine Corpus Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIC Uterine Corpus Cancer|Stage IV Uterine Corpus Cancer|Stage IVA Uterine Corpus September 20, 2011 Phase 1
    NCT00422435 Conor Medsystems Coronary Disease January 2007 Phase 3
    NCT00110695 NSABP Foundation Inc|Celgene Corporation Breast Neoplasms April 2005 Phase 2
    NCT00986674 National Cancer Institute (NCI) Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer September 2009 Phase 2
    NCT00730353 Hoosier Cancer Research Network|Pfizer Esophageal Cancer August 2008 Phase 2
    NCT02403895 AstraZeneca Squamous Non Small Cell Lung Cancer April 2015 Phase 2
    NCT00003350 National Cancer Institute (NCI) AIDS-related Kaposi Sarcoma March 1999 Phase 3
    NCT01512199 Daiichi Sankyo Inc.|ACTIVA Metastatic Breast Cancer January 2012 Phase 1|Phase 2
    NCT00708812 Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd Advanced Non-small Cell Lung Cancer July 2007 Phase 2
    NCT02225652 Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori Women With Primary Breast Cancer September 2010 Phase 2
    NCT03206177 University of Oklahoma|Eli Lilly and Company Carcinosarcoma, Ovarian July 31, 2017 Phase 1
    NCT01081951 AstraZeneca Ovarian Cancer February 4, 2010 Phase 2
    NCT00723957 R-Pharm Advanced/Metastatic Non-Small Cell Lung Cancer December 2008 Phase 2
    NCT02455141 Shanghai Jiao Tong University School of Medicine Breast Neoplasm July 2015 Phase 3
    NCT00399126 AEterna Zentaris Neoplasms November 2004 Phase 1
    NCT01333085 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR) Head and Neck Cancer October 2009 Phase 1|Phase 2
    NCT00617942 William Sikov|Yale University|Brown University Breast Cancer February 2008 Phase 2
    NCT01001676 University Health Network, Toronto Renal Failure February 2012 Phase 2
    NCT00662129 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer November 2008 Phase 2
    NCT03174275 UNC Lineberger Comprehensive Cancer Center|AstraZeneca|Celgene Carcinoma, Squamous Cell|Oral Cancer|Oropharynx Cancer|Larynx Cancer|Lip Cancer|Esophageal Cancer June 1, 2017 Phase 2
    NCT00343083 Department of Radiation Oncology|Bristol-Myers Squibb|University of Maryland Cancer of Head and Neck December 2004 Phase 2
    NCT01009515 New Mexico Cancer Care Alliance Melanoma August 2009 Phase 2
    NCT00915603 SCRI Development Innovations, LLC|Novartis Metastatic Breast Cancer July 2009 Phase 2
    NCT00301028 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Head and Neck Cancer April 2006 Phase 2
    NCT01980810 Chinese Academy of Medical Sciences Gastric Cancer September 2013 Phase 2
    NCT00108745 Gynecologic Oncology Group|National Cancer Institute (NCI) Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Primary Peritoneal Serous Adenocarcinoma|Stage IIIA Fallopian Tube Cancer|St March 2005 Phase 3
    NCT01270724 Nationwide Children's Hospital CNS Germ Cell Tumor August 2010 Phase 2
    NCT02336087 City of Hope Medical Center|National Cancer Institute (NCI) Pancreatic Adenocarcinoma|Unresectable Pancreatic Carcinoma January 2016 Phase 1
    NCT00445458 Puma Biotechnology, Inc. Advanced Breast Cancer|Advanced Malignant Solid Tumors|Breast Neoplasms September 2007 Phase 1|Phase 2
    NCT00001387 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Neoplasms September 1994 Phase 1
    NCT00936702 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Carcinoma of Unknown Primary Origin September 2009 Phase 2
    NCT01006252 Eli Lilly and Company Melanoma December 2009 Phase 3
    NCT00496028 AstraZeneca Neoplasms March 2007 Phase 1
    NCT01560104 AbbVie (prior sponsor, Abbott)|AbbVie Non-Small -Cell Lung Cancer February 2012 Phase 2
    NCT00750386 Hellenic Oncology Research Group|University Hospital of Crete Ovarian Cancer January 2008 Phase 1|Phase 2
    NCT01616303 Quest PharmaTech Inc. Ovarian Neoplasms June 2012 Phase 2
    NCT00481078 National Cancer Institute (NCI) Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer May 2007 Phase 2
    NCT02112552 Albert Einstein College of Medicine, Inc.|National Cancer Institute (NCI) Endometrial Serous Adenocarcinoma|Stage IIIA Uterine Corpus Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIC1 Uterine Corpus Cancer|Stage IIIC2 Uterine Corpus Cancer|Stage IVA Uterine Corpus Cancer|Stage IVB Uterine Corpus Cancer May 2013 Phase 2
    NCT02106546 AbbVie Squamous Non-Small Cell Lung Cancer April 2014 Phase 3
    NCT00097227 ImClone LLC|Bristol-Myers Squibb Non-small Cell Lung Cancer November 2004 Phase 2
    NCT01194869 Emory University|Amgen|Bayer Breast Cancer June 2010 Phase 2
    NCT00287937 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific July 2005 Phase 1
    NCT01858428 Spectranetics Corporation Peripheral Arterial Disease June 2013
    NCT01702714 Hoffmann-La Roche Non-Squamous Non-Small Cell Lung Cancer July 2014 Phase 1
    NCT02317874 National Cancer Institute (NCI) Advanced Malignant Solid Neoplasm|BRCA Rearrangement|BRCA1 Gene Mutation|BRCA2 Gene Mutation|Deleterious BRCA1 Gene Mutation|Deleterious BRCA2 Gene Mutation|Metastatic Malignant Solid Neoplasm|Unresectable Solid Neoplasm July 24, 2015 Phase 1
    NCT02155088 H. Lee Moffitt Cancer Center and Research Institute|Novartis Pancreatic Cancer October 30, 2014 Phase 1
    NCT00851877 University of Texas Southwestern Medical Center Head and Neck Cancer March 2009 Phase 1|Phase 2
    NCT01617928 AbbVie (prior sponsor, Abbott)|AbbVie Solid Tumors May 2012 Phase 1
    NCT01649336 Array BioPharma Epithelial Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer July 2012 Phase 1
    NCT01285466 Novartis Pharmaceuticals|Novartis Metastatic or Locally Advanced Solid Tumors January 2011 Phase 1
    NCT02263495 Asan Medical Center|Eisai Inc.|Dong-A ST Co., Ltd.|Samyang Biopharmaceuticals Corporation Metastatic Breast Cancer November 2014 Phase 2
    NCT00606333 Cordis Corporation|Conor Medsystems Coronary Atherosclerosis March 2008
    NCT01310244 Spectrum Pharmaceuticals, Inc|Onxeo Stage IV Non-small Cell Lung Cancer December 2010 Phase 1|Phase 2
    NCT02451956 Samsung Medical Center Advanced Gastric Cancer January 7, 2015 Phase 2
    NCT00004055 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer November 1999 Phase 2
    NCT02448329 Samsung Medical Center Advanced Gastric Adenocarcinoma January 14, 2015 Phase 2
    NCT02967133 Alliance Foundation Trials, LLC.|Celgene Corporation|Bristol-Myers Squibb Non-Small-Cell Lung Cancer Metastatic|Non-Small Cell Carcinoma of Lung, TNM Stage 4|Nonsmall Cell Lung Cancer|Non Small Cell Lung Cancer Recurrent December 2016 Phase 2
    NCT01086579 Fondazione Mediolanum per Attività e Ricerche Cardiovascolari Onlus Coronary Artery Disease March 2010
    NCT02506842 Fudan University Stage ⅠA Pancreatic Cancer|Stage ⅠB Pancreatic Cancer|Stage ⅡA Pancreatic Cancer|Stage ⅡB Pancreatic Cancer June 2015 Phase 3
    NCT03179904 Mayo Clinic|National Cancer Institute (NCI) HER2 Positive Breast Carcinoma|Stage III Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer July 30, 2017 Phase 2
    NCT00106587 University Hospital, Saarland Coronary Restenosis December 2003 Phase 1|Phase 2
    NCT00176254 Susanne Arnold|Bristol-Myers Squibb|University of Kentucky Squamous Cell Carcinoma May 2000 Phase 2
    NCT01219777 Ritu Salani|Genentech, Inc.|Ohio State University Comprehensive Cancer Center Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer September 2010 Phase 1
    NCT00439608 Brown University|Bristol-Myers Squibb Esophageal Cancer|Gastric Cancer October 2004 Phase 2
    NCT00320541 Eli Lilly and Company|Genentech, Inc. Breast Cancer May 2006 Phase 2
    NCT01239953 Fundación Médica para la Investigación y Desarrollo en el Area Cardiovascular|Hospital San Carlos, Madrid|B.Braun Surgical SA|Abbott Vascular In-Stent Restenosis January 2010 Phase 4
    NCT02611700 Biotech Pharmaceutical Co., Ltd. Esophageal Squamous Cell Carcinomas November 2015 Phase 3
    NCT01239940 Fundación Médica para la Investigación y Desarrollo en el Area Cardiovascular|Hospital San Carlos, Madrid|B.Braun Surgical SA|Abbott Vascular In-stent Restenosis January 2010 Phase 4
    NCT01763710 Asociación Oncosur Breast Cancer December 2012 Phase 2
    NCT00340184 Korean Gynecologic Oncology Group Cervical Cancer August 2004 Phase 2
    NCT00576225 CTI BioPharma NSCLC September 2007 Phase 3
    NCT00409981 University Hospital, Saarland Coronary Restenosis July 2004 Phase 1|Phase 2
    NCT00369551 National Cancer Institute (NCI) Adenocarcinoma of the Lung|Bronchoalveolar Cell Lung Cancer|Large Cell Lung Cancer|Stage II Non-small Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer June 2006 Phase 1
    NCT00322400 Amgen Locally Recurrent and Metastatic Breast Cancer March 2006 Phase 1
    NCT00748553 University of Utah|Celgene Corporation Advanced or Metastatic Solid Tumors|Advanced or Metastatic Breast Cancer September 2008 Phase 1|Phase 2
    NCT02436668 Pharmacyclics LLC. Metastatic Pancreatic Adenocarcinoma May 2015 Phase 2|Phase 3
    NCT00448708 Angiotech Pharmaceuticals Kidney Diseases|ESRD March 2007
    NCT02221999 RenJi Hospital Tubular Breast Cancer|Mucinous Breast Cancer|Invasive Ductal Breast Cancer|Inflammatory Breast Cancer January 2014 Phase 2|Phase 3
    NCT00093756 National Cancer Institute (NCI) Recurrent Non-small Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer September 2004 Phase 1|Phase 2
    NCT01187199 M.D. Anderson Cancer Center Advanced Cancer August 2010 Phase 1
    NCT01367301 Albert Einstein College of Medicine, Inc.|National Cancer Institute (NCI) Stage IA Uterine Sarcoma|Stage IB Uterine Sarcoma|Stage IC Uterine Sarcoma|Stage IIA Uterine Sarcoma|Stage IIB Uterine Sarcoma|Stage IIIA Uterine Sarcoma|Stage IIIB Uterine Sarcoma|Stage IIIC Uterine Sarcoma|Stage IVA Uterine Sarcoma|Stage IVB Uterine Sarcoma|Uterine Carcinosarcoma May 2011
    NCT00129727 Massachusetts General Hospital|Women and Infants Hospital of Rhode Island Ovarian Cancer June 2005 Phase 2
    NCT01774851 Merrimack Pharmaceuticals HER-2 Gene Amplification|Esophagus Cancer|Gastroesophageal Junction Cancer|Stomach Cancer January 2013 Phase 2
    NCT00002587 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific September 1994 Phase 1
    NCT00129922 Spanish Breast Cancer Research Group|Bristol-Myers Squibb|Pfizer|Hoffmann-La Roche Breast Cancer November 1999 Phase 3
    NCT02483104 AbbVie Ovarian Cancer July 2015 Phase 1
    NCT00752115 Hamamatsu University Non-small Cell Lung Cancer February 2007 Phase 2|Phase 3
    NCT00844649 Celgene Metastatic Pancreatic Cancer March 2009 Phase 3
    NCT03199885 National Cancer Institute (NCI) HER2/Neu Positive|Recurrent Breast Carcinoma|Stage IV Breast Cancer July 11, 2018 Phase 3
    NCT00795899 German Breast Group|AGO Study Group Breast Cancer January 2002 Phase 2
    NCT00006929 National Cancer Institute (NCI) Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer September 2000 Phase 2
    NCT00603538 Pfizer Carcinoma, Non-Small-Cell Lung January 2008 Phase 1
    NCT02723331 University of Colorado, Denver|Celgene Corporation|Criterium, Inc. Pancreatic Cancer|Pancreatic Adenocarcinoma|Pancreas Ductal Adenocarcinoma December 30, 2016 Phase 2
    NCT02023710 Beijing Cancer Hospital Melanoma December 2013 Phase 2
    NCT00003622 James Ahlgren|George Washington University Prostate Cancer January 1999 Phase 2
    NCT02661815 Dana-Farber Cancer Institute|Acetylon Pharmaceuticals Incorporated Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Carcinoma January 2016 Phase 1
    NCT00201734 Ohio State University Comprehensive Cancer Center|Roche Pharma AG Tumors|Unknown Primary Tumors|Adenocarcinoma June 2005 Phase 1|Phase 2
    NCT01083537 University Health Network, Toronto Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer|Bowel Obstruction February 2010 Phase 1|Phase 2
    NCT00393315 University Hospital, Saarland|B. Braun Melsungen AG In-Stent Restenosis November 2005 Phase 2
    NCT01204437 German Breast Group Breast Cancer March 2009 Phase 2|Phase 3
    NCT01165216 Bristol-Myers Squibb Non-Small Cell Lung Cancer September 2010 Phase 1
    NCT01998347 Shantou University Medical College Esophageal Cancer November 2013 Phase 3
    NCT01166542 Oncolytics Biotech Carcinoma, Squamous Cell of the Head and Neck June 2010 Phase 3
    NCT02366143 Hoffmann-La Roche Non-Small Cell Lung Cancer March 31, 2015 Phase 3
    NCT00226915 Japanese Gynecologic Oncology Group Epithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer April 2003 Phase 3
    NCT00984464 Oncolytics Biotech|University of Texas Metastatic Melanoma September 2009 Phase 2
    NCT02109445 Pfizer|Academic GI Cancer Consortium Metastatic Cancer Pancreas September 3, 2014 Phase 2
    NCT00049257 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI)|Bristol-Myers Squibb Prostate Cancer October 2002 Phase 2
    NCT03081143 Krankenhaus Nordwest Advanced Gastric or EGJ Cancer May 10, 2017 Phase 2
    NCT02926183 Wakayama Medical University Pancreatic Ductal Adenocarcinoma October 2016 Phase 2
    NCT00803556 Bristol-Myers Squibb Solid Tumor|Breast Cancer January 2006 Phase 1
    NCT02879318 Canadian Cancer Trials Group|AstraZeneca Pancreatic Adenocarcinoma August 2016 Phase 2
    NCT00666991 CritiTech, Inc.|University of Kansas Medical Center|Beckloff Associates, Inc. Peritoneal Neoplasms July 2008 Phase 1
    NCT00005028 University of Maryland|National Cancer Institute (NCI) Prostate Cancer May 2000 Phase 2
    NCT00183820 University of Southern California|Sanofi Testicular Cancer|Germ Cell Neoplasm November 2004 Phase 2
    NCT02526953 Blokhin's Russian Cancer Research Center Anus Neoplasms|Carcinoma, Squamous Cell|Anus Diseases|Neoplasms|Neoplasms, Squamous Cell|Carcinoma January 2016 Phase 3
    NCT00515073 M.D. Anderson Cancer Center Endometrial Cancer April 2001 Phase 2
    NCT00062062 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer October 2004 Phase 2
    NCT00297661 University of Bern|University of Zurich Coronary Heart Disease April 2003 Phase 4
    NCT00891072 National Cancer Institute (NCI) Adult Grade III Lymphomatoid Granulomatosis|Adult Nasal Type Extranodal NK/T-cell Lymphoma|Contiguous Stage II Adult Burkitt Lymphoma|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Contiguous Stage II Adult Lymphoblastic Lymphoma|Contiguous Stage II Grade 1 Follicular Lymphoma|Contiguous Stage II Grade 2 Follicular July 2009 Phase 1
    NCT01591135 Fudan University|Jiangsu Cancer Institute & Hospital|First Affiliated Hospital of Zhejiang University|The First Affiliated Hospital of Xiamen University|Fujian Cancer Hospital|Affiliated Hospital of Jiangnan University|Fudan University Shanghai Cancer Center Minhang Branch Esophageal Squamous Cell Carcinoma April 2012 Phase 3
    NCT00331630 Northwestern University|GlaxoSmithKline|Celgene Corporation Breast Cancer May 2006 Early Phase 1
    NCT00680940 Cadila Pharnmaceuticals Non Small Cell Lung Cancer June 2008 Phase 2
    NCT00998192 Oncolytics Biotech|University of Texas Metastatic or Recurrent Squamous Cell Carcinoma of the Lung October 2009 Phase 2
    NCT00551733 CTI BioPharma|National Cancer Institute (NCI) Lung Cancer August 2007 Phase 3
    NCT01010945 OSI Pharmaceuticals|Astellas Pharma Inc Advanced Pancreatic Cancer December 2009 Phase 1
    NCT01395537 Case Comprehensive Cancer Center Adenocarcinoma of the Esophagus|Adenocarcinoma of the Gastroesophageal Junction August 2011 Phase 1|Phase 2
    NCT00584857 University of Alabama at Birmingham Uterine Cancer July 2004 Phase 2
    NCT01688609 National Cancer Institute (NCI) HER2-positive Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer July 2012 Phase 2
    NCT02065687 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Adenocarcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Endometrial Undifferentiated Carcinoma|Recurrent Uterine Corpus Carcinoma|Stage IIIA Uterine Corpus Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIC Uterine Corpus Cancer|Stage IVA Uterine Corpus Cancer|Stage IVB Uterine Corpus Cancer March 2014 Phase 2|Phase 3
    NCT00499603 M.D. Anderson Cancer Center|Novartis|National Cancer Institute (NCI) Breast Cancer July 2007 Phase 2
    NCT00976573 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Melanoma (Skin) April 2010 Phase 2
    NCT01676649 Jewish General Hospital Untreated Stage III Melanoma or Stage IV Melanoma November 2012 Phase 2
    NCT01423123 NSABP Foundation Inc|Pfizer Breast Cancer May 2011 Phase 1
    NCT01320111 Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH|iOMEDICO AG Metastatic Breast Cancer July 1, 2010 Phase 2
    NCT00006276 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Psoriasis September 2000 Phase 2
    NCT00095914 National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific September 2004 Phase 1
    NCT00080418 INSYS Therapeutics Inc Neoplasm July 2003 Phase 1
    NCT00930930 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Breast Cancer June 2009 Phase 2
    NCT02570711 Acerta Pharma BV Metastatic Pancreatic Cancer October 2015 Phase 2
    NCT02142790 Nanjing Luye Sike Pharmaceutical Co.,Ltd. Breast Cancer May 2014 Phase 4
    NCT00023166 Enzon Pharmaceuticals, Inc. Neoplasm|Lymphomas|Neoplasm Metastasis May 2001 Phase 1
    NCT03038100 Hoffmann-La Roche|GOG|ENGOT Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Neoplasms March 8, 2017 Phase 3
    NCT01196429 National Cancer Institute (NCI) Ovarian Clear Cell Cystadenocarcinoma|Stage III Ovarian Cancer|Stage IV Ovarian Cancer August 2010 Phase 2
    NCT00675259 Ewa Mrozek|Celgene Corporation|Genentech, Inc.|Ohio State University Comprehensive Cancer Center Breast Cancer July 2008 Phase 2
    NCT00846027 Hoffmann-La Roche Breast Cancer January 2009 Phase 2
    NCT03026881 Jiangsu HengRui Medicine Co., Ltd.|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences Recurrent and Metastatic Gastric Cancer January 2017 Phase 1
    NCT00004126 University of Chicago|National Cancer Institute (NCI) Lung Cancer November 1999 Phase 2
    NCT01288261 University of Arizona|National Cancer Institute (NCI) Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|Male Breast Cancer|Recurrent Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer January 2011 Phase 1
    NCT00110019 National Cancer Institute (NCI) Mucosal Melanoma|Recurrent Melanoma|Stage IIIA Skin Melanoma|Stage IIIB Skin Melanoma|Stage IIIC Skin Melanoma|Stage IV Skin Melanoma June 2005 Phase 3
    NCT01953536 Endocyte Breast Neoplasms April 2014 Phase 2
    NCT00005032 University of Chicago|National Cancer Institute (NCI) Lung Cancer April 2000 Phase 1|Phase 2
    NCT01763645 Biocad Non-small Cell Lung Cancer October 2012 Phase 3
    NCT00003054 Gynecologic Oncology Group|National Cancer Institute (NCI) Sarcoma August 1997 Phase 2
    NCT00001442 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Head and Neck Neoplasm|Squamous Cell Carcinoma July 1995 Phase 1
    NCT00005849 University of Chicago|National Cancer Institute (NCI) Lung Cancer April 2000 Phase 2
    NCT00022620 European Organisation for Research and Treatment of Cancer - EORTC Endometrial Cancer June 2001 Phase 2
    NCT00785291 National Cancer Institute (NCI) Estrogen Receptor Negative|Estrogen Receptor Positive|HER2/Neu Negative|HER2/Neu Positive|Male Breast Carcinoma|Progesterone Receptor Negative|Progesterone Receptor Positive|Recurrent Breast Carcinoma|Stage IIIC Breast Cancer AJCC v6|Stage IV Breast Cancer October 2008 Phase 3
    NCT03058939 University of Chicago Breast Cancer|Breast Cancer Stage II|Breast Cancer Stage III November 2017 Phase 2
    NCT00126581 National Cancer Institute (NCI) Adenosquamous Lung Carcinoma|Bronchioloalveolar Carcinoma|Lung Adenocarcinoma|Malignant Pericardial Effusion|Malignant Pleural Effusion|Stage IIIB Non-Small Cell Lung Cancer|Stage IV Non-Small Cell Lung Cancer August 15, 2005 Phase 2
    NCT00972205 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Cervical|Ovarian|Lung|Breast|Renal December 2007
    NCT02269293 Memorial Sloan Kettering Cancer Center Ovarian Cancer|Endometrial Cancer October 13, 2014 Phase 1
    NCT00088114 Synta Pharmaceuticals Corp. Neoplasms January 2003 Phase 1
    NCT00002922 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer January 1997 Phase 2
    NCT00003377 Gynecologic Oncology Group|National Cancer Institute (NCI) Cervical Cancer November 1999 Phase 1
    NCT00002562 Gynecologic Oncology Group|National Cancer Institute (NCI) Cervical Cancer|Vaginal Cancer March 1994 Phase 2
    NCT00768131 Eli Lilly and Company|ImClone LLC Lung Neoplasms|Carcinoma, Non-Small-Cell Lung October 2008 Phase 2
    NCT02159820 Chinese PLA General Hospital Primary Malignant Neoplasm of Ovary|FIGO Stages II to IV June 2014 Phase 2|Phase 3
    NCT00537173 Hoosier Cancer Research Network|United States Department of Defense|Indiana University School of Medicine|University of Colorado, Denver|Baylor University|McGill University Breast Cancer September 2007
    NCT00002917 Mary Babb Randolph Cancer Center at West Virginia University Hospitals|National Cancer Institute (NCI) Bladder Cancer November 1996 Phase 1|Phase 2
    NCT01711970 Vascular Biogenics Ltd. operating as VBL Therapeutics Platinum Resistant Ovarian Cancer November 2012 Phase 1|Phase 2
    NCT00002928 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Ovarian Cancer January 1997 Phase 2
    NCT00356681 Amgen Breast Neoplasms|Breast Tumors|Breast Cancer|Locally Recurrent and Metastatic Breast Cancer December 2006 Phase 2
    NCT00616967 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer May 2008 Phase 2
    NCT00004265 University of Wisconsin, Madison|National Cancer Institute (NCI) Lung Cancer February 1999 Phase 2
    NCT01293630 Sanofi Advanced Solid Tumors January 2011 Phase 1
    NCT02739698 Maimónides Biomedical Research Institute of Córdoba Peritoneal Carcinomatosis July 2012 Phase 2
    NCT00942357 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Stage IA Uterine Corpus Cancer|Stage IB Uterine Corpus Cancer|Stage II Uterine Corpus Cancer|Stage IIIA Uterine Corpus Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIC Uterine Corpus Cancer|Stage IVA Uterine Corpus Cancer June 2009 Phase 3
    NCT00343291 Eli Lilly and Company|ImClone LLC Non-Small Cell Lung Cancer December 2006 Phase 2
    NCT01016041 Maasstad Hospital Stable Angina|Unstable Angina|Acute Coronary Syndrome February 2007 Phase 3
    NCT02322814 Hoffmann-La Roche Breast Cancer November 25, 2014 Phase 2
    NCT00889382 Astellas Pharma Inc Solid Tumors|Ovarian Cancer July 2009 Phase 1|Phase 2
    NCT01182610 Accelerated Community Oncology Research Network|Amgen Gastroesophageal Adenocarcinoma|Adenocarcinoma of the Distal Esophagus|Adenocarcinomas of the Gastroesophageal Junction|Adenocarcinoma of the Proximal Stomach April 2011 Phase 2
    NCT00003327 Theradex|National Cancer Institute (NCI) Head and Neck Cancer September 1997 Phase 2
    NCT00111787 GlaxoSmithKline Neoplasms, Breast April 11, 2005 Phase 2
    NCT02810418 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Neoplasms|Pancreatic Neoplasms June 10, 2016 Phase 1|Phase 2
    NCT00003326 Theradex|National Cancer Institute (NCI) Esophageal Cancer September 1997 Phase 2
    NCT02243007 Massachusetts General Hospital Resectable Pancreatic Cancer|Pancreatic Ductal Carcinoma September 2014 Phase 2
    NCT00028535 National Cancer Institute (NCI) Male Breast Cancer|Recurrent Breast Cancer|Recurrent Endometrial Carcinoma|Recurrent Gastric Cancer|Recurrent Non-small Cell Lung Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Small Cell Lung Cancer November 2001 Phase 1
    NCT03214250 Parker Institute for Cancer Immunotherapy|Bristol-Myers Squibb|Apexigen, Inc.|Cancer Research Institute, New York City Metastatic Pancreatic Adenocarcinoma July 14, 2017 Phase 1|Phase 2
    NCT01644890 Nippon Kayaku Co.,Ltd. Breast Cancer Nos Metastatic Recurrent July 2012 Phase 3
    NCT02412371 AbbVie Non-small Cell Lung Cancer Stage III April 30, 2015 Phase 2
    NCT00130546 University Hospital Freiburg|Cordis Medizinische Apparate GmbH Coronary Artery Disease November 2004 Phase 3
    NCT01570582 Korean Gynecologic Oncology Group Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cancer March 2010 Phase 2
    NCT00272987 Novartis Pharmaceuticals|Novartis Neoplasms, Breast December 13, 2005 Phase 3
    NCT00023907 Gynecologic Oncology Group|National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer July 2001 Phase 2
    NCT02073487 Jenny C. Chang, MD|Celgene Corporation|Novartis|The Methodist Hospital System Breast Cancer February 2014 Phase 2
    NCT02504333 Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) Metastatic Pancreatic Adenocarcinoma July 2015 Phase 1|Phase 2
    NCT00006081 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Esophageal Cancer|Gastric Cancer June 2000 Phase 2
    NCT00002949 University of Chicago|National Cancer Institute (NCI) Bladder Cancer|Cervical Cancer|Endometrial Cancer|Vaginal Cancer July 1996 Phase 1
    NCT02212015 Heidelberg University|Universitätsmedizin Mannheim|HELIOS Klinikum Berlin-Buch|University Hospital Dresden|Universitätsklinikum Hamburg-Eppendorf|University Hospital, Essen|Hannover Medical School|Klinikum der Universitaet Muenchen, Grosshadern|Medical University of Vienna|Medical University of Graz|Medical University Innsbruck|GlaxoSmithKline Angiosarcoma July 2014 Phase 2
    NCT00088556 Telik Carcinoma, Non-Small-Cell Lung August 2004 Phase 1|Phase 2
    NCT00054548 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific October 2002 Phase 1
    NCT02142010 Nanjing Luye Sike Pharmaceutical Co.,Ltd. Breast Cancer August 2014
    NCT00513292 National Cancer Institute (NCI) HER2/Neu Positive|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer July 2007 Phase 3
    NCT00955214 Society for Advancement of Coronary Intervention Research Stable Angina Pectoris|Unstable Angina Pectoris April 2009 Phase 4
    NCT02430311 AstraZeneca Advanced Solid Tumours June 10, 2015 Phase 1
    NCT00583830 Human Genome Sciences Inc. Non Small Cell Lung Cancer January 2007 Phase 2
    NCT00486668 NSABP Foundation Inc|GlaxoSmithKline Invasive Breast Cancer July 2007 Phase 3
    NCT00472472 University Hospital, Saarland Peripheral Arterial Disease April 2004 Phase 1|Phase 2
    NCT00003193 Massachusetts General Hospital Head and Neck Cancer|Oral Complications January 1998 Phase 1|Phase 2
    NCT01918254 Hoffmann-La Roche Breast Cancer August 6, 2013 Phase 1
    NCT01090830 Holy Cross Hospital, Florida Non-Small-Cell Lung Carcinoma April 2010 Phase 1|Phase 2
    NCT00094835 Amgen Lung Cancer|Non-Small Cell Lung Cancer January 2005 Phase 1|Phase 2
    NCT00297804 Boston Scientific Corporation Coronary Artery Disease May 2002 Phase 2|Phase 3
    NCT00113438 Mateon Therapeutics Cancer|Tumor March 2005 Phase 2
    NCT00024375 Theradex|National Cancer Institute (NCI) Pancreatic Cancer June 2001 Phase 2
    NCT01705691 NSABP Foundation Inc|Eisai Inc. Breast Cancer|HER2-negative Breast Cancer September 2012 Phase 2
    NCT01593020 M.D. Anderson Cancer Center|Eisai Inc. Breast Cancer August 2012 Phase 2
    NCT03132532 Mayo Clinic Non Small Cell Lung Cancer June 2017 Phase 2
    NCT00653939 Mateon Therapeutics Tumors March 2008 Phase 2
    NCT00024414 Theradex|National Cancer Institute (NCI) Prostate Cancer April 2001 Phase 2
    NCT03092986 Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Carcinoma, Non-Small-Cell Lung April 2017 Phase 3
    NCT01911598 Genentech, Inc. Head and Neck Cancer September 19, 2013 Phase 1
    NCT00003160 Theradex|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer September 1997 Phase 2
    NCT02936622 Cook Group Incorporated Peripheral Arterial Disease (PAD) February 21, 2017
    NCT02183194 C. R. Bard Dysfunctional AV Graft|Dysfunctional AV Fistula July 2014
    NCT00077688 OncoGenex Technologies Bladder Neoplasms|Ureteral Neoplasms|Urethral Neoplasms|Carcinoma, Transitional Cell November 2003 Phase 2
    NCT01471132 Peking University Gastric Cancer|Metastases to Perineum September 2011 Phase 2
    NCT00001383 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Breast Cancer|Cancer|Carcinoma, Renal Cell|Lymphoma|Ovarian Cancer March 1994 Phase 1
    NCT01100931 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) NSCLC|Solid Tumors February 2010 Phase 1|Phase 2
    NCT00995423 CardioVascular Research Foundation, Korea Coronary Artery Disease April 2008 Phase 4
    NCT00022139 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Esophageal Cancer|Gastric Cancer January 2002 Phase 2
    NCT00459810 OHSU Knight Cancer Institute|National Cancer Institute (NCI) Prostate Cancer February 2007 Phase 2
    NCT00146575 Deutsches Herzzentrum Muenchen Coronary Disease June 2003 Phase 4
    NCT00352690 Washington University School of Medicine|CTI BioPharma Carcinoma, Non-Small-Cell Lung April 2006 Phase 2
    NCT02264990 AbbVie Non-squamous Non-small Cell Lung Cancer September 30, 2014 Phase 3
    NCT00003440 National Cancer Institute (NCI) HER2-negative Breast Cancer|HER2-positive Breast Cancer|Recurrent Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer July 1998 Phase 3
    NCT01656538 Canadian Cancer Trials Group|Oncolytics Biotech Metastatic Breast Cancer July 30, 2012 Phase 2
    NCT00816634 Samsung Medical Center First Line Chemotherapy|Capecitabine Plus Cisplatin Versus Capecitabine Plus Paclitaxel|Advanced or Recurrent Esophageal Squamous Cell Carcinoma October 2008 Phase 2
    NCT02715804 Halozyme Therapeutics Stage IV Pancreatic Ductal Adenocarcinoma February 2016 Phase 3
    NCT00645177 AbbVie (prior sponsor, Abbott)|Genentech, Inc.|AbbVie Metastatic Breast Cancer July 2008 Phase 2
    NCT00002969 Southwest Oncology Group|National Cancer Institute (NCI) Lung Cancer May 1997 Phase 2
    NCT00647218 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Breast Cancer February 2000
    NCT03126708 Peking University Esophageal Cancer, Squamous Cell|Cetuximab Effect|Chemotherapy Effect April 2017 Phase 2
    NCT00158379 North Eastern Germany Society of Gynaecologic Oncology Ovarian Cancer July 2003 Phase 2
    NCT00466960 University of Washington|National Cancer Institute (NCI) Brenner Tumor|Fallopian Tube Cancer|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mixed Epithelial Carcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial Cancer|Stage III Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer May 2006 Phase 2
    NCT00147537 Pfizer Carcinoma, Non-Small-Cell Lung February 2005 Phase 1|Phase 2
    NCT02581943 Wake Forest University Health Sciences|National Cancer Institute (NCI) Recurrent Non-Small Cell Lung Carcinoma|Stage IIIB Non-Small Cell Lung Cancer|Stage IV Non-Small Cell Lung Cancer May 2016 Phase 2
    NCT02426281 Samsung Medical Center Pancreatic Ductal Adenocarcinoma June 4, 2015 Phase 2
    NCT01215136 Matthew Galsky|Hoosier Cancer Research Network|Novartis Pharmaceuticals Transitional Cell Carcinoma|Bladder Carcinoma|Urothelial Carcinoma December 2010 Phase 2
    NCT00301522 Boston Scientific Corporation Coronary Stenosis February 2003 Phase 2|Phase 3
    NCT01848197 Taizhou Hospital Breast Cancer|Paclitaxel|Epirubicin|Cyclophosphamide May 2013
    NCT01523678 Belgian Gynaecological Oncology Group Ovarian Cancer|Endometrial Cancer|Uterine Cervical Cancer February 2012 Phase 2
    NCT02449655 Samsung Medical Center Advanced Gastric Adenocarcinoma February 12, 2015 Phase 2
    NCT00770809 National Cancer Institute (NCI) HER2/Neu Positive|Male Breast Carcinoma|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer December 2008 Phase 3
    NCT00089297 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer December 2004 Phase 2
    NCT01836679 Chipscreen Biosciences, Ltd. Non-small-cell Lung Cancer April 2013 Phase 2
    NCT00915369 Fresenius Kabi Oncology Ltd. Advanced Breast Cancer March 2009 Phase 1
    NCT00955305 National Cancer Institute (NCI) Large Cell Lung Carcinoma|Lung Adenocarcinoma|Recurrent Non-Small Cell Lung Carcinoma|Stage IV Non-Small Cell Lung Cancer|Bronchioloalveolar Lung Carcinoma March 2010 Phase 2
    NCT02520154 M.D. Anderson Cancer Center|Merck Sharp & Dohme Corp. Ovarian Cancer|Metastatic Ovarian Cancer July 2016 Phase 2
    NCT00404235 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Melanoma (Skin) October 2006 Phase 2
    NCT02370498 Merck Sharp & Dohme Corp. Gastric Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma May 2015 Phase 3
    NCT00077246 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Lung Cancer September 2003 Phase 1|Phase 2
    NCT00063999 Gynecologic Oncology Group|National Cancer Institute (NCI) Recurrent Uterine Corpus Carcinoma|Stage IIIA Uterine Corpus Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIC Uterine Corpus Cancer|Stage IVA Uterine Corpus Cancer|Stage IVB Uterine Corpus Cancer August 2003 Phase 3
    NCT01419548 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Neoplasms July 29, 2011 Phase 1
    NCT02158520 Academic and Community Cancer Research United|National Cancer Institute (NCI) Metastatic Melanoma|Mucosal Melanoma|Recurrent Melanoma|Stage IV Skin Melanoma|Stage IV Uveal Melanoma October 2013 Phase 2
    NCT02775435 Merck Sharp & Dohme Corp. Non-small Cell Lung Cancer June 9, 2016 Phase 3
    NCT02172846 Washington University School of Medicine Carcinoma, Non-Small-Cell Lung May 22, 2014 Phase 1
    NCT01820325 Novartis Pharmaceuticals|Novartis Non-Small Cell Lunch Cancer September 2013 Phase 1|Phase 2
    NCT00038246 M.D. Anderson Cancer Center|Celgene Corporation Prostate Cancer October 2000 Phase 1|Phase 2
    NCT00136175 University of Michigan Cancer Center Bladder Cancer November 1999 Phase 2
    NCT01663727 Hoffmann-La Roche Metastatic Breast Cancer August 2012 Phase 3
    NCT00226746 New York Methodist Hospital|Hani Ashamalla, MD, FCCP Carcinoma, Pancreatic Ductal March 2003 Phase 2
    NCT00596830 Pfizer Carcinoma, Squamous Cell|Carcinoma, Adenosquamous|Carcinoma, Large Cell|Carcinoma, Non-Small-Cell Lung April 2008 Phase 3
    NCT00041470 University of Washington|Amgen|Bristol-Myers Squibb|GlaxoSmithKline Breast Cancer March 2001 Phase 1|Phase 2
    NCT00793897 Bristol-Myers Squibb Advanced Solid Tumors|Metastatic Solid Tumors April 2009 Phase 1
    NCT00912639 Korean Breast Cancer Study Group Recurrent Breast Cancer May 2009 Phase 4
    NCT01051934 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Non-Small Cell Lung Cancer|Adenocarcinoma December 29, 2009 Phase 1
    NCT02621398 Rutgers, The State University of New Jersey|National Cancer Institute (NCI)|Rutgers Cancer Institute of New Jersey|Merck Sharp & Dohme Corp. Stage II Non-Small Cell Lung Cancer|Stage IIIA Non-Small Cell Lung Cancer|Stage IIIB Non-Small Cell Lung Cancer April 2016 Phase 1
    NCT00278122 University of Virginia|National Cancer Institute (NCI) Melanoma (Skin) July 2005 Phase 2
    NCT01847326 University of Chicago|National Cancer Institute (NCI) Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Recurrent Verrucous Carcinoma of the Larynx|Recurrent Verrucous Carcinoma of the Oral Cavity|Salivary Gland Squamous Cell Carci March 2013 Phase 1
    NCT02550327 Baylor Research Institute Pancreatic Adenocarcinoma January 2016 Early Phase 1
    NCT01163929 University of Kansas|Novartis|University of Kansas Medical Center Breast Cancer July 2010 Phase 2
    NCT03086369 Eli Lilly and Company Metastatic Pancreatic Cancer June 22, 2017 Phase 1|Phase 2
    NCT01921751 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|NRG Oncology Pancreatic Adenocarcinoma|Stage III Pancreatic Cancer August 2013 Phase 2
    NCT01587482 Nantes University Hospital Peripheral Arterial Disease December 2011
    NCT00322569 Cordis Corporation|Conor Medsystems Coronary Disease July 2006 Phase 3
    NCT02101021 Gilead Sciences Metastatic Pancreatic Ductal Adenocarcinoma June 2, 2014 Phase 3
    NCT01593306 Indira Gandhi Medical College Carcinoma Cervix July 2011 Phase 3
    NCT00806286 Daiichi Sankyo Inc. Metastatic Non-small Cell Lung Cancer December 2008 Phase 2
    NCT00042809 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific May 2002 Phase 1
    NCT00265733 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer February 2006 Phase 2
    NCT00154804 National Taiwan University Hospital Esophageal Cancer August 2001 Phase 2
    NCT00002972 European Organisation for Research and Treatment of Cancer - EORTC Lung Cancer January 1997 Phase 2
    NCT00874848 Biothera NSCLC August 2009 Phase 2
    NCT03125928 Fox Chase Cancer Center|Genentech, Inc. HER2-positive Breast Cancer June 6, 2017 Phase 2
    NCT02898077 Eli Lilly and Company Gastroesophageal Junction Adenocarcinoma|Gastric Adenocarcinoma March 2, 2017 Phase 3
    NCT00378313 NSABP Foundation Inc Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IV Breast Cancer|Breast Cancer|Locally Advanced November 2001 Phase 2
    NCT00748163 Masonic Cancer Center, University of Minnesota Lung Cancer August 2008 Phase 2
    NCT00084214 Synta Pharmaceuticals Corp. Melanoma May 2004 Phase 1|Phase 2
    NCT00087802 Sanofi Carcinoma, Non-Small-Cell Lung March 2004 Phase 3
    NCT02053597 Jules Bordet Institute Breast Cancer October 2014 Phase 2
    NCT00295789 Haruhiko Fukuda|Ministry of Health, Labour and Welfare, Japan|Japan Clinical Oncology Group Uterine Cervical Neoplasms February 2006 Phase 3
    NCT00453323 National Cancer Center, Korea Esophageal Cancer June 2006 Phase 2
    NCT00609791 City of Hope Medical Center|National Cancer Institute (NCI) Breast Cancer January 25, 2008 Phase 2
    NCT01519804 Genentech, Inc. Non-Squamous Non-Small Cell Lung Cancer April 2012 Phase 2
    NCT02037529 Academic and Community Cancer Research United Metastatic Breast Cancer|Locally Recurrent Breast Cancer March 2014 Phase 3
    NCT00729612 Greg Otterson|National Comprehensive Cancer Network|Celgene Corporation|Ohio State University Comprehensive Cancer Center Lung Cancer August 2008 Phase 2
    NCT01320592 Abramson Cancer Center of the University of Pennsylvania Breast Cancer March 2011 Phase 1
    NCT00535119 National Cancer Institute (NCI) Adult Solid Neoplasm|BRCA1 Mutation Carrier|BRCA2 Mutation Carrier|Hereditary Breast and Ovarian Cancer Syndrome September 2007 Phase 1
    NCT01862328 Millennium Pharmaceuticals, Inc.|Takeda Solid Tumors July 1, 2013 Phase 1
    NCT02743923 The Netherlands Cancer Institute|Dutch Society of Physicians for Pulmonology and Tuberculosis Carcinoma, Non-Small Cell Lung April 2016 Phase 3
    NCT01493505 Amgen Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cancer January 2012 Phase 3
    NCT02364999 Pfizer Non-Small Cell Lung Cancer April 20, 2015 Phase 3
    NCT00002632 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer March 1995 Phase 2
    NCT00002662 Aventis Pharmaceuticals|National Cancer Institute (NCI) Breast Cancer August 1994 Phase 3
    NCT01090128 University of Utah|Celgene Corporation Stages II-III Breast Cancer September 2008 Phase 1
    NCT00316407 Swedish Medical Center|GlaxoSmithKline Ovarian Epithelial Cancer Stage III|Stage IV Ovarian Cancer|Stage IV Breast Cancer August 2005 Phase 1|Phase 2
    NCT00807768 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Fatigue|Neurotoxicity Syndrome|Obesity|Stage I Uterine Corpus Cancer|Stage II Uterine Corpus Cancer March 2009 Phase 3
    NCT00373256 Pfizer Breast Neoplasms November 2006 Phase 3
    NCT00733408 University of Washington|National Cancer Institute (NCI) Estrogen Receptor-negative Breast Cancer|HER2-negative Breast Cancer|Progesterone Receptor-negative Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer|Triple-negative Breast Cancer April 23, 2008 Phase 2
    NCT00680758 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Breast Cancer May 2008 Phase 1
    NCT00642759 Massachusetts General Hospital|Dana-Farber Cancer Institute|Celgene Corporation|Genentech, Inc. Non-small Cell Lung Cancer April 2008 Phase 2
    NCT01927068 Spectranetics Corporation Peripheral Arterial Disease July 2013
    NCT00003117 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer October 1997 Phase 3
    NCT00738699 Morphotek Ovarian Cancer September 2008 Phase 2
    NCT00066716 Weill Medical College of Cornell University|Pfizer Esophageal Cancer June 2003 Phase 2
    NCT00151060 University of Michigan Cancer Center Prostate Cancer December 1998 Phase 2
    NCT01873326 Memorial Sloan Kettering Cancer Center|University of Southern California|Mayo Clinic|University of Pittsburgh|University of North Carolina|University of Chicago|Stanford University|University of Texas Southwestern Medical Center Germ Cell Tumors June 2013 Phase 2
    NCT00421889 Onxeo Ovarian Cancer|Epithelial Ovarian Cancer|Fallopian Tube Cancer|Bladder Cancer August 2005 Phase 1|Phase 2
    NCT00091377 MEI Pharma, Inc. Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer August 2004 Phase 1|Phase 2
    NCT00077129 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Kidney Cancer September 2004 Phase 2
    NCT00009802 University of Pittsburgh|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific June 1998 Phase 1
    NCT02774473 Abramson Cancer Center of the University of Pennsylvania Breast Neoplasms February 2016
    NCT01938846 Boehringer Ingelheim Neoplasms September 5, 2013 Phase 1
    NCT00003230 Swiss Group for Clinical Cancer Research Leukemia January 1998 Phase 1|Phase 2
    NCT00861627 Oncolytics Biotech Carcinoma, Non-small Cell Lung March 2009 Phase 2
    NCT00063401 ImClone LLC|Bristol-Myers Squibb Ovarian Cancer|Peritoneal Neoplasms|Fallopian Tube Neoplasms September 2003 Phase 2
    NCT00016315 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Lung Cancer May 2001 Phase 1
    NCT00003299 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|North Central Cancer Treatment Group|Eastern Cooperative Oncology Group|Southwest Oncology Group Lung Cancer April 1998 Phase 3
    NCT00006459 Eli Lilly and Company Breast Cancer July 2000 Phase 3
    NCT00084448 Gynecologic Oncology Group|National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer April 2004 Phase 2
    NCT02051868 Royal Marsden NHS Foundation Trust|Cancer Research UK|Australasian Gastro-Intestinal Trials Group|ECOG-ACRIN Cancer Research Group|European Organisation for Research and Treatment of Cancer - EORTC|International Rare Cancers Initiative (IRCI ) This study is indorsed by IRCI Squamous Cell Carcinoma of the Anus December 2013 Phase 2
    NCT00014599 European Organisation for Research and Treatment of Cancer - EORTC Vulvar Cancer February 2001 Phase 2
    NCT00322452 AstraZeneca Non-Small Cell Lung Cancer March 2006 Phase 3
    NCT02414685 National Cancer Institute, Slovakia Germ Cell Tumor April 2015 Phase 2
    NCT00117442 Amgen Breast Cancer|Lung Cancer|Ovarian Cancer August 2002 Phase 2
    NCT00262847 National Cancer Institute (NCI) Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Malignant Ovarian Mixed Epithelial Tumor|Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Primary Peritoneal Serous Adenocarcinoma|Stage IIIA Fallopian Tube September 2005 Phase 3
    NCT00025688 Theradex|National Cancer Institute (NCI) Breast Cancer January 2001 Phase 3
    NCT00096200 National Cancer Institute (NCI) Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma August 2004 Phase 2
    NCT02461043 Chinese Academy of Medical Sciences Esophageal Cancer April 2015 Phase 3
    NCT00001450 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Carcinoma, Non-Small-Cell Lung|Lung Neoplasms September 1995 Phase 2
    NCT00440674 Conor Medsystems Coronary Artery Disease February 2007 Phase 4
    NCT00879359 The Cleveland Clinic|Genentech, Inc. Endometrial Carcinoma December 2007 Phase 2
    NCT00989651 National Cancer Institute (NCI) Fallopian Tube Carcinosarcoma|Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Neoplasm|Fallopian Tube Transitional Cell Carcinoma|Ovarian Brenner Tumor|Ovarian Carcinosarcoma|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Seromucinous Tumor|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Primary Peritoneal Serous Adenoca October 28, 2009 Phase 1
    NCT00002937 City of Hope Medical Center|National Cancer Institute (NCI) Breast Cancer June 1996 Phase 2
    NCT02588443 Abramson Cancer Center of the University of Pennsylvania Pancreatic Cancer October 2015 Phase 1
    NCT01036087 M.D. Anderson Cancer Center|Celgene Corporation|Amgen Breast Cancer November 2010 Phase 2
    NCT00838656 Warwick Medical School|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer October 2007 Phase 2
    NCT00964626 Russian Academy of Medical Sciences|National Cancer Institute (NCI) Ovarian Cancer April 2009 Phase 2
    NCT01362374 Genentech, Inc. Neoplasms July 11, 2011 Phase 1
    NCT02020707 Mayo Clinic|National Cancer Institute (NCI) Cervical Adenosarcoma|Cervical Adenosquamous Carcinoma|Cervical Carcinosarcoma|Cervical Squamous Cell Carcinoma, Not Otherwise Specified|Endometrial Clear Cell Adenocarcinoma|Endometrial Endometrioid Adenocarcinoma|Endometrial Mixed Adenocarcinoma|Endometrial Mucinous Adenocarcinoma|Endometrial Squamous Cell Carcinoma|Endometrial Transitional Cell Carcinoma|Endometrial Undifferentiated Carcinoma|Fallopian Tube Adenocarcinoma|Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Mucinous Adenoc March 2014 Phase 1
    NCT00434252 Genentech, Inc. Melanoma February 2007 Phase 2
    NCT00347412 Cellectar Biosciences, Inc. Non Small Cell Lung Cancer November 2006 Phase 3
    NCT00409383 Genta Incorporated Melanoma November 2006 Phase 1
    NCT01253525 Eli Lilly and Company Adenocarcinoma November 2010 Phase 1
    NCT00005046 Gynecologic Oncology Group|National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer April 2000 Phase 1
    NCT00704145 A.O. Ospedale Papa Giovanni XXIII|Case Western Reserve University|Boston Scientific Corporation Coronary Artery Disease November 2007 Phase 4
    NCT02358200 University of California, San Francisco|QuantumLeap Healthcare Collaborative Triple Negative Metastatic Breast Cancer|BRCA-mutated Solid Tumor February 23, 2015 Phase 1
    NCT00584909 University of Alabama at Birmingham Uterine Cancer March 2006 Phase 2
    NCT00003592 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer September 1998 Phase 3
    NCT03168880 Tata Memorial Hospital Triple Negative Breast Cancer April 2010 Phase 3
    NCT00408070 UConn Health|Genentech, Inc. Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer|Stage 3 Cancer|Stage 4 Cancer October 2006 Phase 2
    NCT00004013 Fred Hutchinson Cancer Research Center|National Cancer Institute (NCI) Breast Cancer January 1999 Phase 2
    NCT00193206 SCRI Development Innovations, LLC|Eli Lilly and Company|Celgene Corporation Breast Cancer September 2005 Phase 2
    NCT01930292 Debiopharm International SA Solid Tumors April 2013 Phase 1
    NCT01015118 Boehringer Ingelheim Ovarian Neoplasms|Peritoneal Neoplasms November 2009 Phase 3
    NCT00316199 Eli Lilly and Company Metastatic Breast Cancer April 2006 Phase 2
    NCT02560298 ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group Anal Basaloid Carcinoma|Anal Canal Cloacogenic Carcinoma|Anal Squamous Cell Carcinoma|Metastatic Anal Canal Carcinoma|Recurrent Anal Canal Carcinoma|Stage IIIB Anal Canal Cancer|Stage IV Anal Canal Cancer January 2016 Phase 2
    NCT00367471 Novartis Pharmaceuticals|Novartis Neoplasms, Breast December 7, 2006 Phase 1
    NCT00903942 University of Rochester|Celgene Corporation Non-small Cell Lung Cancer, Stage III March 2008 Phase 2
    NCT01015339 Peking University|Roche Pharma AG Advanced Gastric Cancer November 2009 Phase 3
    NCT02876107 M.D. Anderson Cancer Center|Amgen Malignant Neoplasm of Breast October 2016 Phase 2
    NCT00041119 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer May 2002 Phase 3
    NCT00189553 ARCAGY/ GINECO GROUP|Schering-Plough|Arbeitsgemeinschaft Gynaekologische Onkologie Austria|AGO Study Group|ANZGOG|European Organisation for Research and Treatment of Cancer - EORTC|NCIC Clinical Trials Group|NSGO Ovarian Cancer|Fallopian Tube Cancer April 2005 Phase 3
    NCT02599363 Abramson Cancer Center of the University of Pennsylvania Advanced Breast Cancer January 2016 Phase 1
    NCT01329627 Instituto do Cancer do Estado de São Paulo|Fundação Faculdade de Medicina Locally Advanced HER2-negative Breast Cancer August 2010 Phase 2
    NCT00004057 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific December 1998 Phase 1
    NCT02607332 Asan Medical Center Gastrointestinal Stromal Tumors November 2015 Phase 2
    NCT00977574 National Cancer Institute (NCI) Endometrial Adenocarcinoma|Endometrial Adenosquamous Carcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Recurrent Uterine Corpus Carcinoma|Stage IIIA Uterine Corpus Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIC Uterine Corpus Cancer|Stage IVA Uterine Corpus Cancer|Stage IVB Uterine Corpus Cancer September 2009 Phase 2
    NCT01009983 Wake Forest University Health Sciences Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer March 2010 Phase 2
    NCT00655876 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|NRG Oncology Esophageal Cancer June 2008 Phase 3
    NCT02501954 Women's Cancer Care Associates, LLC Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Stage IIIA Uterine Corpus Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIC Uterine Corpus Cancer|Stage IVA Uterine Corpus Cancer March 2015 Phase 3
    NCT01378533 Chinese Academy of Medical Sciences Breast Cancer May 2011 Phase 3
    NCT01853748 Dana-Farber Cancer Institute Breast Cancer May 2013 Phase 2
    NCT00334802 Eli Lilly and Company Metastatic Breast Cancer June 2006 Phase 2
    NCT00270491 ARCAGY/ GINECO GROUP Breast Cancer|Neoplasm Metastasis December 2005 Phase 2
    NCT02317419 Hoffmann-La Roche Cancer December 2014 Phase 1
    NCT00003518 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Ovarian Cancer|Testicular Germ Cell Tumor January 1999 Phase 2
    NCT01898117 The Netherlands Cancer Institute|Borstkanker Onderzoek Groep|Roche Pharma AG Breast Cancer July 2013 Phase 2
    NCT00299026 Boston Scientific Corporation Coronary Artery Disease June 2001 Phase 2
    NCT00387374 National Cancer Institute (NCI) Adenosquamous Cell Lung Cancer|Drug/Agent Toxicity by Tissue/Organ|Hemoptysis|Squamous Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer October 2006 Phase 2
    NCT00467012 Chugai Pharmaceutical Metastatic Breast Cancer April 2007 Phase 2
    NCT00795340 NCIC Clinical Trials Group|Canadian Cancer Trials Group Lung Cancer November 2008 Phase 3
    NCT01042522 Gynecologic Oncology Group|National Cancer Institute (NCI) Ovarian Granulosa Cell Tumor|Ovarian Gynandroblastoma|Ovarian Sertoli-Leydig Cell Tumor|Ovarian Sex Cord Tumor With Annular Tubules|Ovarian Sex Cord-Stromal Tumor|Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types|Ovarian Steroid Cell Tumor February 2010 Phase 2
    NCT00796991 Bristol-Myers Squibb|Medarex Advanced Melanoma February 2009 Phase 1
    NCT00021372 Fox Chase Cancer Center|National Cancer Institute (NCI) Lymphoma February 1996 Phase 2
    NCT00003717 St. Barnabas Medical Center|National Cancer Institute (NCI) Prostate Cancer October 1998 Phase 2
    NCT00004173 Ohio State University Comprehensive Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific October 1999 Phase 1
    NCT01031446 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Breast Cancer October 2009 Phase 1|Phase 2
    NCT00003614 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Prostate Cancer December 1998 Phase 2
    NCT00247208 North Texas Veterans Healthcare System|Clark R. Gregg Fund, Harris Methodist Foundation|University of Arkansas|VA Office of Research and Development|Michael Debakey Veterans Affairs Medical Center|Southern Arizona VA Health Care System|Onassis Cardiac Surgery Centre Coronary Artery Bypass|Arteriosclerosis May 2005 Phase 3
    NCT02395705 Henan Cancer Hospital|Tianjin Medical University Cancer Institute and Hospital|Cancer Institute and Hospital, Chinese Academy of Medical Sciences|Beijing Cancer Hospital|Hunan Province Tumor Hospital|Sun Yat-sen University Esophageal Neoplasm June 2015 Phase 3
    NCT00533585 M.D. Anderson Cancer Center|Bayer Lung Cancer May 2006 Phase 1
    NCT00281658 Novartis Pharmaceuticals|Novartis Neoplasms, Breast January 2, 2006 Phase 3
    NCT02625740 University of Rome Tor Vergata Peripheral Arterial Disease, Angioplasty November 2013
    NCT00005649 Hoffmann-La Roche|National Cancer Institute (NCI) Breast Cancer July 1998 Phase 2
    NCT00479817 Amgen Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer July 5, 2007 Phase 2
    NCT00031876 Swiss Group for Clinical Cancer Research Breast Cancer May 2000 Phase 1|Phase 2
    NCT00176267 Susanne Arnold|Bristol-Myers Squibb|University of Kentucky Squamous Cell Carcinoma September 2002 Phase 2
    NCT00001569 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Carcinoma|Peritoneal Neoplasm January 1997 Phase 1
    NCT00006257 City of Hope Medical Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific November 2000 Phase 1
    NCT02121990 Memorial Sloan Kettering Cancer Center|AstraZeneca|Genentech, Inc. Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer April 21, 2014 Phase 1
    NCT02012192 Medical University Innsbruck|European Commission Epithelial Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer June 2014 Phase 1|Phase 2
    NCT00326456 National Cancer Institute, Naples Ovarian Cancer January 2003 Phase 3
    NCT00003896 Southwest Oncology Group|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer September 1999 Phase 2
    NCT00245154 NCIC Clinical Trials Group|Canadian Cancer Trials Group Lung Cancer September 2005 Phase 2|Phase 3
    NCT01156961 Hoffmann-La Roche Breast Cancer October 2010 Phase 4
    NCT03101748 M.D. Anderson Cancer Center|Puma Biotechnology, Inc. Malignant Neoplasm of Breast August 2017 Phase 1|Phase 2
    NCT00600340 Central European Cooperative Oncology Group Metastatic Breast Cancer April 2008 Phase 3
    NCT00518284 Celgene Corporation|Celgene Vascular Disease, Peripheral January 2008 Phase 2
    NCT01334268 Medtronic Vascular Ischemic Heart Disease|Stenotic Coronary Lesion|Cardiovascular Diseases|Arteriosclerosis|Coronary Artery Disease September 2011
    NCT00403130 George Albert Fisher|Genentech, Inc.|Eli Lilly and Company|Stanford University Breast Cancer|Metastatic Breast Cancer February 2006 Phase 2
    NCT00003555 State University of New York - Upstate Medical University|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific July 1998 Phase 1
    NCT00724386 University of Chicago|Amgen Breast Cancer June 1999 Phase 1
    NCT00370552 R-Pharm Metastatic Breast Cancer March 2007 Phase 2
    NCT01260870 Bayer PAD August 2011 Phase 2
    NCT00004159 University of Alabama at Birmingham|National Cancer Institute (NCI) Lung Cancer February 2000 Phase 1|Phase 2
    NCT02048020 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) Human Papilloma Virus Infection|Stage III Squamous Cell Carcinoma of the Hypopharynx|Stage III Squamous Cell Carcinoma of the Larynx|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage III Verrucous Carcinoma of the Larynx|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Verrucous Carcinoma of the Larynx|Stage IVA Squamous Cell Carcinoma of the Larynx|Stage IVA Squamous Cell Carcinoma of the Oropharynx|Stage IVA Verrucous Carcinoma of the Larynx|Stage IVB Squamous Cell Carcinom December 26, 2013 Phase 2
    NCT00251472 Veeda Oncology|Celgene Corporation Metastatic Breast Cancer March 2005 Phase 2
    NCT00006120 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)|National Cancer Institute (NCI) Breast Cancer May 2000 Phase 2
    NCT01332656 Sanofi Ovarian Cancer Recurrent May 2011 Phase 2
    NCT00916279 C. R. Bard In-Stent Restenosis June 2009 Phase 1|Phase 2
    NCT00003206 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer April 1998 Phase 2
    NCT00019019 National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) Brain and Central Nervous System Tumors|Breast Cancer|Kidney Cancer|Lung Cancer|Lymphoma|Melanoma (Skin)|Ovarian Cancer|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol Specific October 1994 Phase 1
    NCT00226590 H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI) Lung Cancer April 2003 Phase 2
    NCT03169335 Qilu Pharmaceutical Co., Ltd. Non-squamous Non-small Cell Lung Cancer December 1, 2017 Phase 3
    NCT01069328 Bayer Carcinoma, Non-Small-Cell Lung|Lung Cancer July 2006 Phase 1
    NCT02562716 Southwest Oncology Group|National Cancer Institute (NCI) Pancreatic Adenocarcinoma|Resectable Pancreatic Carcinoma October 2015 Phase 2
    NCT02598310 Osaka Medical College Breast Cancer|Estrogen Receptor Negative Neoplasm|HER-2 Positive Breast Cancer November 2015 Phase 2
    NCT01970579 B. Braun Melsungen AG Stenosis|Restenosis October 2013 Phase 3
    NCT00005599 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Esophageal Cancer|Gastric Cancer February 2000 Phase 2
    NCT00803062 National Cancer Institute (NCI) Cervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Cervical Squamous Cell Carcinoma|Recurrent Cervical Carcinoma|Stage IVB Cervical Cancer April 2009 Phase 3
    NCT00716534 AbbVie (prior sponsor, Abbott)|Genentech, Inc.|AbbVie Advanced or Metastatic Non-Small Cell Lung Cancer June 2008 Phase 2
    NCT02250599 Sun Yat-sen University Nasopharyngeal Neoplasms August 2014 Phase 2
    NCT00861705 National Cancer Institute (NCI) Estrogen Receptor Negative|HER2/Neu Negative|Male Breast Carcinoma|Progesterone Receptor Negative|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Triple-Negative Breast Carcinoma May 2009 Phase 2
    NCT00434226 Genentech, Inc. Non-Small Cell Lung Cancer March 2007 Phase 2
    NCT00004924 Yale University|National Cancer Institute (NCI) Lung Cancer March 1999 Phase 2
    NCT00004979 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific Phase 1|Phase 2
    NCT00006245 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Esophageal Cancer July 2000 Phase 2
    NCT01989676 Pfizer Metastatic Breast Cancer February 24, 2014 Phase 3
    NCT01980472 Grupo de Investigación y Divulgación Oncológica Non-small Cell Lung Cancer (NSCLC) August 2013 Phase 2
    NCT00002717 Gynecologic Oncology Group|National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer March 1996 Phase 3
    NCT00060359 Gynecologic Oncology Group|National Cancer Institute (NCI) Fallopian Tube Carcinoma|Malignant Ovarian Mixed Epithelial Tumor|Ovarian Brenner Tumor|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Primary Peritoneal Carcinoma|Stage III Ovarian Cancer|Stage IV Ovarian Cancer|Undifferentiated Ovarian Carcinoma April 2003 Phase 1
    NCT00401674 National Cancer Institute, Naples Ovarian Cancer June 2003 Phase 2
    NCT02717091 Nagoya University Borderline Resectable Pancreatic Cancer July 2015 Phase 2
    NCT00176241 Susanne Arnold|Eli Lilly and Company|University of Kentucky Head and Neck Cancer December 2005 Phase 1
    NCT00789581 SCRI Development Innovations, LLC|Bristol-Myers Squibb Breast Cancer December 2008 Phase 3
    NCT00005635 Genentech, Inc.|National Cancer Institute (NCI) Breast Cancer January 2000 Phase 2
    NCT01494415 First People's Hospital of Hangzhou Carcinoma, Non-Small-Cell Lung|Carcinoma, Squamous Cell July 2012 Phase 2
    NCT00607048 Hoffmann-La Roche Neoplasms November 2007 Phase 1
    NCT00031577 Children's Hospital of Philadelphia Brain and Central Nervous System Tumors August 1999 Phase 1
    NCT02639650 Weiguo Lv|First Affiliated Hospital of Zhongshan Medical University|Shandong University|Huazhong University of Science and Technology|Women's Hospital School Of Medicine Zhejiang University Gestational Trophoblastic Neoplasms March 2016 Phase 3
    NCT01868022 GlaxoSmithKline Cancer October 9, 2013 Phase 1
    NCT00974584 Genentech, Inc. Non-Squamous Non-Small Cell Lung Cancer October 2009 Phase 1
    NCT00392392 SCRI Development Innovations, LLC|Celgene Corporation|Genentech, Inc. Breast Cancer October 2006 Phase 2
    NCT03003546 Mayo Clinic|National Cancer Institute (NCI) Aggressive Non-Hodgkin Lymphoma|CD20 Positive|Recurrent B-Cell Non-Hodgkin Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory B-Cell Non-Hodgkin Lymphoma|Refractory Small Lymphocytic Lymphoma August 2017 Phase 1
    NCT00618657 University of California, Irvine|National Institutes of Health (NIH)|National Cancer Institute (NCI) Breast Cancer|HER2-negative Breast Cancer|HER2-positive Breast Cancer|Recurrent Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer February 2008 Phase 2
    NCT00960960 Genentech, Inc. Breast Cancer August 2009 Phase 1
    NCT00020007 National Cancer Institute (NCI) Lung Cancer|Metastatic Cancer December 1999 Phase 1
    NCT01735825 University Hospital Ostrava Restenosis January 2012 Phase 4
    NCT00874107 Biothera Non-Small Cell Lung Cancer June 2009 Phase 2
    NCT02565953 Fundación Pública Andaluza Progreso y Salud|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud Arteriovenous Fistula Renal Dialysis Devices Obstruction October 2015 Phase 3
    NCT00687687 Sanofi|Gynecologic Oncology Group Uterine Carcinosarcoma May 2008 Phase 2
    NCT00616031 Kyoto University|Translational Research Informatics Center, Kobe, Hyogo, Japan|National Cancer Institute (NCI) Lung Cancer January 2008 Phase 2
    NCT00807859 Amgen Breast Cancer|Breast Neoplasms|Breast Tumors|Cancer|Locally Recurrent and Metastatic Breast Cancer|Metastases|Metastatic Cancer|Oncology|Solid Tumors|Tumors March 2009 Phase 1
    NCT01131195 Swiss Group for Clinical Cancer Research Breast Cancer July 19, 2010 Phase 3
    NCT01316757 Fox Chase Cancer Center|National Cancer Institute (NCI) Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma|Recurrent Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Na February 16, 2011 Phase 2
    NCT01294293 Gynecologic Oncology Group|National Cancer Institute (NCI) Malignant Ovarian Mixed Epithelial Tumor|Ovarian Brenner Tumor|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Undifferentiated Ovarian Carcinoma March 2011 Phase 1
    NCT00520013 Dana-Farber Cancer Institute|Genentech, Inc.|Beth Israel Deaconess Medical Center|Brigham and Women's Hospital|Massachusetts General Hospital Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer|Papillary Serous Mullerian Tumor|Clear Cell Mullerian Tumor August 2007 Phase 2
    NCT00809133 Boehringer Ingelheim Neoplasms May 2007 Phase 1
    NCT00589238 National Cancer Centre, Singapore Breast Cancer January 2008 Phase 2
    NCT00753038 Oncolytics Biotech Carcinoma, Squamous Cell of the Head and Neck August 2008 Phase 2
    NCT00054210 CTI BioPharma|National Cancer Institute (NCI) Lung Cancer January 2003 Phase 3
    NCT01256268 H. Lee Moffitt Cancer Center and Research Institute|Merck Sharp & Dohme Corp. Endometrial Cancer|Ovarian Cancer June 13, 2011 Phase 1
    NCT01281176 National Cancer Institute (NCI) Adult Solid Neoplasm February 9, 2011 Phase 1
    NCT00526890 Roswell Park Cancer Institute Lung Cancer October 2006 Phase 2
    NCT02607982 Hangzhou Cancer Hospital Esophageal Cancer|Concurrent Chemoradiotherapy|Oxaliplatin|Paclitaxel January 2005 Phase 2
    NCT00499525 Northwestern University|Amgen Breast Cancer June 2007 Phase 2
    NCT00600821 Pfizer Non-Small-Cell Lung Carcinoma|Adenocarcinoma April 2008 Phase 2
    NCT01666418 University of Zurich Melanoma August 2012 Phase 2
    NCT00003539 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Breast Cancer April 1998 Phase 2
    NCT02551055 Millennium Pharmaceuticals, Inc.|Takeda Neoplasms, Advanced or Metastatic September 2015 Phase 1
    NCT00151034 University of Michigan Cancer Center|Genentech, Inc. Urologic Neoplasms September 2000 Phase 2
    NCT01023347 Samyang Biopharmaceuticals Corporation Non Small Cell Lung Cancer June 2008 Phase 2
    NCT01167712 National Cancer Institute (NCI) Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Malignant Ovarian Mixed Epithelial Tumor|Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinofibroma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Primary Peritoneal Serous Adenocarcinoma|Stage IIA Fallopian Tube Cancer|Stage IIA Ovarian Cancer|Stage IIB Fallopian Tube Cancer|Stage IIB September 2010 Phase 3
    NCT00147680 Queensland Centre for Gynaecological Cancer Uterine Cancer September 2004 Phase 2
    NCT00618826 Barbara Ann Karmanos Cancer Institute|Eli Lilly and Company|Genentech, Inc. Metastatic Breast Cancer November 2006 Phase 2
    NCT02726997 M.D. Anderson Cancer Center|AstraZeneca Malignant Neoplasms of Female Genital Organs|Ovarian Cancer|Primary Peritoneal Carcinoma|Fallopian Tube Cancer July 2016 Phase 1|Phase 2
    NCT02256436 Merck Sharp & Dohme Corp. Urothelial Cancer October 22, 2014 Phase 3
    NCT02488967 NRG Oncology|National Cancer Institute (NCI) Breast Adenocarcinoma|Estrogen Receptor Negative|HER2/Neu Negative|Progesterone Receptor Negative|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIC Breast Cancer|Triple-Negative Breast Carcinoma July 2015 Phase 3
    NCT01578551 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Carcinoma, Non-Small-Cell Lung|Lung Adenocarcinoma April 2012 Phase 2
    NCT01960647 Eurocor GmbH Peripheral Artery Disease May 2011 Phase 3
    NCT02066103 Mercator MedSystems, Inc.|National Cancer Institute (NCI) Malignant Airway Obstruction Secondary to Non-small Cell Lung Cancer January 2014
    NCT00081042 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) Melanoma (Skin) February 2004 Phase 2
    NCT00001426 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Ovarian Neoplasm February 3, 1995 Phase 2
    NCT00407888 University of Washington|National Cancer Institute (NCI) Estrogen Receptor-positive Breast Cancer|HER2-positive Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer May 2006 Phase 2
    NCT00006229 NCIC Clinical Trials Group|Canadian Cancer Trials Group Lung Cancer April 2000 Phase 2|Phase 3
    NCT01858363 Spectranetics Corporation Peripheral Arterial Disease|Claudication November 2012
    NCT00960297 SCRI Development Innovations, LLC|Genentech, Inc. Non-Small Cell Lung Cancer August 2009 Phase 2
    NCT00004863 Montefiore Medical Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific July 1999 Phase 1
    NCT00035152 Bristol-Myers Squibb Carcinoma, Non-Small-Cell Lung June 2000 Phase 3
    NCT02194829 National Cancer Institute (NCI) Metastatic Pancreatic Adenocarcinoma|Stage III Pancreatic Cancer AJCC v6 and v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Unresectable Pancreatic Carcinoma July 1, 2014 Phase 1|Phase 2
    NCT00193596 SCRI Development Innovations, LLC|AstraZeneca|Pharmacia and Upjohn|Eli Lilly and Company Neoplasms, Unknown Primary September 2003 Phase 3
    NCT02948075 NewVac LLC|Janssen Pharmaceutica N.V., Belgium Ovarian Cancer September 2015 Phase 2
    NCT00191646 Eli Lilly and Company Genital Neoplasms, Female|Fallopian Tube Neoplasms|Ovarian Neoplasms|Pelvic Neoplasms|Peritoneal Neoplasms October 2002 Phase 3
    NCT00083057 National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) Head and Neck Cancer May 2004 Phase 1
    NCT01989780 Japan Breast Cancer Research Group|Chugai Pharmaceutical Metastatic Breast Cancer January 2014 Phase 2
    NCT02327169 Millennium Pharmaceuticals, Inc.|Takeda Advanced Nonhematologic Malignancies February 2, 2015 Phase 1
    NCT01225302 Abbott Non-Small Cell Lung Cancer September 2010 Phase 1
    NCT02593708 Michelle Melisko|University of California, San Francisco Solid Tumor October 2015 Phase 1
    NCT00093223 Celgene Corporation Angina Pectoris|Coronary Artery Disease September 2001 Phase 2
    NCT00539331 AstraZeneca Carcinoma, Non-Small-Cell Lung September 2007 Phase 1
    NCT01697293 Albert Einstein College of Medicine, Inc.|National Cancer Institute (NCI) Breast Adenocarcinoma|Estrogen Receptor Positive|HER2/Neu Negative|Recurrent Breast Carcinoma|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer January 2012 Phase 1|Phase 2
    NCT01227408 University of Southern California|CTI BioPharma Breast Cancer February 2009 Phase 2
    NCT00951665 Genentech, Inc. Metastatic Breast Cancer August 2009 Phase 1|Phase 2
    NCT01830270 Centre Hospitalier Universitaire de Besancon Stomach Neoplasms|Oesophageal Junction Cancer|Lower Oesophagus Cancer May 2011 Phase 2
    NCT00276796 Gynecologic Oncology Group|National Cancer Institute (NCI) Cervical Cancer Phase 2
    NCT02258659 University of Chicago|National Cancer Institute (NCI) Human Papilloma Virus Infection|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage IVA Squamous Cell Carcinoma of the Oropharynx|Stage IVB Squamous Cell Carcinoma of the Oropharynx September 2014 Phase 2
    NCT00016406 Southwest Oncology Group|National Cancer Institute (NCI) Breast Cancer May 2001 Phase 3
    NCT00511459 Amgen Locally Recurrent and Metastatic Breast Cancer July 2007 Phase 2
    NCT00017407 Ionis Pharmaceuticals, Inc.|National Cancer Institute (NCI) Lung Cancer October 2000 Phase 3
    NCT01938872 Ospedale San Donato Critical Limb Ischemia September 2013
    NCT00513695 University of Washington|National Cancer Institute (NCI) Inflammatory Breast Cancer|Male Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer June 2007 Phase 2
    NCT01031212 University of California, San Francisco|Novartis Pharmaceuticals Tumors January 2010 Phase 1
    NCT00578149 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Massachusetts General Hospital Non-Small Cell Lung Cancer May 2006 Phase 2
    NCT01855828 Lajos Pusztai|Genentech, Inc.|Yale University Her2-Positive Breast Cancer September 2013 Phase 2
    NCT00034346 Amgen Non-Small Cell Lung Cancer|Neoplasm Metastasis|Lung Cancer January 2002 Phase 2
    NCT00005087 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer March 2000 Phase 2
    NCT03002103 SynCore Biotechnology Co., Ltd. Triple-Negative Breast Cancer November 2016 Phase 3
    NCT02954172 Innovent Biologics (Suzhou) Co. Ltd.|WuXi CDS Clinical Research (Shanghai) Co.Ltd. NSCLC November 2016 Phase 3
    NCT00936780 Sahajanand Medical Technologies Pvt. Ltd. Coronary Artery Disease July 2008 Phase 4
    NCT02845908 Fujian Cancer Hospital Malignant Neoplasm of Stomach Stage IV September 2016 Phase 2
    NCT00006454 AGO Study Group Fallopian Tube Cancer|Ovarian Cancer December 1999 Phase 3
    NCT00314678 John P. Fruehauf|GlaxoSmithKline|University of California, Irvine Epithelial Ovarian Cancer|Primary Peritoneal Cancer September 2005 Phase 2
    NCT00946712 Southwest Oncology Group|National Cancer Institute (NCI) Recurrent Large Cell Lung Carcinoma|Recurrent Lung Adenocarcinoma|Recurrent Squamous Cell Lung Carcinoma|Stage IV Large Cell Lung Carcinoma|Stage IV Lung Adenocarcinoma|Stage IV Squamous Cell Lung Carcinoma July 2009 Phase 3
    NCT00807612 NantCell, Inc. Advanced Squamous Non-Small Cell Lung Cancer January 2009 Phase 1|Phase 2
    NCT00423852 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Brain and Central Nervous System Tumors|Extragonadal Germ Cell Tumor|Ovarian Cancer|Teratoma|Testicular Germ Cell Tumor August 2006 Phase 1|Phase 2
    NCT01081262 National Cancer Institute (NCI) Borderline Ovarian Mucinous Tumor|Ovarian Mucinous Cystadenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Stage IA Fallopian Tube Cancer|Stage IA Ovarian Cancer|Stage IB Fallopian Tube Cancer|Stage IB Ovarian Cancer|Stage IC Fallopian Tube Cancer|Stage IC Ovarian Cancer|Stage IIA Fallopian Tube Cancer|Stage IIA Ovarian Cancer|Stage IIB Fallopian Tube Cancer|Stage IIB Ovarian Cancer|Stage IIC Fallopian Tube Cancer|Stage IIC Ovarian Cancer|Stage IIIA Fallopian Tube Cance October 12, 2010 Phase 3
    NCT00084565 Fox Chase Cancer Center Prostate Cancer November 2003 Phase 2
    NCT00025389 University of Chicago|National Cancer Institute (NCI) Lung Cancer November 2001 Phase 2
    NCT00071188 Genzyme, a Sanofi Company|Sanofi Carcinoma, Non-Small-Cell Lung February 2004 Phase 2
    NCT02965677 ZhuHai Cardionovum Medical Device Co., Ltd. Peripheral Arterial Disease December 2016
    NCT02065466 University of Arizona Metastatic Melanoma|Brain Metastases July 2014 Phase 1|Phase 2
    NCT02921022 Memorial Sloan Kettering Cancer Center|Halozyme Therapeutics|Miami Cancer Institute Pancreatic Cancer|Advanced Pancreatic Ductal Adenocarcinoma October 2016
    NCT01796197 Dana-Farber Cancer Institute Breast Cancer March 2013 Phase 2
    NCT01769391 Eli Lilly and Company Squamous Non Small Cell Lung Cancer January 2013 Phase 2
    NCT00489541 Boston Scientific Corporation Coronary Artery Disease July 2007 Phase 3
    NCT02207465 Abramson Cancer Center of the University of Pennsylvania Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy|Borderline Resectable Pancreatic Cancer Treated With Chemoradiotherapy July 2014 Phase 1
    NCT01075464 Genentech, Inc. Solid Cancers February 2010 Phase 1
    NCT00001499 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Carcinoma, Non-Small-Cell Lung|Lung Neoplasms March 1996 Phase 2
    NCT00490711 Eli Lilly and Company Epithelial Ovarian Cancer July 2003 Phase 2
    NCT00546156 Ian E. Krop, MD, PhD|Genentech, Inc.|Massachusetts General Hospital|Brigham and Women's Hospital|New Hampshire Oncology-Hematology PA|Dana-Farber Cancer Institute Breast Cancer October 2007 Phase 2
    NCT01752205 The Affiliated Hospital of the Chinese Academy of Military Medical Sciences Esophageal Squamous Carcinoma November 2012 Phase 3
    NCT00057928 Southwest Oncology Group|National Cancer Institute (NCI) Cervical Cancer April 2003 Phase 3
    NCT01303926 Gruppo Oncologico Italia Meridionale Non-squamous Nonsmall Cell Neoplasm of Lung January 2010 Phase 3
    NCT00170664 North Eastern Germany Society of Gynaecologic Oncology Ovarian Cancer January 1999 Phase 2
    NCT00003128 Gynecologic Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group Sarcoma November 1997 Phase 3
    NCT00397761 Washington Hospital Center|National Cancer Institute (NCI) Breast Cancer July 2006 Phase 2|Phase 3
    NCT00193531 SCRI Development Innovations, LLC|Bristol-Myers Squibb Neuroendocrine Carcinoma December 1998 Phase 2
    NCT01172223 Prof Dirk Elling|Sana-Klinikum Lichtenberg Breast Cancer September 2007 Phase 1|Phase 2
    NCT03155971 The People's Hospital of Liaoning Province Stable Angina Pectoris|Unstable Angina Pectoris July 1, 2017
    NCT00009828 University of Pittsburgh|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific December 1999 Phase 1
    NCT01526369 Cancer Trials Ireland Metastatic Breast Cancer January 2012 Phase 3
    NCT00028587 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific December 2001 Phase 1
    NCT00276588 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Lung Cancer July 2005 Phase 2
    NCT00016874 Vion Pharmaceuticals|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific December 2000 Phase 1
    NCT00598247 University of Southern California|CTI BioPharma|ASCEND Therapeutics Advanced Colorectal Cancer January 2008 Phase 1
    NCT01024712 Cancer Institute and Hospital, Chinese Academy of Medical Sciences|National Cancer Institute (NCI) Lung Cancer May 2009 Phase 2
    NCT00193297 SCRI Development Innovations, LLC|GlaxoSmithKline Ovary Cancer February 2002 Phase 2
    NCT00088088 Synta Pharmaceuticals Corp. Stage IIIB Non-Small Cell Lung Cancer|Stage IV Non-Small Cell Lung Cancer March 2004 Phase 1|Phase 2
    NCT00111007 Bayer|Amgen Melanoma May 2005 Phase 3
    NCT02395744 Horizons International Peripheral Group|Advanced Catheter Therapies, Inc. Cardiovascular Diseases|Peripheral Vascular Disease|Arterial Occlusive Diseases|Peripheral Arterial Disease|Critical Limb Ischemia March 11, 2015
    NCT00544167 SCRI Development Innovations, LLC|Bayer Breast Cancer May 2007
    NCT00318136 Genentech, Inc. Non-small Cell Lung Cancer September 2005 Phase 2
    NCT02307227 Centro di Riferimento Oncologico - Aviano Breast Neoplasms April 2006 Phase 2
    NCT00997906 National Cancer Centre, Singapore Head and Neck Cancer September 2009 Phase 2|Phase 3
    NCT00154882 National Taiwan University Hospital Breast Cancer September 2003 Phase 2
    NCT00538603 King Faisal Specialist Hospital & Research Center Epithelial Ovarian Cancer June 2005
    NCT00434356 Genentech, Inc. Metastatic Breast Cancer March 2007 Phase 2
    NCT01493843 Genentech, Inc. Non-Small Cell Lung Cancer January 20, 2012 Phase 2
    NCT00511992 University of Oklahoma|Genentech, Inc. Advanced Ovarian Carcinoma|Primary Peritoneal Carcinoma|Ovarian Carcinosarcoma July 2007 Phase 2
    NCT00565851 National Cancer Institute (NCI) Clear Cell Adenocarcinoma|Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Mucinous Adenocarcinoma|Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinofibroma|Ovarian Endometrioid Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Adenocarcinoma|Primary Peritoneal Serous Adenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal December 6, 2007 Phase 3
    NCT01138137 OHSU Knight Cancer Institute Ovarian Carcinoma, Stage 3 or 4|Epithelial Ovarian Carcinoma|Primary Peritoneal Carcinoma June 2010 Phase 1
    NCT01093300 Seoul National University Hospital In-stent Restenosis Lesion Phase 4
    NCT00431080 Hellenic Oncology Research Group|University Hospital of Crete Breast Cancer August 2004 Phase 3
    NCT00482391 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI)|Dana-Farber Cancer Institute|GlaxoSmithKline Breast Cancer March 2007 Phase 2
    NCT01732640 Sidney Kimmel Comprehensive Cancer Center|Vanderbilt-Ingram Cancer Center|National Comprehensive Cancer Network Squamous Cell Carcinoma of the Head and Neck December 2012 Phase 1|Phase 2
    NCT00568451 Mayo Clinic|National Cancer Institute (NCI) Melanoma (Skin) June 2006 Phase 2
    NCT02109328 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Bladder Cancer|Transitional Cell Carcinoma April 2014 Phase 2
    NCT00493025 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Esophageal Cancer April 2005 Phase 2
    NCT00004077 Medical Research Council|National Cancer Institute (NCI) Testicular Germ Cell Tumor May 1996 Phase 2
    NCT01005329 National Cancer Institute (NCI) Endometrial Adenocarcinoma|Endometrial Adenosquamous Cell Carcinoma|Endometrial Clear Cell Carcinoma|Endometrial Papillary Serous Carcinoma|Stage I Endometrial Carcinoma|Stage II Endometrial Carcinoma|Stage III Endometrial Carcinoma|Stage IV Endometrial Carcinoma November 2009 Phase 2
    NCT00005048 New York University School of Medicine|National Cancer Institute (NCI) Prostate Cancer April 1997 Phase 1
    NCT02458911 iVascular S.L.U. Peripheral Vascular Disease May 2014
    NCT01721746 Bristol-Myers Squibb Unresectable or Metastatic Melanoma December 2012 Phase 3
    NCT00003242 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific February 1998 Phase 1
    NCT00005078 City of Hope Medical Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific March 2000 Phase 1
    NCT00280787 UNC Lineberger Comprehensive Cancer Center|AstraZeneca|Amgen Non Small Cell Lung Cancer November 2003 Phase 2
    NCT00005840 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Stage III Uterine Corpus Cancer|Stage IV Uterine Corpus Cancer July 2000 Phase 1
    NCT00006118 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)|National Cancer Institute (NCI) Bladder Cancer July 1999 Phase 2
    NCT00052312 European Organisation for Research and Treatment of Cancer - EORTC Endometrial Cancer September 2002 Phase 2
    NCT00055835 Southwest Oncology Group|National Cancer Institute (NCI) Bladder Cancer|Urethral Cancer November 2002 Phase 2
    NCT00002894 Medical Research Council|National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer March 1996 Phase 3
    NCT00068757 European Organisation for Research and Treatment of Cancer - EORTC Breast Cancer August 2003 Phase 1
    NCT00003379 Gynecologic Oncology Group|National Cancer Institute (NCI) Cervical Cancer November 1999 Phase 1|Phase 2
    NCT00063258 M.D. Anderson Cancer Center Lung Cancer June 2003 Phase 2
    NCT00002953 Medical Research Council|National Cancer Institute (NCI) Breast Cancer December 1996 Phase 3
    NCT00077220 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)|National Cancer Institute (NCI) Lung Cancer June 2002 Phase 3
    NCT00470301 National Cancer Institute (NCI) Breast Cancer|Male Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer April 2007 Phase 1|Phase 2
    NCT00536939 Eli Lilly and Company|Genentech, Inc. Breast Cancer November 2007 Phase 2
    NCT00433511 National Cancer Institute (NCI)|Cancer and Leukemia Group B|Eastern Cooperative Oncology Group|North Central Cancer Treatment Group Estrogen Receptor Negative|Estrogen Receptor Positive|HER2/Neu Negative|Male Breast Carcinoma|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer December 2009 Phase 3
    NCT00022191 European Organisation for Research and Treatment of Cancer - EORTC|National Cancer Institute (NCI)|Groupe D'Etude des Tumeurs Uro-Genitales|Institute of Cancer Research, United Kingdom|Central European Cooperative Oncology Group|NCIC Clinical Trials Group|Southwest Oncology Group|German Association of Urologic Oncology|Spanish Oncology Genito-Urinary Group|Medical Research Council Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral Cancer May 2001 Phase 3
    NCT00165035 Cordis Corporation|Conor Medsystems Coronary Disease May 2005 Phase 3
    NCT01461915 Cantex Pharmaceuticals|Translational Drug Development Metastatic Pancreatic Cancer November 2011 Phase 2
    NCT01008150 NSABP Foundation Inc|Puma Biotechnology, Inc. Breast Cancer October 2010 Phase 2
    NCT00499291 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Cancer September 2006
    NCT00006377 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Endometrial Cancer June 2000 Phase 2
    NCT00310011 Wake Forest University Health Sciences|National Cancer Institute (NCI) Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter June 1998 Phase 2
    NCT00974181 Cordis Corporation|Conor Medsystems Treatment of Symptomatic Ischemic Heart Disease January 2004 Phase 3
    NCT02015676 Hoffmann-La Roche Breast Cancer July 2001 Phase 1|Phase 2
    NCT00289263 MANTA 1 Study Italian Collaborative Group|Bristol-Myers Squibb Breast Cancer April 1998 Phase 3
    NCT00024310 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) Drug/Agent Toxicity by Tissue/Organ|Unspecified Adult Solid Tumor, Protocol Specific September 2001 Phase 1
    NCT00929162 AstraZeneca|ISTITUTO REGINA ELENA - CENTRO RICERCHE SPERIMENTALI Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy June 2009 Phase 2
    NCT01971034 Instituto do Cancer do Estado de São Paulo Pancreatic Adenocarcinoma Advanced or Metastatic June 2011 Phase 2
    NCT00140530 Deutsches Herzzentrum Muenchen|Bayerische Forschungsstiftung Muenchen Coronary Disease March 2004 Phase 4
    NCT00004934 Nordic Society for Gynaecologic Oncology|European Organisation for Research and Treatment of Cancer - EORTC|NCIC Clinical Trials Group|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer August 1999 Phase 3
    NCT02427841 OHSU Knight Cancer Institute|National Cancer Institute (NCI) Pancreatic Adenocarcinoma|Resectable Pancreatic Cancer January 2016 Phase 2
    NCT01527864 Protgen Ltd Non Small Cell Lung Cancer May 2011 Phase 2
    NCT00484315 Boston Scientific Corporation Coronary Artery Disease July 2007 Phase 3
    NCT00856492 Southwest Oncology Group|National Cancer Institute (NCI) Breast Cancer April 2010 Phase 2
    NCT00002519 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Lung Cancer January 1997 Phase 1
    NCT00553462 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer March 2008 Phase 2
    NCT00050960 Eisai Inc. Non-small Cell Lung Cancer May 2002 Phase 3
    NCT00003612 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer April 1999 Phase 2
    NCT00458315 Rigshospitalet, Denmark Unknown Primary Tumors May 2007 Phase 2
    NCT02979392 Yung-Jue Bang|Seoul National University Hospital Advanced Solid Tumor December 2016 Phase 1
    NCT00231075 ARCAGY/ GINECO GROUP Ovarian Cancer January 2001 Phase 2
    NCT02315196 Rutgers, The State University of New Jersey|National Cancer Institute (NCI)|Rutgers Cancer Institute of New Jersey Estrogen Receptor-negative Breast Cancer|HER2-negative Breast Cancer|Progesterone Receptor-negative Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Triple-negative Breast Cancer December 2014 Phase 2
    NCT00473889 Merck Sharp & Dohme Corp. Stage IIIB or IV Non-Small Cell Lung Cancer May 2007 Phase 2|Phase 3
    NCT00045630 Southwest Oncology Group|National Cancer Institute (NCI) Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral Cancer January 2003 Phase 2
    NCT02934464 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Stomach Neoplasms December 2016 Phase 3
    NCT02446574 Chinese Academy of Medical Sciences Esophageal Neoplasms July 2007 Phase 1|Phase 2
    NCT02883062 National Cancer Institute (NCI) Estrogen Receptor Negative|HER2/Neu Negative|Invasive Breast Carcinoma|Progesterone Receptor Negative|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Triple-Negative Breast Carcinoma May 25, 2017 Phase 2
    NCT00426556 Novartis Pharmaceuticals|Novartis Metastatic Breast Cancer July 2007 Phase 1
    NCT00269828 CTI BioPharma NSCLC December 2005 Phase 3
    NCT00883116 R-Pharm Endometrial Cancer August 2009 Phase 3
    NCT01706120 National Cancer Institute, Naples|Mario Negri Institute for Pharmacological Research Ovarian Cancer October 2012 Phase 4
    NCT00396929 University Hospital Tuebingen|Acrostak Stable or Unstable Angina Pectoris|Myocardial Ischemia August 2005 Phase 3
    NCT00022217 Matrix Pharmaceutical|National Cancer Institute (NCI) Head and Neck Cancer November 2000 Phase 2
    NCT02297217 AHS Cancer Control Alberta Esophageal Cancer September 2016 Phase 2
    NCT00003387 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer July 1998 Phase 3
    NCT00193362 SCRI Development Innovations, LLC|Eli Lilly and Company|GlaxoSmithKline Lung Cancer June 2004 Phase 3
    NCT01234038 Ionis Pharmaceuticals, Inc. Non-small Cell Lung Cancer November 2010 Phase 1|Phase 2
    NCT00696956 University Hospital Tuebingen Atherosclerosis|Restenosis|Limb Ishemia April 2008 Phase 2|Phase 3
    NCT01364012 Hoffmann-La Roche Non-Squamous Non-Small Cell Lung Cancer May 2011 Phase 3
    NCT00072215 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Extragonadal Germ Cell Tumor|Testicular Germ Cell Tumor April 2004 Phase 3
    NCT00189371 AGO Study Group Epithelial Ovarian Cancer, Fallopian Tube or Peritoneum|Platinum Sensitve Relapse|Anemia February 2004 Phase 3
    NCT01643460 Indiana University Pancreatic Cyst|Pancreatic Intraductal Papillary-Mucinous Neoplasm|Cystadenoma, Mucinous|Papillary Mucinous Cystadenoma, Borderline Malignancy September 2009
    NCT00551122 University of Southampton|University Hospital Southampton NHS Foundation Trust Brain and Central Nervous System Tumors|Extragonadal Germ Cell Tumor|Ovarian Cancer|Testicular Germ Cell Tumor November 2006 Phase 1|Phase 2
    NCT00449657 Leo W. Jenkins Cancer Center Non Small Cell Lung Cancer February 2007 Phase 2
    NCT00850577 Bristol-Myers Squibb Non-small Cell Lung Cancer (NSCLC) June 2009 Phase 2
    NCT00003065 Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI) Cervical Cancer January 1997 Phase 2
    NCT00003998 University of Glasgow|National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer October 1998 Phase 3
    NCT00574587 Albert Einstein College of Medicine, Inc.|Merck Sharp & Dohme Corp. Breast Cancer December 2007 Phase 1|Phase 2
    NCT01491217 Hanmi Pharmaceutical Company Limited Advanced Metastatic Gastric Cancer|Recurrent Gastric Cancer May 2009 Phase 1|Phase 2
    NCT00021333 Fox Chase Cancer Center|National Cancer Institute (NCI) Head and Neck Cancer|Lung Cancer September 1999 Phase 2
    NCT03126812 The Netherlands Cancer Institute|Merck Sharp & Dohme Corp. Ovarian Cancer Stage IV|Peritoneal Cancer|Fallopian Tube Cancer June 2017 Phase 1|Phase 2
    NCT01329640 Instituto do Cancer do Estado de São Paulo|Fundação Faculdade de Medicina Locally Advanced HER2-positive Breast Cancer September 2010 Phase 2
    NCT00626405 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Melanoma (Skin) August 2008 Phase 2
    NCT01649947 Rutgers, The State University of New Jersey|National Cancer Institute (NCI)|Rutgers Cancer Institute of New Jersey Non-small Cell Lung Cancer|Advanced Non-small Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer December 23, 2011 Phase 2
    NCT00278148 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Lung Cancer October 2005 Phase 1|Phase 2
    NCT01412229 UNC Lineberger Comprehensive Cancer Center|Celgene Corporation Head and Neck Cancer February 2012 Phase 2
    NCT00001384 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Breast Cancer|Breast Neoplasms May 1994 Phase 2
    NCT00111904 Theradex|National Cancer Institute (NCI) Pancreatic Cancer May 2005 Phase 2
    NCT02413320 University of Kansas Medical Center Triple-negative Breast Cancer July 2015 Phase 2
    NCT00189566 ARCAGY/ GINECO GROUP Ovarian Cancer|Fallopian Tube Cancer|Malignant Tumor of Peritoneum April 2004 Phase 2
    NCT02214381 West German Study Group|TEVA Early Primary Breast Cancer in the Elderly. July 2014 Phase 2
    NCT01822756 Incyte Corporation Metastatic Cancer|Metastatic Pancreatic Cancer April 2013 Phase 1
    NCT02307812 Eli Lilly and Company Gastric Cancer|Gastroesophageal Junction Adenocarcinoma
    NCT00003569 Roswell Park Cancer Institute|National Cancer Institute (NCI) Head and Neck Cancer|Lung Cancer|Neurotoxicity|Ovarian Cancer March 1998 Phase 1
    NCT00598715 Deutsches Herzzentrum Muenchen Coronary Artery Disease October 2007 Phase 4
    NCT00024401 Theradex|National Cancer Institute (NCI) Colorectal Cancer May 2001 Phase 2
    NCT00201435 Norwegian Breast Cancer Group Breast Neoplasm March 2005 Phase 2|Phase 3
    NCT00039039 IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|National Cancer Institute (NCI) Lung Cancer February 2000 Phase 3
    NCT01968915 Novartis Pharmaceuticals|Novartis Neoplasms November 2013 Phase 1
    NCT00470366 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Brain and Central Nervous System Tumors|Extragonadal Germ Cell Tumor|Ovarian Cancer|Teratoma|Testicular Germ Cell Tumor March 2007 Phase 2
    NCT00006108 UNC Lineberger Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer August 1999 Phase 1|Phase 2
    NCT00369070 Amgen Advanced Non-squamous NSCLC January 2007 Phase 2
    NCT00933387 National Health Research Institutes, Taiwan|China Medical University Hospital|National Cheng-Kung University Hospital|Chi Mei Medical Hospital|Changhua Christian Hospital|Chang Gung Memorial Hospital Oral Cancer September 2009 Phase 2
    NCT01694576 Jiangsu Cancer Institute & Hospital Nasopharyngeal Carcinoma September 2012 Phase 2
    NCT00849472 GlaxoSmithKline|NSABP Foundation Inc Neoplasms, Breast July 2009 Phase 2
    NCT01254526 Genentech, Inc. Breast Cancer December 2010 Phase 1
    NCT00689715 Asan Medical Center Cystic Tumors of the Pancreas June 2006 Phase 2|Phase 3
    NCT02637375 University of Chicago Breast Cancer May 2016
    NCT01862081 Genentech, Inc. Breast Cancer, Non-small Lung Cancer July 16, 2013 Phase 1
    NCT00026104 National Cancer Institute (NCI) Adenocarcinoma of the Pancreas|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer November 2001 Phase 2
    NCT02608216 University of Pennsylvania Breast Neoplasm|Metastatic Breast Cancer|Rb+ Breast Cancer November 2015 Phase 1
    NCT00483782 Medical Research Council|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer April 2006 Phase 3
    NCT00591851 Memorial Sloan Kettering Cancer Center|Amgen|Genentech, Inc. Breast Cancer December 2004 Phase 2
    NCT00070564 Southwest Oncology Group|National Cancer Institute (NCI) Breast Cancer November 2003 Phase 3
    NCT00003008 Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|AIDS Associated Malignancies Clinical Trials Consortium Sarcoma June 1997 Phase 2
    NCT02855788 Huashan Hospital|Seattle Integrative Cancer Center Metastatic Gastric Cancer|Locally Advanced Gastric Cancer May 2015 Phase 2
    NCT01192165 GlaxoSmithKline Cancer September 2010 Phase 1
    NCT00072319 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI)|Pharmacia|Amgen Breast Cancer August 2003 Phase 2
    NCT00768859 The Netherlands Cancer Institute Breast Cancer|HER2 Positive September 2008 Phase 2
    NCT00009776 University of California, Davis|National Cancer Institute (NCI) Lymphoma March 2001 Phase 1
    NCT02272790 AstraZeneca Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation January 30, 2015 Phase 2
    NCT02546232 Oslo University Hospital Breast Cancer March 2015 Phase 2
    NCT02389751 M.D. Anderson Cancer Center|Synta Pharmaceuticals Corp. Esophageal Cancer April 2015 Phase 1
    NCT01229930 University of Glasgow|National Cancer Institute (NCI) Cervical Cancer June 2010 Phase 2
    NCT02713386 NRG Oncology|National Cancer Institute (NCI) Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Serous Neoplasm|High Grade Ovarian Serous Adenocarcinoma|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Primary Peritoneal Serous Adenocarcinoma|Stage III Fallopian Tube Cancer|Stage III Ovarian Cancer|Stage III Primary Peritoneal Cancer|Stage IIIA Fallopian Tube Cancer|Stage IIIA Ovarian Cancer|Stage IIIA Primary Peritoneal Cancer|Stage IIIB Fallopian Tube Cancer|Stage IIIB May 2016 Phase 1|Phase 2
    NCT01366131 Genentech, Inc. Non-Squamous Non-Small Cell Lung Cancer June 2011 Phase 2
    NCT00079287 Japan Multinational Trial Organization|National Cancer Institute (NCI) Lung Cancer March 2001 Phase 3
    NCT03020329 Sun Yat-sen University Nasopharyngeal Carcinoma|Children January 2017 Phase 2
    NCT00003127 Southwest Oncology Group|National Cancer Institute (NCI) Endometrial Cancer February 1998 Phase 2
    NCT00460317 Amgen|Takeda Non-Small Cell Lung Cancer July 2007 Phase 3
    NCT02117817 Rutgers, The State University of New Jersey|Rutgers Cancer Institute of New Jersey|National Cancer Institute (NCI) Ovarian Cancer|Endometrial Cancer|Recurrent Ovarian Cancer|Recurrent Endometrial Cancer February 2015 Phase 1
    NCT00005819 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific April 2000 Phase 1
    NCT00404404 Premiere Oncology|National Cancer Institute (NCI) Breast Cancer October 2006 Phase 2
    NCT02962232 ZhuHai Cardionovum Medical Device Co., Ltd. Peripheral Artery Disease November 2016
    NCT02470585 AbbVie|Gynecologic Oncology Group|Australia New Zealand Gynaecological Oncology Group Ovarian Cancer|Ovarian Neoplasm July 14, 2015 Phase 3
    NCT02996214 Nanjing Luye Sike Pharmaceutical Co.,Ltd. Lung Squamous Cell Carcinoma November 2016 Phase 4
    NCT00948675 Eli Lilly and Company Advanced Non-Small Cell Lung Cancer September 2009 Phase 3
    NCT01594099 Health Science Center of Xi’an Jiaotong University Cervical Cancer April 2012 Phase 2
    NCT02962141 ZhuHai Cardionovum Medical Device Co., Ltd. Peripheral Arterial Disease|Fistula October 2016
    NCT02766582 Medical College of Wisconsin Ovarian Cancer October 2016 Phase 2
    NCT00798954 Vulnerable Plaque Society Ischemic Heart Disease|Restenosis June 2007 Phase 4
    NCT00003035 Georgetown University|National Cancer Institute (NCI) Breast Cancer March 1997 Phase 2
    NCT00004887 The Christie NHS Foundation Trust|National Cancer Institute (NCI) Lung Cancer January 1999 Phase 3
    NCT02810457 Centus Biotherapeutics Limited Carcinoma, Non-Small-Cell Lung June 2016 Phase 3
    NCT00003050 University of Southern California|National Cancer Institute (NCI) Breast Cancer April 1997 Phase 2
    NCT00777673 University of Tennessee Cancer Institute|National Comprehensive Cancer Network|Celgene Corporation|Genentech, Inc. Breast Cancer October 2008 Phase 2
    NCT00004547 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Abdominal Neoplasm|Colonic Neoplasm|Mesothelioma|Peritoneal Neoplasm January 2000 Phase 2
    NCT00133237 Deutsches Herzzentrum Muenchen|Technische Universität München Coronary Disease July 2005 Phase 4
    NCT02753036 Charite University, Berlin, Germany Cognition Disorders|Polyneuropathies January 2016
    NCT02912715 Biotronik (Beijing) Medical Device Ltd. Peripheral Arterial Disease November 2016 Phase 3
    NCT00002837 M.D. Anderson Cancer Center|National Cancer Institute (NCI)|Bristol-Myers Squibb Breast Cancer September 1995 Phase 1|Phase 2
    NCT01998906 Hoffmann-La Roche Breast Cancer May 2002 Phase 3
    NCT01050075 City of Hope Medical Center Breast Cancer|Stage I Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer January 2010
    NCT00280150 UNC Lineberger Comprehensive Cancer Center|Genentech, Inc.|Eli Lilly and Company Lung Cancer January 2006 Phase 1|Phase 2
    NCT02905578 University of Iowa|National Institutes of Health (NIH)|National Cancer Institute (NCI)|Holden Comprehensive Cancer Center Pancreatic Neoplasms|Cancer of Pancreas|Cancer of the Pancreas|Neoplasms, Pancreatic|Pancreas Cancer|Pancreas Neoplasms|Adenocarcinoma July 31, 2017 Phase 2
    NCT00024388 Theradex|National Cancer Institute (NCI) Kidney Cancer April 2001 Phase 2
    NCT00009763 University of California, Davis|National Cancer Institute (NCI) Breast Cancer March 2001 Phase 1
    NCT01929941 Incyte Corporation Advanced Solid Tumors|Advanced Hodgkin's Lymphoma|Advanced Aggressive Non-Hodgkin's Lymphoma|Advanced Indolent Non-Hodgkin's Lymphoma|Advanced Pancreatic Adenocarcinoma|Advanced Triple-Negative Breast Cancer|Advanced Urothelial Carcinoma September 2013 Phase 1
    NCT02879513 RenJi Hospital Invasive Ductal Breast Cancer|Tubular Breast Cancer|Mucinous Breast Cancer|Inflammatory Breast Cancer January 2014 Phase 3
    NCT02392377 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Stage IB Esophageal Adenocarcinoma|Stage IIA Esophageal Adenocarcinoma|Stage IIB Esophageal Adenocarcinoma|Stage IIIA Esophageal Adenocarcinoma|Stage IIIB Esophageal Adenocarcinoma|Stage IIIC Esophageal Adenocarcinoma February 2015 Phase 2
    NCT00140101 Abbott Vascular Coronary Disease|Coronary Artery Disease|Coronary Restenosis May 2005 Phase 2
    NCT02041429 Dana-Farber Cancer Institute|Incyte Corporation Recurrent Breast Cancer|Metastatic Breast Cancer February 2014 Phase 1|Phase 2
    NCT00148356 Abbott Vascular Coronary Disease|Coronary Artery Disease|Coronary Restenosis September 2004 Phase 2|Phase 3
    NCT03112590 H. Lee Moffitt Cancer Center and Research Institute|Horizon Pharma Ireland, Ltd., Dublin Ireland Breast Cancer|Breast Cancer, Male|Breast Cancer Female|HER2-positive Breast Cancer April 28, 2017 Phase 1|Phase 2
    NCT01967199 Seung-Jung Park|CardioVascular Research Foundation, Korea|Asan Medical Center Coronary Restenosis April 18, 2013 Phase 4
    NCT00298415 Intergroupe Francophone de Cancerologie Thoracique NSCLC March 2006 Phase 3
    NCT01301716 Genentech, Inc. Solid Cancers September 2011 Phase 1
    NCT00045682 Gynecologic Oncology Group|National Cancer Institute (NCI) Primary Peritoneal Carcinoma|Recurrent Ovarian Carcinoma September 2002 Phase 2
    NCT00034190 OncoGenex Technologies Colorectal Adenocarcinoma March 2002 Phase 2
    NCT01454102 Bristol-Myers Squibb Non-small Cell Lung Cancer December 9, 2011 Phase 1
    NCT02943798 Shanghai Chest Hospital Pulmonary Large Cell Neuroendocrine Carcinoma December 2016 Phase 2
    NCT00034151 OncoGenex Technologies Ovarian Cancer March 2002 Phase 2
    NCT00034164 OncoGenex Technologies Carcinoma, Non-Small-Cell Lung April 2002 Phase 2
    NCT02525757 M.D. Anderson Cancer Center|Genentech, Inc. Lung Cancer|Non-Small Cell Lung Cancer January 26, 2016 Phase 2
    NCT00023673 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Lung Cancer July 2001 Phase 1|Phase 2
    NCT00034177 OncoGenex Technologies Urologic Neoplasms April 2002 Phase 2
    NCT01066832 Eurocor GmbH Instent Restenosis February 2010 Phase 4
    NCT00254592 University of California, Irvine Breast Cancer October 2005 Phase 2
    NCT01065532 University Hospital, Gasthuisberg Restenosis May 2009
    NCT02492503 All India Institute of Medical Sciences, New Delhi Metastatic Carcinoma to the Uterine Cervix|Recurrent Carcinoma Cervix|Cervix Carcinoma Recurrent November 2013 Phase 1|Phase 2
    NCT00004916 Northwestern University|National Cancer Institute (NCI) Lymphoma February 1999 Phase 1|Phase 2
    NCT01496742 Genentech, Inc. Non-Squamous Non-Small Cell Lung Cancer April 2012 Phase 2
    NCT01488552 Pancreatic Cancer Research Team Stage IV Pancreatic Cancer November 2011 Phase 1|Phase 2
    NCT01154920 M.D. Anderson Cancer Center|Dana-Farber Cancer Institute Head and Neck Squamous Cell Carcinoma July 2010 Phase 2
    NCT02682693 German Breast Group|Amgen|Celgene Corporation Breast Cancer Female NOS|Tubular Breast Cancer Stage II|Mucinous Breast Cancer Stage II|Invasive Ductal Breast Cancer|HER2 Positive Breast Cancer|Inflammatory Breast Cancer|Tubular Breast Cancer Stage III February 13, 2017 Phase 2
    NCT00191672 Eli Lilly and Company Breast Neoplasms December 2003 Phase 2
    NCT00553358 Novartis Pharmaceuticals|Breast International Group|SOLTI Breast Cancer Research Group|Novartis Neoplasms, Breast January 5, 2008 Phase 3
    NCT00686114 Wenzhou Medical University Esophageal Cancer May 2008 Phase 3
    NCT00756470 M.D. Anderson Cancer Center|GlaxoSmithKline Breast Cancer October 2008 Phase 2
    NCT01653470 Bristol-Myers Squibb Cancer October 12, 2012 Phase 1
    NCT00070278 Cambridge University Hospitals NHS Foundation Trust|National Cancer Institute (NCI) Breast Cancer January 2005 Phase 3
    NCT00668616 North Eastern Germany Society of Gynaecologic Oncology Breast Cancer March 2000 Phase 3
    NCT00436709 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Breast Cancer July 2006
    NCT01935492 Borstkanker Onderzoek Groep|Roche Pharma AG|Teva Pharma Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|Metastatic Breast Cancer November 2010 Phase 3
    NCT02954055 International Breast Cancer Study Group Breast Cancer May 2017 Phase 2
    NCT00038545 M.D. Anderson Cancer Center Non-Hodgkin's Lymphoma May 2001 Phase 2
    NCT00054184 CTI BioPharma Lung Cancer January 2003 Phase 3
    NCT00976677 National Cancer Institute (NCI) Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer January 2010 Phase 2
    NCT00193193 SCRI Development Innovations, LLC|Bristol-Myers Squibb Prostate Cancer August 2000 Phase 2
    NCT02487277 Andrew Ko|University of California, San Francisco Adenocarcinoma July 2015 Phase 2
    NCT00191854 Eli Lilly and Company Breast Cancer March 2005 Phase 2
    NCT03072992 National Center of Oncology, Armenia|BRIU GmbH Advanced Breast Cancer|Metastatic Breast Cancer March 20, 2017 Phase 2
    NCT01850628 NSABP Foundation Inc|Breast Cancer Research Foundation|Washington University School of Medicine Breast Cancer July 2013
    NCT00033657 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Esophageal Cancer|Gastric Cancer May 2002 Phase 2
    NCT00194753 University of Washington|Amgen|Bristol-Myers Squibb Breast Neoplasm December 2001 Phase 2
    NCT01755845 xie congying|Wenzhou Medical University Cervical Cancer January 2011 Phase 3
    NCT00505492 M.D. Anderson Cancer Center Uterine Neoplasms February 2002 Phase 2
    NCT00954642 Genentech, Inc. Solid Cancers August 2009 Phase 1
    NCT00096226 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Lung Cancer September 2004 Phase 2
    NCT00128856 Spanish Breast Cancer Research Group|Eli Lilly and Company|Bristol-Myers Squibb Breast Cancer December 2002 Phase 2
    NCT00021060 National Cancer Institute (NCI) Adenocarcinoma of the Lung|Bronchoalveolar Cell Lung Cancer|Large Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer August 2002 Phase 2|Phase 3
    NCT02429687 Beihua Kong|Huazhong University of Science and Technology|Zhejiang University|Sun Yat-sen University|Shandong University Ovarian Germ Cell Cancer|Ovarian Neoplasms|Ovarian Cancer April 2015 Phase 3
    NCT00561795 GlaxoSmithKline Primary Peritoneal Carcinoma|Tumor|Epithelial Ovarian Cancer|Uterine Disease|Cervix Diseases|Neoplasms, Ovarian|Cancer September 2007 Phase 2
    NCT00886717 Asan Medical Center|National Cancer Institute (NCI) Ovarian Cancer May 2008 Phase 1|Phase 2
    NCT02429700 Beihua Kong|Huazhong University of Science and Technology|Zhejiang University|Sun Yat-sen University|Shandong University Ovarian Sex Cord Stromal Tumor|Ovarian Neoplasms|Ovarian Cancer April 2015 Phase 3
    NCT00050167 M.D. Anderson Cancer Center|Roche Pharma AG Breast Cancer November 2002 Phase 1
    NCT00006110 UNC Lineberger Comprehensive Cancer Center Breast Cancer December 1998 Phase 2
    NCT03138720 HonorHealth Research Institute Resectable Pancreatic Cancer|Unresectable Pancreatic Cancer|Pancreatic Adenocarcinoma May 23, 2017 Phase 2
    NCT00154700 National Taiwan University Hospital Esophageal Cancer January 2001 Phase 2
    NCT00787852 Brown University|Rhode Island Hospital|Memorial Hospital of Rhode Island Non-Small Cell Lung Cancer March 2009 Phase 1
    NCT02182245 Boehringer Ingelheim Genital Neoplasms, Female October 2005 Phase 1
    NCT00517621 ARCAGY/ GINECO GROUP Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Neoplasms February 2006 Phase 2
    NCT01763476 Herz-Zentrums Bad Krozingen|Medical University of Graz Peripheral Artery Disease|Occlusion of Artery January 2013
    NCT02442362 The First People's Hospital of Changzhou Gastric Cancer January 2012 Phase 2|Phase 3
    NCT00007904 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer July 2000 Phase 2
    NCT00832494 Antisoma Research Non-Small Cell Lung Cancer September 2004 Phase 1|Phase 2
    NCT00001498 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Breast Cancer|Breast Neoplasms February 1996 Phase 2
    NCT01604863 Human Genome Sciences Inc., a GSK Company|GlaxoSmithKline Cancer June 2012 Phase 1
    NCT00524303 GlaxoSmithKline Neoplasms, Breast August 2007 Phase 2
    NCT00495170 M.D. Anderson Cancer Center Lung Cancer April 14, 2006 Phase 2
    NCT00002826 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Breast Cancer June 1997 Phase 2
    NCT02059967 Virginia Commonwealth University|National Cancer Institute (NCI) Adenocarcinoma of the Lung|Large Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIA Non-small Cell Lung Cancer|Stage IIB Non-small Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer March 2014 Phase 1
    NCT00475670 Hoffmann-La Roche Breast Cancer October 2005 Phase 2
    NCT00547443 Simmons Cancer Center|National Cancer Institute (NCI) Lung Cancer July 2007 Phase 1|Phase 2
    NCT00042302 QLT Inc. Stage IIIb Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer June 2002 Phase 3
    NCT00997009 National Cancer Institute, Naples Cervical Cancer October 2009 Phase 2
    NCT00002628 St. Louis University|National Cancer Institute (NCI) Breast Cancer November 1994 Phase 1|Phase 2
    NCT00002627 St. Louis University|National Cancer Institute (NCI) Breast Cancer November 1994 Phase 1|Phase 2
    NCT02125513 Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi Ovarian Cancer|Fallopian Tube Carcinoma|Peritoneal Carcinoma January 2014 Phase 2
    NCT00003317 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer May 1998 Phase 3
    NCT01792050 NewLink Genetics Corporation Metastatic Breast Cancer February 2013 Phase 2
    NCT01928498 Centre hospitalier de l'Université de Montréal (CHUM)|Biotronik Canada Inc Arteriovenous Fistulae|Arteriovenous Graft October 2013
    NCT02779855 H. Lee Moffitt Cancer Center and Research Institute|Amgen Breast Cancer|Ductal Carcinoma|Invasive Breast Carcinoma|Invasive Ductal Breast Carcinoma March 22, 2017 Phase 1|Phase 2
    NCT02312804 The University of Texas Health Science Center at San Antonio Cancer of Cervix|Tumors January 2015 Phase 1
    NCT00655850 University of Alabama at Birmingham|Genentech, Inc. Non-Small Cell Lung Cancer March 2008 Phase 2
    NCT00005970 National Cancer Institute (NCI)|Cancer and Leukemia Group B|Eastern Cooperative Oncology Group|Canadian Cancer Trials Group|Southwest Oncology Group Breast Adenocarcinoma|HER2 Positive Breast Carcinoma|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer May 19, 2000 Phase 3
    NCT02640755 AstraZeneca|Quintiles, Inc. Solid Malignancies January 28, 2016 Phase 1
    NCT02450058 IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy Breast Cancer|Chemotherapy, Adjuvant November 1996 Phase 3
    NCT00527735 Bristol-Myers Squibb Lung Cancer|Small Cell Lung Cancer|Carcinoma, Non-Small-Cell Lung February 2008 Phase 2
    NCT00582205 University of Oklahoma Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Carcinoma|Uterine Cancer January 2006 Phase 2
    NCT00693030 A.O. Ospedale Papa Giovanni XXIII|Case Western Reserve University|Medtronic Vascular|Boston Scientific Corporation Coronary Artery Disease August 2006 Phase 4
    NCT01730222 IRCCS San Raffaele Pancreatic Cancer November 2012 Phase 1|Phase 2
    NCT01372202 Sidney Kimmel Comprehensive Cancer Center Esophageal Cancer June 2011 Phase 2
    NCT00003253 Oncotech|National Cancer Institute (NCI) Breast Cancer July 1997 Phase 2
    NCT00180310 Abbott Vascular Coronary Disease|Coronary Artery Disease|Coronary Restenosis July 2005 Phase 3
    NCT00019812 National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) Breast Cancer August 1999 Phase 2
    NCT00085501 Southwest Oncology Group|National Cancer Institute (NCI) Lung Cancer July 2004 Phase 2
    NCT03081689 Spanish Lung Cancer Group Non Small Cell Lung Cancer April 15, 2017 Phase 2
    NCT00662597 Novartis Pharmaceuticals|Novartis Non-Small Cell Lung Cancer April 2008 Phase 3
    NCT00434135 Southern Italy Cooperative Oncology Group Non-Small Cell Lung Cancer|Stage IIIB or IV May 2006 Phase 2
    NCT00993655 Canadian Cancer Trials Group|National Cancer Institute (NCI)|Grupo Español de Investigación en Cáncer de Ovario|Cancer Research UK|Southwest Oncology Group Fallopian Tube Cancer|Metastatic Cancer|Ovarian Cancer|Peritoneal Cavity Cancer September 2009 Phase 2
    NCT00373217 Craig L Slingluff, Jr|National Cancer Institute (NCI)|University of Virginia Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer February 2008 Phase 2
    NCT02446652 National Institute of Cancerología|Psicofarma S.A. de C.V. Cervical Cancer July 2015 Phase 3
    NCT00144053 West Japan Thoracic Oncology Group Lung Cancer April 2001 Phase 3
    NCT02514421 The University of Texas Health Science Center, Houston Pancreatic Adenocarcinoma July 2015
    NCT00798252 Bristol-Myers Squibb Advanced Cancer March 2009 Phase 1
    NCT00471289 Netherlands Society for Interventional Radiology Peripheral Vascular Disease August 2007 Phase 2|Phase 3
    NCT00702975 Radboud University Locally Advanced Non-Small Cell Lung Cancer|NSCLC September 2008 Phase 2
    NCT02460042 B. Braun Melsungen AG Peripheral Arterial Occlusive Disease May 2015
    NCT01739218 Hoffmann-La Roche Ovarian Cancer February 2013 Phase 2
    NCT00003334 New York University School of Medicine|National Cancer Institute (NCI) Endometrial Cancer|Fallopian Tube Cancer|Ovarian Cancer|Sarcoma March 1997 Phase 2
    NCT01843829 Lisette Nixon|Cancer Research UK|Velindre NHS Trust Oesophageal Cancer October 2013 Phase 2
    NCT01902875 Jinling Hospital, China Non Small Cell Lung Cancer June 2013
    NCT00235092 Cordis Corporation Coronary Artery Disease August 2003 Phase 4
    NCT00180479 Abbott Vascular Stents|Coronary Artery Disease|Total Coronary Occlusion|Coronary Artery Restenosis|Stent Thrombosis|Vascular Disease|Myocardial Ischemia|Coronary Artery Stenosis June 2005 Phase 3
    NCT00287989 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Lung Cancer November 2004 Phase 2
    NCT00003298 ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group Gastric Cancer February 1999 Phase 2
    NCT00448305 MediGene Breast Neoplasms January 2007 Phase 2
    NCT02319889 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Stage I Non-Small Cell Lung Cancer|Stage II Non-Small Cell Lung Cancer February 2, 2016 Early Phase 1
    NCT01815242 West German Study Group|Celgene Corporation Breast Cancer June 2013 Phase 2
    NCT00467051 Children's Oncology Group|National Cancer Institute (NCI) Childhood Extracranial Germ Cell Tumor|Childhood Extragonadal Germ Cell Tumor|Childhood Malignant Ovarian Germ Cell Tumor|Childhood Malignant Testicular Germ Cell Tumor|Ovarian Choriocarcinoma|Ovarian Embryonal Carcinoma|Ovarian Yolk Sac Tumor|Recurrent Childhood Malignant Germ Cell Tumor|Recurrent Malignant Testicular Germ Cell Tumor|Recurrent Ovarian Germ Cell Tumor|Testicular Choriocarcinoma|Testicular Choriocarcinoma and Embryonal Carcinoma|Testicular Choriocarcinoma and Yolk Sac Tumor|Testi November 2007 Phase 2
    NCT02734290 Providence Health & Services|Merck Sharp & Dohme Corp. Triple Negative Breast Cancer May 2016 Phase 1|Phase 2
    NCT01023919 Harbin Medical University Coronary Artery Disease|Diabetes Mellitus November 2009 Phase 4
    NCT00533949 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|North Central Cancer Treatment Group|Cancer and Leukemia Group B|NRG Oncology Lung Cancer|Radiation Toxicity November 2007 Phase 3
    NCT01414608 Gynecologic Oncology Group|National Cancer Institute (NCI) Cervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Cervical Squamous Cell Carcinoma, Not Otherwise Specified|Chemotherapeutic Agent Toxicity|Cognitive Side Effects of Cancer Therapy|Psychological Impact of Cancer|Radiation Toxicity|Sexual Dysfunction and Infertility|Stage IB Cervical Cancer|Stage IIA Cervical Cancer|Stage IIB Cervical Cancer|Stage IIIB Cervical Cancer|Stage IVA Cervical Cancer January 2012 Phase 3
    NCT03162510 National Health Research Institutes, Taiwan|National Cheng-Kung University Hospital|National Taiwan University Hospital Gastric Cancer in Situ|Pancreatic Cancers|Biliary Cancers July 2017 Phase 1
    NCT00005065 National Cancer Institute (NCI) Stage IIIA Non-small Cell Lung Cancer January 2000 Phase 1
    NCT00290537 M.D. Anderson Cancer Center|AstraZeneca Lung Cancer January 2006 Phase 2
    NCT02102438 Instituto do Cancer do Estado de São Paulo Breast Cancer|HER-2 Positive Breast Cancer April 2014
    NCT00003880 Merck Sharp & Dohme Corp. Ovarian Cancer|Primary Peritoneal Cavity Cancer February 1999 Phase 2|Phase 3
    NCT00049790 CASI Pharmaceuticals, Inc. Carcinoma, Non-Small-Cell Lung Phase 2
    NCT01196390 National Cancer Institute (NCI) Esophageal Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma|Stage IB Esophageal Cancer AJCC v7|Stage IIA Esophageal Cancer AJCC v7|Stage IIB Esophageal Cancer AJCC v7|Stage IIIA Esophageal Cancer AJCC v7|Stage IIIB Esophageal Cancer AJCC v7 December 30, 2010 Phase 3
    NCT00031954 AGO Study Group Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer August 2001 Phase 2
    NCT00003088 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer September 1997 Phase 3
    NCT02368197 Shaare Zedek Medical Center Dialysis Access Dysfunction July 2015 Phase 2|Phase 3
    NCT00550771 Merck Sharp & Dohme Corp. Breast Neoplasm July 16, 2007 Phase 2
    NCT00054197 CTI BioPharma|National Cancer Institute (NCI) Lung Cancer January 2003 Phase 3
    NCT00433966 Cardiovascular Research Foundation, New York|Boston Scientific Corporation|The Medicines Company Myocardial Infarction March 2005 Phase 3
    NCT00006011 Gynecologic Oncology Group|Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Endometrial Adenocarcinoma|Endometrial Adenosquamous Carcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation|Endometrial Serous Adenocarcinoma|Stage III Uterine Corpus Cancer July 2000 Phase 3
    NCT01690572 Prof. Dr. med. Christoph Hehrlein|Herz-Zentrums Bad Krozingen Coronary Disease|Diabetes Mellitus October 2012
    NCT01110603 Tesaro, Inc. Cancer: Solid Tumors July 2010 Phase 1
    NCT00898417 ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group Lung Cancer March 14, 2008
    NCT00660842 National Cancer Institute, Naples Ovarian Cancer November 2008 Phase 3
    NCT03107182 University of Chicago HPV-Related Squamous Cell Carcinoma|HNSCC June 27, 2017 Phase 2
    NCT00455533 Bristol-Myers Squibb Breast Cancer October 2007 Phase 2
    NCT00002734 National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer March 1996 Phase 1
    NCT00512096 M.D. Anderson Cancer Center Penile Cancer August 1999 Phase 2
    NCT02033551 AbbVie Breast Cancer|Ovarian Cancer|Colon Cancer|Lung Cancer|Gastric Cancer|Solid Tumors December 2013 Phase 1
    NCT02564263 Merck Sharp & Dohme Corp. Esophageal Carcinoma|Esophagogastric Junction Carcinoma December 1, 2015 Phase 3
    NCT00016900 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Esophageal Cancer December 2000 Phase 2
    NCT03056833 University of Michigan Cancer Center Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Carcinoma June 10, 2017 Phase 1
    NCT01517997 University of Patras Arterial Occlusive Disease August 2011 Phase 2|Phase 3
    NCT01216111 Fudan University|Chinese Anti-Cancer Association Triple Negative Breast Cancer
    NCT02297230 New York University School of Medicine Breast Cancer June 2002 Phase 1|Phase 2
    NCT00055133 Angiotech Pharmaceuticals Rheumatoid Arthritis September 2002 Phase 2
    NCT00193141 SCRI Development Innovations, LLC|Bristol-Myers Squibb Esophagus Cancer October 1999 Phase 2
    NCT00093795 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer October 2004 Phase 3
    NCT00009932 Ohio State University Comprehensive Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific January 2001 Phase 1
    NCT03223974 Beijing Hospital Coronary Disease July 2017
    NCT00003587 Southwest Oncology Group|National Cancer Institute (NCI) Lung Cancer October 1998 Phase 2
    NCT02613208 Hoffmann-La Roche Metastatic Breast Cancer December 2015
    NCT00236899 Eli Lilly and Company Metastatic Breast Cancer (MBC) September 2005 Phase 3
    NCT00003237 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Esophageal Cancer|Gastric Cancer March 1998 Phase 2
    NCT00415961 Conor Medsystems|Getz Pharma Coronary Disease November 2006
    NCT00997503 Boston Scientific Corporation|Eli Lilly and Company|Daiichi Sankyo Inc. Coronary Artery Disease December 2009 Phase 4
    NCT02129127 TriReme Medical, LLC Peripheral Vascular Disease March 2014
    NCT02705196 Lokon Pharma AB Pancreatic Cancer November 2016 Phase 1|Phase 2
    NCT01462890 AGO Study Group|ARCAGY/ GINECO GROUP|Nordic Society for Gynaecologic Oncology Genital Diseases, Female|Ovarian Diseases|Ovarian Neoplasms|Fallopian Tube Neoplasms|Peritoneal Neoplasms November 2011 Phase 3
    NCT01126216 University of Erlangen-Nürnberg Medical School|Deutsche Krebshilfe e.V., Bonn (Germany) Head and Neck Cancer May 2010 Phase 3
    NCT01847677 Grupo Español de Investigación en Cáncer de Ovario|Roche Pharma AG Cancer, Ovarian April 2013 Phase 2
    NCT00006378 Case Comprehensive Cancer Center|National Cancer Institute (NCI)|American College of Radiology Lung Cancer December 1999 Phase 2
    NCT02879097 Cipla BioTec Pvt. Ltd. Non-Small Cell Lung Carcinoma December 2016 Phase 3
    NCT00256243 University of California, Irvine Inflammatory Breast Cancer|Locally Advanced Breast Cancer April 2004 Phase 2
    NCT00003004 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific July 1997 Phase 1
    NCT00336791 M.D. Anderson Cancer Center|Breast Cancer Research Foundation Breast Cancer September 2003 Phase 3
    NCT02420314 University of Iowa|National Cancer Institute (NCI)|National Institutes of Health (NIH) Carcinoma, Non-Small-Cell Lung April 2015 Phase 2
    NCT02584478 Advenchen Laboratories, LLC Endometrial Carcinoma|Ovarian Carcinoma|Fallopian Tube Carcinoma|Primary Peritoneal Carcinoma|Cervical Carcinoma December 2015 Phase 1|Phase 2
    NCT00730925 Boehringer Ingelheim Carcinoma, Non-Small-Cell Lung June 2008 Phase 2
    NCT00002568 Gynecologic Oncology Group|National Cancer Institute (NCI) Ovarian Cancer June 1994 Phase 3
    NCT00934752 C. R. Bard Coronary Artery Stenosis July 2009 Phase 1|Phase 2
    NCT00864318 Institut Claudius Regaud Germ Cell Tumors March 2009 Phase 2
    NCT00011960 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Esophageal Cancer|Gastric Cancer May 2001 Phase 2
    NCT01084863 Celltrion Metastatic Breast Cancer January 2010 Phase 1|Phase 2
    NCT00081302 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Lung Cancer March 2004 Phase 2
    NCT00003992 National Cancer Institute (NCI) Breast Cancer August 1999 Phase 2
    NCT00003449 University of Southern California|National Cancer Institute (NCI) Ovarian Cancer May 1998 Phase 2
    NCT00003235 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Lung Cancer April 1998 Phase 3
    NCT01820754 Duke University Non Small Cell Lung Cancer March 2013 Phase 2
    NCT02876302 Dana-Farber Cancer Institute|Incyte Corporation Inflammatory Breast Cancer (IBC) April 26, 2017 Phase 2
    NCT02944071 Boston Scientific Corporation Femoropopliteal Artery Lesions October 2016
    NCT00566540 Ohio State University Comprehensive Cancer Center Head and Neck Cancer December 2007 Phase 2
    NCT02107378 Sotio a.s. Epithelial Ovarian Carcinoma January 2014 Phase 2
    NCT02375204 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|European Organisation for Research and Treatment of Cancer - EORTC|Movember Foundation|Institute of Cancer Research (ICR), United Kingdom|Cancer Research UK (CRUK)|UNICANCER|Irish Group CTI Germ Cell Tumor|Teratoma|Choriocarcinoma|Germinoma|Mixed Germ Cell Tumor|Yolk Sac Tumor|Childhood Teratoma|Malignant Germ Cell Neoplasm|Extragonadal Seminoma|Non-seminomatous Germ Cell Tumor|Seminoma March 2015 Phase 3
    NCT02419742 Hoffmann-La Roche Breast Cancer August 18, 2015 Phase 4
    NCT00003881 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Lung Cancer May 1999 Phase 2
    NCT03197935 Hoffmann-La Roche Triple-negative Breast Cancer July 31, 2017 Phase 3
    NCT00002814 Dartmouth-Hitchcock Medical Center Brain and Central Nervous System Tumors August 1996 Phase 2
    NCT00095927 Dana-Farber Cancer Institute|National Cancer Institute (NCI)|MedImmune LLC|AstraZeneca Chemotherapeutic Agent Toxicity|Head and Neck Cancer|Mucositis|Radiation Toxicity|Xerostomia May 2003 Phase 2
    NCT01891357 West German Study Group|GlaxoSmithKline Carcinoma, Ductal, Breast June 2013 Phase 2
    NCT00003624 Gynecologic Oncology Group|National Cancer Institute (NCI) Cervical Cancer|Endometrial Cancer|Fallopian Tube Cancer|Neurotoxicity|Ovarian Cancer|Primary Peritoneal Cavity Cancer|Sarcoma December 1998 Phase 2
    NCT02930902 M.D. Anderson Cancer Center|Merck Sharp & Dohme Corp. Pancreatic Cancer February 20, 2017 Phase 1
    NCT00064077 Gynecologic Oncology Group|National Cancer Institute (NCI) Cervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Cervical Squamous Cell Carcinoma|Recurrent Cervical Carcinoma|Stage IVB Cervical Cancer May 2003 Phase 3
    NCT02905591 University of Iowa|National Institutes of Health (NIH)|National Cancer Institute (NCI)|Holden Comprehensive Cancer Center Carcinoma, Non-Small-Cell Lung|Non-Small Cell Lung Cancer|Nonsmall Cell Lung Cancer|Non-Small-Cell Lung Carcinoma|NSCLC July 31, 2017 Phase 2
    NCT00002888 Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|Southwest Oncology Group Head and Neck Cancer March 1997 Phase 3
    NCT01566435 Washington University School of Medicine Head and Neck Neoplasms August 9, 2012 Phase 2
    NCT00006484 Southwest Oncology Group|National Cancer Institute (NCI) Lung Cancer November 2000 Phase 3
    NCT02754726 HonorHealth Research Institute|Translational Genomics Research Institute|Bristol-Myers Squibb Untreated Metastatic Pancreatic Ductal Adenocarcinoma April 2016 Phase 2
    NCT00003732 Rigshospitalet, Denmark|National Cancer Institute (NCI) Ovarian Cancer September 1998 Phase 2
    NCT03150576 Cambridge University Hospitals NHS Foundation Trust|AstraZeneca|Cancer Research UK Breast Cancer May 2016 Phase 2|Phase 3
    NCT00006012 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Drug/Agent Toxicity by Tissue/Organ|Lung Cancer|Radiation Toxicity February 2001 Phase 1|Phase 2
    NCT00003072 University of California, San Francisco Lung Cancer|Neurotoxicity|Ovarian Cancer May 1997 Phase 2
    NCT00004105 New York University School of Medicine|National Cancer Institute (NCI) Leukemia|Lymphoma|Sarcoma|Unspecified Adult Solid Tumor, Protocol Specific September 1998 Phase 1|Phase 2
    NCT00054392 Fox Chase Cancer Center|National Cancer Institute (NCI) Lung Cancer September 2001 Phase 3
    NCT00002684 Memorial Sloan Kettering Cancer Center Bladder Cancer|Urethral Cancer May 1995 Phase 2
    NCT00634595 Sun Yat-sen University|Doublle Bioproduct Inc Head and Neck Squamous Carcinoma|Nasopharyngeal Carcinoma March 2008 Phase 2
    NCT00028769 Southwest Oncology Group|National Cancer Institute (NCI) Prostate Cancer December 2001 Phase 2
    NCT03094884 Fox Chase Cancer Center Lung Cancer|Esophageal Cancer February 24, 2017 Phase 1
    NCT02435186 Shenzhen SiBiono GeneTech Co.,Ltd Ovarian Epithelial Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer June 2015 Phase 2
    NCT01084083 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer|Precancerous Condition March 2010 Phase 2
    NCT00003385 Gynecologic Oncology Group|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer March 1999 Phase 1
    NCT00069953 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|NRG Oncology Esophageal Cancer September 2003 Phase 2
    NCT01797900 Chinese Academy of Medical Sciences Nasopharyngeal Neoplasms March 2013 Phase 2
    NCT03101358 NanOlogy, LLC|US Biotest, Inc. Cutaneous Metastasis September 2017 Phase 2
    NCT00004011 Southwest Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group|North Central Cancer Treatment Group|Radiation Therapy Oncology Group Lung Cancer October 1999 Phase 3
    NCT00281788 Duke University|National Cancer Institute (NCI) Esophageal Cancer September 2003 Phase 1
    NCT01271725 Boehringer Ingelheim Breast Neoplasms May 24, 2011 Phase 2
    NCT02551991 Ipsen Pancreatic Cancer September 2015 Phase 2
    NCT00307047 Abbott Vascular Coronary Artery Disease August 2006 Phase 3
    NCT00944047 University of Kansas Medical Center|Celgene Corporation Breast Cancer July 2009 Phase 2
    NCT00055601 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group|NRG Oncology Bladder Cancer December 2002 Phase 2
    NCT01084408 University Hospital, Saarland Coronary De-novo Stenoses March 2010 Phase 3
    NCT02213497 Abramson Cancer Center of the University of Pennsylvania Esophageal Cancer April 2014 Phase 1
    NCT00581971 University of Alabama at Birmingham|Bristol-Myers Squibb|Pharmacia Cancer September 2002 Phase 1|Phase 2
    NCT00563784 M.D. Anderson Cancer Center|Genentech, Inc.|United States Department of Defense Non-Small Cell Lung Cancer|Lung Cancer November 2007 Phase 2
    NCT00801736 University College, London|Eli Lilly and Company|Cancer Research UK Lung Cancer October 2009 Phase 3
    NCT02409186 Shandong Cancer Hospital and Institute Prosthesis Survival March 2015 Phase 3
    NCT01750073 University of Nebraska|National Cancer Institute (NCI) Estrogen Receptor-negative Breast Cancer|Estrogen Receptor-positive Breast Cancer|HER2-negative Breast Cancer|HER2-positive Breast Cancer|Progesterone Receptor-negative Breast Cancer|Progesterone Receptor-positive Breast Cancer|Stage IA Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Triple-negative Breast Cancer December 2012 Phase 2
    NCT00003084 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Prostate Cancer December 1997 Phase 2
    NCT02570893 Zhejiang Cancer Hospital Esophageal Cancer May 2015 Phase 3
    NCT00656669 Indiana University|Pfizer Breast Cancer April 2008
    NCT00154687 National Taiwan University Hospital Transitional Cell Carcinoma October 2000 Phase 2
    NCT00800202 Hoffmann-La Roche Non-Small Cell Lung Cancer April 2009 Phase 2
    NCT01818063 Sidney Kimmel Cancer Center at Thomas Jefferson University|Susan G. Komen Breast Cancer Foundation|Thomas Jefferson University Estrogen Receptor-negative Breast Cancer|HER2-negative Breast Cancer|Progesterone Receptor-negative Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Triple-negative Breast Cancer April 25, 2013 Phase 2
    NCT00028743 NCIC Clinical Trials Group|European Organisation for Research and Treatment of Cancer - EORTC|Grupo Español de Investigación en Cáncer de Ovario|Canadian Cancer Trials Group Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer August 2001 Phase 3
    NCT00462397 University College London Hospitals|National Cancer Institute (NCI) Cervical Cancer June 2005 Phase 2
    NCT00391118 Eli Lilly and Company Ovarian Cancer|Fallopian Tube Neoplasms|Peritoneal Neoplasm November 2006 Phase 2
    NCT03128008 Duke University Carcinoma, Non Small Cell Lung (NSCLC) July 2017 Phase 2
    NCT03125772 Fortis Escorts Heart Institute|Boston Scientific Corporation|Max Neeman Medical International Ltd. Type 2 Diabetes|Coronary Heart Disease June 2011
    NCT00004160 University of Alabama at Birmingham|National Cancer Institute (NCI) Lung Cancer February 2000 Phase 1|Phase 2
    NCT00069901 CTI BioPharma Ovarian Neoplasm February 2003 Phase 2
    NCT00005021 Fox Chase Cancer Center|National Cancer Institute (NCI) Lymphoma|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol Specific July 1996 Phase 1
    NCT02583477 AstraZeneca Metastatic Pancreatic Ductal Adenocarcinoma March 25, 2016 Phase 1|Phase 2
    NCT02229149 US Oncology Research|Genentech, Inc. Breast Neoplasms|Malignant Tumor of the Breast December 2014 Phase 2
    NCT00005644 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral Cancer May 2000 Phase 2
    NCT00011999 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer March 2001 Phase 2
    NCT01696032 Astex Pharmaceuticals Ovarian Cancer September 2012 Phase 1|Phase 2
    NCT00479765 BTG International Inc. Glioblastoma Multiforme|Brain Neoplasms March 2007 Phase 1|Phase 2
    NCT01205217 GlaxoSmithKline Neoplasms, Breast December 2010 Phase 2
    NCT02227940 Roswell Park Cancer Institute|National Cancer Institute (NCI) Advanced Malignant Solid Neoplasm|ALK Positive|Metastatic Pancreatic Adenocarcinoma|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer January 8, 2015 Phase 1
    NCT02590003 Yale University Carcinoma, Non-small Cell Lung November 2015 Phase 2
    NCT00003251 University of Illinois at Chicago|National Cancer Institute (NCI) Drug/Agent Toxicity by Tissue/Organ|Head and Neck Cancer|Radiation Toxicity December 1997 Phase 1|Phase 2
    NCT00003158 Southwest Oncology Group|National Cancer Institute (NCI) Lung Cancer February 1998 Phase 2
    NCT00980954 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Cervical Cancer September 2009 Phase 3
    NCT00454649 Pfizer Neoplasms December 2005 Phase 1
    NCT01021930 Harbin Medical University Coronary Heart Disease|Diabetes Mellitus November 2009 Phase 4
    NCT01672671 Russian Academy of Medical Sciences Early Triple Negative Breast Cancer August 2011 Phase 2
    NCT02073968 Albert Einstein College of Medicine, Inc.|National Cancer Institute (NCI) Metastatic Malignant Neoplasm in the Brain|Recurrent Non-Small Cell Lung Carcinoma|Stage IIA Non-Small Cell Lung Carcinoma|Stage IIB Non-Small Cell Lung Carcinoma|Stage IIIA Non-Small Cell Lung Cancer|Stage IIIB Non-Small Cell Lung Cancer|Stage IV Non-Small Cell Lung Cancer July 2013 Phase 2
    NCT01969032 Russian Academy of Medical Sciences Triple Negative Breast Cancer August 2011 Phase 2
    NCT01314833 Fudan University|Chinese Anti-Cancer Association Breast Cancer June 2010 Phase 3
    NCT00003089 Sidney Kimmel Cancer Center at Thomas Jefferson University|National Cancer Institute (NCI) Drug/Agent Toxicity by Tissue/Organ|Lung Cancer July 1997 Phase 2
    NCT02789657 William Sikov|Women and Infants Hospital of Rhode Island|Rhode Island Hospital|Brown University Breast Cancer November 2016 Phase 2
    NCT02798536 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Mesothelioma June 7, 2016 Phase 1
    NCT00194779 University of Washington|National Cancer Institute (NCI) Estrogen Receptor-negative Breast Cancer|Estrogen Receptor-positive Breast Cancer|HER2-positive Breast Cancer|Progesterone Receptor-negative Breast Cancer|Progesterone Receptor-positive Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer October 2003 Phase 2
    NCT00499083 University of Nebraska|National Cancer Institute (NCI) Breast Cancer May 2006 Phase 2
    NCT00003294 Roswell Park Cancer Institute|National Cancer Institute (NCI) Leukemia|Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific May 1997 Phase 1
    NCT00870038 Ospedale della Misericordia Angioplasty, Transluminal, Percutaneous Coronary|Percutaneous Coronary Intervention December 2010 Phase 4
    NCT00003691 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Cancer December 1998 Phase 3
    NCT01084876 Celltrion Metastatic Breast Cancer June 2010 Phase 3
    NCT03085004 Milton S. Hershey Medical Center Precancerous Type Pancreatic Cyst June 2017 Phase 2|Phase 3
    NCT00737243 SCRI Development Innovations, LLC|Genentech, Inc. Carcinoma August 2008 Phase 2
    NCT02730416 Nordic Society for Gynaecologic Oncology|North Eastern Germany Society of Gynaecologic Oncology|Belgian Gynaecological Oncology Group|ARCAGY/ GINECO GROUP Endometrial Cancer November 2016 Phase 2
    NCT00480831 Genentech, Inc. Non-Small Cell Lung Cancer June 2007 Phase 2
    NCT03117933 University of Oxford|AstraZeneca Ovarian Cancer March 9, 2017 Phase 2
    NCT00161278 University of Michigan Cancer Center Advanced Non-Small Cell Lung Cancer December 2004 Phase 2
    NCT00005831 National Cancer Institute (NCI) Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter|Recurrent Bladder Cancer|Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter|Squamous Cell Carcinoma of the Bladder|Stage IV Bladder Cancer|Transitional Cell Carcinoma of the Bladder March 2000 Phase 2
    NCT01918124 Fan Ming|Fudan University Prosthesis Survival January 2008 Phase 2
    NCT02567799 Humanetics Corporation|National Cancer Institute (NCI)|Henry Ford Health System Carcinoma, Non-Small-Cell Lung November 2015 Phase 1|Phase 2
    NCT00268450 Medical University of South Carolina Bladder Cancer September 2005 Phase 2
    NCT02891083 Shanghai Chest Hospital|Tianjin Medical University Cancer Institute and Hospital|Sun Yat-sen University|Sichuan Cancer Hospital and Research Institute|Hunan Cancer Hospital|Fujian Cancer Hospital|Fudan University|Qingdao University|Fujian Medical University|Wuhan TongJi Hospital Esophageal Neoplasms January 2016 Phase 3
    NCT01912625 National Cancer Institute (NCI) KRAS Activating Mutation|Recurrent Non-Small Cell Lung Carcinoma|Stage III Non-Small Cell Lung Cancer AJCC v7|Stage IIIA Non-Small Cell Lung Cancer AJCC v7|Stage IIIB Non-Small Cell Lung Cancer AJCC v7 October 28, 2013 Phase 1
    NCT00114972 Boston Scientific Corporation|Cardialysis BV Coronary Artery Disease March 2005 Phase 3
    NCT00323583 Seattle Cancer Treatment and Wellness Center Adenocarincoma of Pancreas|Stage III Pancreatic Cancer|Stage IVA Pancreatic Cancer|Stage IVB Pancreatic Cancer May 2006 Phase 2
    NCT01244789 Danish Gynecological Cancer Group|European Organisation for Research and Treatment of Cancer - EORTC|Arbeitsgemeinschaft Gynaekologische Onkologie Austria|North Eastern Germany Society of Gynaecologic Oncology|Mayo Clinic|Nordic Society for Gynaecologic Oncology|Belgian Gynaecological Oncology Group|Mario Negri Gynecologic Oncology group (MaNGO) Italy Endometrial Cancer December 2011 Phase 3
    NCT01345279 GlaxoSmithKline Cervical Intraepithelial Neoplasia June 2009
    NCT00252798 AstraZeneca Non Small Cell Lung Carcinoma July 2002 Phase 1
    NCT00040794 National Cancer Institute (NCI) Adenocarcinoma of the Lung|Adenosquamous Cell Lung Cancer|Bronchoalveolar Cell Lung Cancer|Large Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer May 2002 Phase 2
    NCT01303679 ARCAGY/ GINECO GROUP First Line Metastatic Breast Cancer June 2010 Phase 3
    NCT00334763 Northwestern University|National Cancer Institute (NCI) Lung Cancer May 2006 Phase 2
    NCT00032032 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer May 2002 Phase 1
    NCT00008047 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)|National Cancer Institute (NCI) Esophageal Cancer August 1999 Phase 1|Phase 2
    NCT01676259 Silenseed Ltd Pancreatic Ductal Adenocarcinoma|Pancreatic Cancer February 2017 Phase 2
    NCT01538108 N.M.B. Medical Applications Ltd Obstructive Lesions of Arteriovenous Dialysis Fistulae July 2012
    NCT00277043 New Mexico Cancer Care Alliance Supportive|Ill-defined Sites June 2002 Phase 3
    NCT02619448 State University of New York - Upstate Medical University Non-small Cell Lung Cancer December 2014 Early Phase 1
    NCT01057069 The Netherlands Cancer Institute Breast Cancer January 2010 Phase 2|Phase 3
    NCT00900172 ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group Lung Cancer March 15, 2008
    NCT00436566 Mayo Clinic|National Cancer Institute (NCI) Breast Cancer|Cardiac Toxicity March 2007 Phase 2
    NCT00411138 Leiden University Medical Center|Cancer Research UK|Australia New Zealand Gynaecological Oncology Group|NCIC Clinical Trials Group|Mario Negri Institute for Pharmacological Research|UNICANCER Endometrial Cancer October 2006 Phase 3
    NCT00848718 Merck Sharp & Dohme Corp. Locally Advanced, Metastatic Solid Tumors March 2009 Phase 1
    NCT01077999 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Squamous Cell Carcinoma|Adenocarcinoma|Esophageal Cancer|Gastro-esophageal Junction Cancer January 2010 Phase 2
    NCT02591615 Alliance Foundation Trials, LLC.|Merck Sharp & Dohme Corp. Non-Small Cell Lung Cancer March 2016 Phase 2
    NCT01019616 Tao OUYANG|Beijing Municipal Science & Technology Commission|Peking Union Medical College Hospital|Chinese Academy of Medical Sciences|Peking University First Hospital|Peking University People's Hospital|Beijing Chao Yang Hospital|307 Hospital of PLA|Peking University Primary Breast Cancer December 2010 Phase 3
    NCT02333188 University of Chicago|National Cancer Institute (NCI) Adenocarcinoma of Unknown Primary|Adult Cholangiocarcinoma|Gallbladder Carcinoma|Gastric Adenocarcinoma|Malignant Gastrointestinal Neoplasm|Metastatic Pancreatic Adenocarcinoma|Pancreatic Adenocarcinoma|Stage III Ampulla of Vater Cancer|Stage III Pancreatic Cancer|Stage IIIA Gallbladder Cancer|Stage IIIA Gastric Cancer|Stage IIIB Gallbladder Cancer|Stage IIIB Gastric Cancer|Stage IV Ampulla of Vater Cancer|Stage IV Gallbladder Cancer|Stage IV Gastric Cancer|Stage IV Pancreatic Cancer December 2014 Phase 1|Phase 2
    NCT00039546 Cancer Research Campaign Clinical Trials Centre|National Cancer Institute (NCI) Breast Cancer August 2001 Phase 3
    NCT01820637 Boston Scientific Corporation Atherosclerosis of Native Arteries of the Extremities July 2013
    NCT03136055 University of California, San Francisco|Merck Sharp & Dohme Corp. High Grade Malignant Neuroendocrine Carcinoma (Diagnosis) June 20, 2017 Phase 2
    NCT02272699 Peking University Esophageal Squamous Cell Carcinoma November 2014 Phase 2|Phase 3
    NCT00334321 Washington University School of Medicine Endometrial Cancer April 2006 Phase 1
    NCT00610714 AstraZeneca Ovarian Neoplasms|Ovarian Cancer April 2008 Phase 2
    NCT00979212 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Lung Cancer February 2011 Phase 2
    NCT00815308 Shandong Cancer Hospital and Institute|Chinese Academy of Medical Sciences|Beijing Cancer Hospital|Hebei Fourth Hospital|Jiangsu Cancer Institute & Hospital|RenJi Hospital|The Affiliated Cancer Hospital of Zhengzhou University|West China Hospital Esophageal Cancer January 2009 Phase 2
    NCT01711697 Emory University Stage IIA Non-small Cell Lung Cancer|Stage IIB Non-small Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer September 2012 Phase 1
    NCT02044601 M.D. Anderson Cancer Center|Genentech, Inc. Lung Cancer June 2014 Phase 1|Phase 2
    NCT00003342 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter December 1997 Phase 1
    NCT00006374 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Lung Cancer October 1999 Phase 2
    NCT02013271 C. R. Bard Femoral Artery Occlusion|Femoral Arterial Stenosis December 2013
    NCT01556542 Leonardo Bolognese, MD|Ospedale San Donato Peripheral Arterial Disease November 2010 Phase 4
    NCT01566240 University College, London|Cancer Research UK Cervical Cancer September 2012 Phase 3
    NCT01486602 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer March 2012 Phase 1
    NCT01897441 Albert Einstein College of Medicine, Inc.|National Cancer Institute (NCI) Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer June 2013
    NCT02249013 Professor Fernando Figueira Integral Medicine Institute|Hospital de Câncer de Pernambuco|AC Camargo Cancer Center Ovarian Cancer February 2015 Phase 2
    NCT01756170 xie congying|Wenzhou Medical University Cervical Cancer January 2011 Phase 3
    NCT01646788 N.M.B. Medical Applications Ltd Obstructive Lesions of Arteriovenous Dialysis Fistulae January 2013
    NCT00009997 New York University School of Medicine|National Cancer Institute (NCI) Breast Cancer March 1999 Phase 1
    NCT00679029 University of Nebraska|National Cancer Institute (NCI) HER2-negative Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer May 2008 Phase 2
    NCT01144442 Masonic Cancer Center, University of Minnesota Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Carcinoma August 2010
    NCT00002558 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Extragonadal Germ Cell Tumor|Ovarian Cancer|Testicular Germ Cell Tumor January 1994 Phase 1|Phase 2
    NCT02597036 Eli Lilly and Company Solid Tumors November 2015 Phase 1
    NCT01347424 Sun Yat-sen University Non Small Cell Lung Cancer|Nasopharyngeal Cancer|Liver Metastasis January 2011 Phase 2
    NCT02944396 AbbVie Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC) December 28, 2016 Phase 2
    NCT00003322 Gynecologic Oncology Group|National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer March 1998 Phase 3
    NCT00433420 Gruppo Italiano Mammella (GIM)|National Cancer Institute (NCI) Breast Cancer April 2003 Phase 3
    NCT00003394 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Prostate Cancer April 1998 Phase 1|Phase 2
    NCT00004253 Baptist Health South Florida|National Cancer Institute (NCI) Lung Cancer March 2000 Phase 2
    NCT02539225 Eli Lilly and Company Metastatic Gastric Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma October 2015 Phase 2
    NCT02517827 Herz-Zentrums Bad Krozingen Peripheral Artery Disease|Artery Stenosis November 2016
    NCT02474186 New York University School of Medicine Breast Cancer|Metastatic Breast Cancer|Solid Tumor April 2003 Phase 2
    NCT01654146 Medical Research Council|Cancer Research UK Ovarian Cancer June 2011 Phase 3
    NCT00657878 National Cancer Institute, Naples Ovarian Cancer November 2008 Phase 3
    NCT00002819 Gynecologic Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group|Southwest Oncology Group|Cancer and Leukemia Group B Ovarian Cancer November 1996 Phase 3
    NCT00003742 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific October 1998 Phase 1
    NCT02603679 Thomas Hatschek|Karolinska University Hospital Early-Stage Breast Carcinoma|Estrogen Receptor Positive Tumor February 2015 Phase 2
    NCT01134523 Chinese Academy of Medical Sciences Breast Cancer May 2010 Phase 3
    NCT00003733 SmithKline Beecham|National Cancer Institute (NCI) Ovarian Cancer December 1997 Phase 2
    NCT00008138 Southwest Oncology Group|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer March 2001 Phase 2
    NCT00016913 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Prostate Cancer May 2001 Phase 2
    NCT02756130 Jonsson Comprehensive Cancer Center|TetraLogic Pharmaceuticals Advanced Newly Diagnosed or Recurrent High Grade Serous Carcinomas (HGSC) January 2017 Phase 2
    NCT00005806 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Lung Cancer September 1999 Phase 1
    NCT02468557 Gilead Sciences Pancreatic Ductal Adenocarcinoma July 2015 Phase 1
    NCT00003378 Gynecologic Oncology Group|National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer August 1998 Phase 1
    NCT00006248 Southwest Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer November 2000 Phase 2
    NCT00005026 Gynecologic Oncology Group|National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer February 2000 Phase 1
    NCT01345851 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) Adenocarcinoma of the Lung|Adenosquamous Cell Lung Cancer|Large Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIA Non-small Cell Lung Cancer|Stage IIB Non-small Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer March 23, 2011
    NCT00168883 Charite University, Berlin, Germany|Bristol-Myers Squibb|Pierre Fabre Pharma GmbH Carcinoma, Non-Small-Cell Lung October 2002 Phase 2
    NCT00191256 Eli Lilly and Company Carcinoma, Non Small Cell Lung June 2001 Phase 2
    NCT00008021 University of California, Davis|National Cancer Institute (NCI) Lymphoma February 2001 Phase 1
    NCT02754882 Samsung Bioepis Co., Ltd. Lung Cancer|Non-small Cell Lung Cancer June 2016 Phase 3
    NCT00951496 National Cancer Institute (NCI) Malignant Ovarian Mixed Epithelial Tumor|Ovarian Brenner Tumor|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Stage IIA Fallopian Tube Cancer|Stage IIA Ovarian Cancer|Stage IIB Fallopian Tube Cancer|Stage IIB Ovarian Cancer|Stage IIC Fallopian Tube Cancer|Stage IIC Ovarian Cancer|Stage IIIA Fallopian Tube Cancer|Stage IIIA Ovarian Cancer|Stage IIIA Primary Peritoneal Cancer|Stage IIIB Fallopian Tube July 2009 Phase 3
    NCT01301729 Hoffmann-La Roche Breast Cancer March 2011 Phase 4
    NCT00006049 AstraZeneca|National Cancer Institute (NCI) Lung Cancer May 2000 Phase 3
    NCT03045770 Fujian Cancer Hospital Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction February 10, 2017
    NCT03188432 Wake Forest University Health Sciences|National Cancer Institute (NCI) Stage IIIC Fallopian Tube Cancer|Stage IIIC Ovarian Cancer|Stage IIIC Primary Peritoneal Cancer|Stage IV Fallopian Tube Cancer|Stage IV Ovarian Cancer|Stage IV Primary Peritoneal Cancer July 1, 2017 Phase 2
    NCT01684878 Hoffmann-La Roche Ovarian Cancer October 22, 2012 Phase 3
    NCT01711541 National Cancer Institute (NCI) Head and Neck Squamous Cell Carcinoma|Stage IVA Oropharyngeal Carcinoma AJCC v7|Stage IVB Oropharyngeal Carcinoma AJCC v7 October 22, 2012 Phase 1|Phase 2
    NCT00550784 City of Hope Medical Center|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer January 2001 Phase 1
    NCT03095209 Fox Chase Cancer Center Lung Cancer|Esophageal Cancer February 24, 2017
    NCT02390427 Dana-Farber Cancer Institute|Genentech, Inc. Metastatic Breast Cancer|Recurrent Breast Cancer April 2015 Phase 1
    NCT00033696 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer September 2001 Phase 2
    NCT02118532 Medtronic Endovascular Atherosclerosis March 2014
    NCT00085839 OSI Pharmaceuticals|Astellas Pharma Inc Non-Small Cell Lung Cancer February 2004 Phase 2
    NCT01631357 Tianjin Medical University Cancer Institute and Hospital Lung Cancer November 2016 Phase 2|Phase 3
    NCT03087864 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|UMC Utrecht Esophageal Cancer, Stage II|Esophageal Cancer Stage III June 28, 2017 Phase 2
    NCT00011986 Gynecologic Oncology Group|Southwest Oncology Group|Medical Research Council|National Cancer Institute (NCI) Primary Peritoneal Carcinoma|Stage III Ovarian Cancer|Stage IV Ovarian Cancer January 2001 Phase 3
    NCT02569242 Ono Pharmaceutical Co. Ltd|Bristol-Myers Squibb Esophageal Cancer December 2015 Phase 3
    NCT01690702 German Breast Group|Celgene|Amgen Breast Cancer September 2012 Phase 3
    NCT02707328 The Cooper Health System Pancreas Cancer|Pancreatic Cancer|Adenocarcinoma of the Pancreas|Pancreas Adenocarcinoma|Pancreatic Adenocarcinoma January 2015 Phase 1
    NCT01940497 Hoffmann-La Roche Breast Cancer November 16, 2013 Phase 3
    NCT00003812 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer March 1999 Phase 2
    NCT02276846 Second Hospital of Jilin University Angioplasty|Percutaneous Coronary Intervention October 2014
    NCT02858206 Chinese Academy of Medical Sciences|Hebei Medical University Fourth Hospital|Affiliated Hospital of Hebei University|Beijing Army General Hospital|Beijing Hospital|Peking University First Hospital|Tianjin Medical University Cancer Institute and Hospital|Henan Cancer Hospital|The Affiliated Hospital of Inner Mongolia Medical University|The First Affiliated Hospital with Nanjing Medical University|Fujian Cancer Hospital Esophageal Neoplasms June 2016 Phase 2
    NCT01572038 Hoffmann-La Roche Breast Neoplasms June 1, 2012 Phase 3
    NCT00446836 The Methodist Hospital System|Cellular Therapeutics Prostatic Neoplasms March 2005 Phase 2
    NCT00198354 Intergroupe Francophone de Cancerologie Thoracique Non-small Cell Lung Cancer Stage I and II|Peri-operative Chemotherapy May 2001 Phase 3
    NCT00762034 Eli Lilly and Company Non-small Cell Lung Cancer December 2008 Phase 3
    NCT00113516 Pfizer Non-small Cell Lung Cancer September 2005 Phase 2
    NCT00016276 National Cancer Institute (NCI) Cardiac Toxicity|Inflammatory Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IV Breast Cancer May 2001 Phase 3
    NCT01688700 Zhejiang Cancer Hospital Esophageal Squamous Cell Carcinoma Resectable September 2012 Phase 2
    NCT01612351 UNC Lineberger Comprehensive Cancer Center|GlaxoSmithKline Head and Neck Cancer|Squamous Cell Carcinoma of the Head and Neck June 2012 Phase 2
    NCT02597946 Boehringer Ingelheim Carcinoma, Non-Small-Cell Lung March 18, 2016 Phase 2
    NCT02599324 Pharmacyclics LLC. Renal Cell Carcinoma (RCC)|Urothelial Carcinoma|Gastric Adenocarcinoma|Colorectal Adenocarcinoma (CRC) November 2015 Phase 1|Phase 2
    NCT01225523 Health Science Center of Xi’an Jiaotong University Squamous Carcinoma of Esophagus|Esophagus Disorders January 1997 Phase 1
    NCT02393898 Hoffmann-La Roche Ovarian Cancer April 25, 2015
    NCT00003087 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Esophageal Cancer August 1997 Phase 2
    NCT02460432 Taewoong Medical Co., Ltd. Biliary Neoplasms|Biliary Obstruction|Pancreatic Neoplasms May 2015
    NCT00017303 Cytran|National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer January 2001 Phase 2
    NCT02101788 National Cancer Institute (NCI) Low Grade Ovarian Serous Adenocarcinoma|Micropapillary Serous Carcinoma|Ovarian Serous Adenocarcinoma|Primary Peritoneal Serous Adenocarcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma February 27, 2014 Phase 2|Phase 3
    NCT00002559 Memorial Sloan Kettering Cancer Center Ovarian Cancer|Testicular Germ Cell Tumor January 1994 Phase 1|Phase 2
    NCT02132949 Hoffmann-La Roche Breast Cancer July 14, 2014 Phase 2
    NCT02539940 Jena University Hospital|Zentrum für Klinische Studien Jena|Aachen Resonance GmbH Critical Limb Ischemia|Peripheral Artery Disease September 2015
    NCT00479856 GlaxoSmithKline Relapsed Breast Cancer|Neoplasms, Breast November 2007 Phase 2
    NCT02728492 NewVac LLC|Janssen Pharmaceutica N.V., Belgium Non-small Cell Lung Cancer|Epithelial Ovarian Cancer August 2013 Phase 1
    NCT01953926 Puma Biotechnology, Inc. Solid Tumors September 30, 2013 Phase 2
    NCT02231723 Boston Biomedical, Inc Metastatic Pancreatic Adenocarcinoma August 2014 Phase 1
    NCT01836432 NewLink Genetics Corporation Pancreatic Cancer|Pancreatic Carcinoma Non-resectable|Locally Advanced Malignant Neoplasm May 2013 Phase 3
    NCT00002852 National Cancer Institute (NCI) Adenocarcinoma of the Lung|Adenosquamous Cell Lung Cancer|Bronchoalveolar Cell Lung Cancer|Large Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IB Non-small Cell Lung Cancer October 1996 Phase 3
    NCT00393068 SCRI Development Innovations, LLC|Genentech, Inc. Esophageal Cancer February 2007 Phase 2
    NCT01404156 Dr. Gordon Buduhan|Nova Scotia Health Authority|CancerCare Manitoba Esophageal Cancer|Adenocarcinoma, Esophageal|Adenocarcinoma, Gastroesophageal Junction September 2015 Phase 2|Phase 3
    NCT02916511 Fudan University Esophageal Squamous Cell Carcinoma September 2016 Phase 2
    NCT00004097 National Cancer Institute (NCI) Head and Neck Cancer August 1999 Phase 1
    NCT01487226 Korean Gynecologic Oncology Group Cervical Cancer January 2008 Phase 2
    NCT00569751 Boston Scientific Corporation Cardiovascular Disease|de Novo Coronary Lesions October 2004 Phase 4
    NCT00033410 California Cancer Consortium|National Cancer Institute (NCI) Lung Cancer March 2002 Phase 1
    NCT01688791 Endocyte Advanced Cancer December 2012 Phase 1
    NCT00193310 SCRI Development Innovations, LLC|Bristol-Myers Squibb|Eli Lilly and Company Lung Cancer November 2000 Phase 2
    NCT00002772 Southwest Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group|Cancer and Leukemia Group B Breast Cancer July 1996 Phase 3
    NCT02302807 Hoffmann-La Roche Bladder Cancer January 13, 2015 Phase 3
    NCT01946074 AbbVie Advanced Solid Tumors August 27, 2013 Phase 1
    NCT03029611 University of Washington|National Cancer Institute (NCI) Stage III Fallopian Tube Cancer|Stage III Ovarian Cancer|Stage III Primary Peritoneal Cancer|Stage IIIA Fallopian Tube Cancer|Stage IIIA Ovarian Cancer|Stage IIIA Primary Peritoneal Cancer|Stage IIIB Fallopian Tube Cancer|Stage IIIB Ovarian Cancer|Stage IIIB Primary Peritoneal Cancer|Stage IIIC Fallopian Tube Cancer|Stage IIIC Ovarian Cancer|Stage IIIC Primary Peritoneal Cancer|Stage IV Fallopian Tube Cancer|Stage IV Ovarian Cancer|Stage IV Primary Peritoneal Cancer April 3, 2017 Phase 2
    NCT01399463 Medical University of Vienna Coronary Artery Disease August 2011
    NCT00004137 Southwest Oncology Group|National Cancer Institute (NCI) Lung Cancer October 1999 Phase 2
    NCT01057563 Catholic University of the Sacred Heart Coronary Artery Disease November 2009 Phase 4
    NCT02644863 Shenzhen Hornetcorn Bio-technology Company, LTD|Affiliated Tumor Hospital of Guangzhou Medical University Esophageal Neoplasms|Neoplasms|Digestive System Neoplasms|Esophageal Cancer December 2015 Phase 2
    NCT02962063 Memorial Sloan Kettering Cancer Center|AstraZeneca Esophageal Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma November 2016 Phase 1|Phase 2
    NCT00005581 IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|National Cancer Institute (NCI) Breast Cancer June 2000 Phase 3
    NCT01966003 Amgen|Actavis Inc. Non-small Cell Lung Cancer Metastatic November 11, 2013 Phase 3
    NCT00915005 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Non-Small-Cell Lung Carcinoma June 2009 Phase 2
    NCT03095001 Chinese PLA General Hospital Peritoneal Adhesion June 1, 2017 Phase 2
    NCT01279291 Kyowa Hakko Kirin Pharma, Inc.|Kyowa Kirin Pharmaceutical Development, Inc. Neoplasms|Ovarian Neoplasms|Fallopian Tube Neoplasms|Primary Peritoneal Neoplasm January 2011 Phase 1
    NCT00006004 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Lung Cancer May 2000 Phase 2
    NCT00005051 New York University School of Medicine|National Cancer Institute (NCI) Ovarian Cancer August 1999 Phase 2
    NCT00004054 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Prostate Cancer January 2000 Phase 3
    NCT00014222 NCIC Clinical Trials Group|North Central Cancer Treatment Group|Southwest Oncology Group|Cancer and Leukemia Group B|Canadian Cancer Trials Group Breast Cancer December 2000 Phase 3
    NCT02365935 Campus Bio-Medico University Uterine Cervical Neoplasms February 2007
    NCT00006469 Washington Hospital Center|National Cancer Institute (NCI) Lung Cancer August 1999 Phase 2
    NCT01755897 Huazhong University of Science and Technology|Zhejiang University|Shandong University Uterine Cervical Neoplasms|Cervical Cancer|Uterine Cervical Cancer November 2012 Phase 3
    NCT00009880 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Esophageal Cancer|Gastric Cancer April 2001 Phase 2
    NCT00033553 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer March 2002 Phase 2
    NCT02741856 Lisette Nixon|Cancer Research UK|Velindre NHS Trust Oesophageal Cancer June 2016 Phase 2|Phase 3
    NCT00520975 National Cancer Institute (NCI) Breast Carcinoma|Recurrent Breast Carcinoma|Stage IV Breast Cancer November 2007 Phase 3
    NCT01822613 Novartis Pharmaceuticals|Novartis Esophageal Squamous Cell Carcinoma July 26, 2013 Phase 1
    NCT00002711 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Esophageal Cancer October 1995 Phase 1
    NCT01820312 University of Arkansas Squamous Cell Carcinoma of the Head and Neck January 2013 Phase 2
    NCT01816412 C. R. Bard|Medicon, Inc. Femoral Arterial Stenosis|Stenosis of Popliteal Arteries|Femoral Artery Occlusion|Occlusion of Popliteal Arteries March 2013 Phase 2
    NCT01633970 Genentech, Inc. Cancer July 11, 2012 Phase 1
    NCT01275677 National Cancer Institute (NCI) Estrogen Receptor Negative|Estrogen Receptor Positive|HER2/Neu Positive|Progesterone Receptor Negative|Progesterone Receptor Positive|Recurrent Breast Carcinoma|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIC Breast Cancer January 6, 2011 Phase 3
    NCT00002984 UNC Lineberger Comprehensive Cancer Center|National Cancer Institute (NCI) Esophageal Cancer March 1997 Phase 1|Phase 2
    NCT01218516 Morphotek Adenocarcinoma of the Lung April 2011 Phase 2
    NCT00384826 Intergroupe Francophone de Cancerologie Thoracique Adenocarcinoma, Bronchiolo-Alveolar September 2006 Phase 2
    NCT02495896 University of Southern California|National Cancer Institute (NCI)|Vasgene Therapeutics, Inc Head and Neck Squamous Cell Carcinoma|Metastatic Pancreatic Adenocarcinoma|Non-Resectable Cholangiocarcinoma|Pancreatic Adenocarcinoma|Recurrent Gallbladder Carcinoma|Recurrent Non-Small Cell Lung Carcinoma|Stage III Pancreatic Cancer|Stage IIIA Gallbladder Cancer|Stage IIIA Non-Small Cell Lung Cancer|Stage IIIB Gallbladder Cancer|Stage IIIB Non-Small Cell Lung Cancer|Stage IV Gallbladder Cancer|Stage IV Non-Small Cell Lung Cancer|Stage IV Pancreatic Cancer|Unresectable Gallbladder Carcinoma|Unr September 2015 Phase 1
    NCT02019277 Hoffmann-La Roche Breast Cancer December 2013 Phase 3
    NCT00003643 European Organisation for Research and Treatment of Cancer - EORTC Extragonadal Germ Cell Tumor|Teratoma|Testicular Germ Cell Tumor October 1998 Phase 2|Phase 3
    NCT00006472 Washington Hospital Center|National Cancer Institute (NCI) Esophageal Cancer January 2000 Phase 2
    NCT02220894 Merck Sharp & Dohme Corp. Non-small Cell Lung Cancer October 30, 2014 Phase 3
    NCT02957968 Virginia Commonwealth University|Merck Sharp & Dohme Corp.|National Cancer Institute (NCI) Locally Advanced Breast Cancer|Invasive Adenocarcinoma of the Breast|Breast Cancer Stage II|Breast Cancer Stage III|Breast Cancer Stage IV January 24, 2017 Phase 2
    NCT02978755 GamaMabs Pharma Neoplasm, Gynecologic June 2016 Phase 1
    NCT00004202 Spectrum Pharmaceuticals, Inc Lung Cancer October 1998 Phase 2
    NCT01712919 Jiangsu Cancer Institute & Hospital Nasopharyngeal Carcinoma May 2010 Phase 1|Phase 2
    NCT02322281 Clovis Oncology, Inc. Non-small Cell Lung Cancer February 2015 Phase 3
    NCT01835236 Swiss Group for Clinical Cancer Research Metastatic Breast Cancer April 29, 2013 Phase 2
    NCT01646034 The Netherlands Cancer Institute Breast Cancer September 2014 Phase 3
    NCT01704287 Merck Sharp & Dohme Corp. Malignant Melanoma November 20, 2012 Phase 2
    NCT02036164 Siriwan Tangjitgamol, MD|National Research Council of Thailand|Navamindradhiraj University|Chiang Mai University|Prince of Songkla University|Bhumibol Adulyadej Hospital|Lopburi Cancer Hospital|Ubonratchathani Cancer Hospital|Udonthani Cancer Hospital|Chonburi Cancer Hospital|Lampang Cancer Hospital|Health Intervention and Technology Assessment Program|Rajburi Hospital Uterine Cervical Cancer January 2014 Phase 3
    NCT02718417 Pfizer Ovarian Cancer May 19, 2016 Phase 3
    NCT01993810 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|NRG Oncology Stage IIA Non-small Cell Lung Cancer|Stage IIB Non-small Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer February 2014 Phase 3
    NCT00003313 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|NRG Oncology Drug/Agent Toxicity by Tissue/Organ|Lung Cancer|Oral Complications|Radiation Toxicity September 1998 Phase 3
    NCT02135042 NRG Oncology|National Cancer Institute (NCI) Epstein-Barr Virus Infection|Stage II Nasopharyngeal Carcinoma|Stage III Nasopharyngeal Carcinoma|Stage IVA Nasopharyngeal Carcinoma|Stage IVB Nasopharyngeal Carcinoma April 2014 Phase 2|Phase 3
    NCT02312245 Mayo Clinic|National Cancer Institute (NCI) Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma July 2015 Phase 2
    NCT02186847 NRG Oncology|National Cancer Institute (NCI) Adenosquamous Lung Carcinoma|Bronchioloalveolar Carcinoma|Large Cell Lung Carcinoma|Lung Adenocarcinoma|Non-Small Cell Lung Carcinoma|Recurrent Non-Small Cell Lung Carcinoma|Squamous Cell Lung Carcinoma|Stage IIIA Non-Small Cell Lung Cancer|Stage IIIB Non-Small Cell Lung Cancer August 2014 Phase 2
    NCT00004093 Northwestern University|National Cancer Institute (NCI) Lung Cancer August 1999 Phase 1|Phase 2
    NCT00004174 Northwestern University|National Cancer Institute (NCI) Breast Cancer October 1999 Phase 1
    NCT03117049 Ono Pharmaceutical Co. Ltd|Bristol-Myers Squibb Non-Small Cell Lung Cancer May 2017 Phase 3
    NCT02694224 Clinica Universidad de Navarra, Universidad de Navarra Breast Cancer April 2016 Phase 2
    NCT02195336 Karl Kölbeck|Karolinska University Hospital Non-small Cell Lung Cancer August 2014
    NCT03025477 Groupe Hospitalier Diaconesses Croix Saint-Simon|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR) Ovarian Cancer, Epithelial May 2016 Phase 2
    NCT03165994 University of California, San Francisco|Apexigen, Inc. Esophageal Cancer|GastroEsophageal Cancer July 1, 2017 Phase 2
    NCT00573131 BTG International Inc. Esophageal Cancer|Adenocarcinoma of the Esophagus|Squamous Cell Carcinoma January 2008 Phase 2
    NCT00021320 Fox Chase Cancer Center|National Cancer Institute (NCI) Esophageal Cancer May 2000 Phase 2
    NCT00828841 Accelerated Community Oncology Research Network Non-Small Cell Lung Cancer December 2008 Phase 2
    NCT00564733 University of Washington|National Cancer Institute (NCI) Malignant Pleural Effusion|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer October 2007 Phase 2
    NCT02625623 EMD Serono Research & Development Institute, Inc.|Merck KGaA|EMD Serono Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma|Gastric Cancer Third Line December 28, 2015 Phase 3
    NCT00003133 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter September 1997 Phase 1
    NCT02629718 Sun Yat-sen University PFS|OS|Quality of Life December 2015 Phase 3
    NCT03083470 DFB Soria, LLC|US Biotest, Inc. Actinic Keratosis May 18, 2017 Phase 2
    NCT00542191 Leo W. Jenkins Cancer Center Breast Cancer July 2007 Phase 2
    NCT01632306 Eli Lilly and Company|Mayo Clinic Pancreatic Cancer March 2013 Phase 1|Phase 2
    NCT02595554 Sun Yat-sen University Cervical Carcinoma Stage IIB November 2015 Phase 3
    NCT02194166 Hoffmann-La Roche Breast Cancer July 18, 2014 Phase 3
    NCT00003943 Fox Chase Cancer Center|National Cancer Institute (NCI) Carcinoma of Unknown Primary|Lung Cancer September 1998 Phase 2
    NCT02024009 University of Oxford|Celgene|Cancer Research UK Pancreatic Neoplasms (Locally Advanced Non-metastatic) March 2016 Phase 1|Phase 2
    NCT00004221 Gynecologic Oncology Group|National Cancer Institute (NCI) Malignant Ovarian Mixed Epithelial Tumor|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Primary Peritoneal Carcinoma|Stage III Ovarian Cancer|Undifferentiated Ovarian Carcinoma November 1999 Phase 2
    NCT00113399 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer April 2005 Phase 3
    NCT01331941 Amgen Advanced Solid Tumors|Kidney Disease|Renal Impairment September 2011 Phase 1
    NCT02125344 German Breast Group|Amgen|Roche Pharma AG|TEVA|Vifor Pharma Tubular Breast Cancer Stage II|Tubular Breast Cancer Stage III|Mucinous Breast Cancer Stage II|Breast Cancer Female NOS|Invasive Ductal Breast Cancer|HER2 Positive Breast Cancer|Inflammatory Breast Cancer December 2014 Phase 3
    NCT00004094 National Cancer Institute (NCI) Head and Neck Cancer August 1999 Phase 2
    NCT00119262 National Cancer Institute (NCI) Male Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer October 2005 Phase 2
    NCT01838538 Chinese PLA General Hospital Ovarian Cancer With Malignant Ascites June 2011 Phase 2
    NCT00003582 University of Miami Carcinoma of Unknown Primary|Head and Neck Cancer May 1988 Phase 1|Phase 2
    NCT01120184 Hoffmann-La Roche|Genentech, Inc. Breast Cancer July 2010 Phase 3
    NCT00003558 Academisch Ziekenhuis Maastricht|National Cancer Institute (NCI) Carcinoma of Unknown Primary August 1998 Phase 3
    NCT00295893 City of Hope Medical Center|National Cancer Institute (NCI) Breast Cancer September 2005 Phase 2
    NCT00003944 Fox Chase Cancer Center|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer August 1998 Phase 2
    NCT00531011 Abbott Vascular Coronary Disease|Coronary Artery Disease|Coronary Artery Stenosis|Coronary Artery Restenosis September 2007 Phase 4
    NCT00392704 SCRI Development Innovations, LLC|Genentech, Inc. Head and Neck Cancer December 2006 Phase 2
    NCT00003376 Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|Cancer and Leukemia Group B Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral Cancer September 1998 Phase 3
    NCT00003927 City of Hope Medical Center|National Cancer Institute (NCI) Breast Cancer April 22, 1999
    NCT00004125 Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|North Central Cancer Treatment Group|Southwest Oncology Group|Cancer and Leukemia Group B Breast Cancer October 1999 Phase 3
    NCT00004092 City of Hope Medical Center|National Cancer Institute (NCI) Breast Cancer May 1999 Phase 2
    NCT00005847 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Prostate Cancer January 2001 Phase 2
    NCT02041338 Chinese Academy of Medical Sciences Breast Cancer|Neoadjuvant Chemotherapy January 2014 Phase 2
    NCT00003701 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Bladder Cancer|Urethral Cancer March 1999 Phase 3
    NCT00016341 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Cancer May 2001 Phase 3
    NCT02730546 Mayo Clinic|National Cancer Institute (NCI) Gastric Cardia Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma|Stage IB Gastric Cancer AJCC v7|Stage II Gastric Cancer AJCC v7|Stage IIA Gastric Cancer AJCC v7|Stage IIB Gastric Cancer AJCC v7|Stage IIIA Gastric Cancer AJCC v7|Stage IIIB Gastric Cancer AJCC v7 June 24, 2016 Phase 1|Phase 2
    NCT02037048 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Adenocarcinoma of the Esophagus|Adenocarcinoma of the Gastroesophageal Junction|Adenocarcinoma of the Gastric Cardia|Stage IIIA Esophageal Cancer|Stage IIIB Esophageal Cancer|Stage IIIC Esophageal Cancer January 2014 Phase 2
    NCT00028873 European Organisation for Research and Treatment of Cancer - EORTC Breast Cancer September 2001 Phase 2
    NCT00003105 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter September 1997 Phase 1|Phase 2
    NCT03195569 Qilu Pharmaceutical Co., Ltd.|Tianjin Medical University Cancer Institute and Hospital Non Small Cell Lung Cancer March 1, 2017
    NCT00580333 Massachusetts General Hospital|Dana-Farber Cancer Institute|Beth Israel Deaconess Medical Center|Brigham and Women's Hospital|Genentech, Inc. Breast Cancer September 2007 Phase 2
    NCT00820690 Barretos Cancer Hospital|University of Sao Paulo Breast Cancer July 2008
    NCT01840579 Merck Sharp & Dohme Corp. Solid Tumor|Non-small Cell Lung Cancer|Small Cell Lung Cancer April 26, 2013 Phase 1
    NCT00003284 Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI) Lung Cancer January 1998 Phase 2
    NCT02715531 Hoffmann-La Roche Solid Tumor April 30, 2016 Phase 1
    NCT02472964 Mylan Inc.|Mylan GmbH Breast Cancer July 2012 Phase 3
    NCT00009750 University of California, Davis|National Cancer Institute (NCI) Prostate Cancer March 2001 Phase 1
    NCT00003013 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|National Cancer Institute (NCI) Breast Cancer October 1996 Phase 3
    NCT02630264 Guangzhou Double Bioproducts Co., Ltd Head and Neck Neoplasms June 2013 Phase 3
    NCT03177291 H. Lee Moffitt Cancer Center and Research Institute Lung Cancer|Non Small Cell Lung Cancer|Advanced Cancer|Metastatic Lung Cancer|Squamous Cell Lung Cancer|Non-Squamous Non-Small Cell Neoplasm of Lung October 2017 Phase 1
    NCT03181100 M.D. Anderson Cancer Center|Genentech, Inc. Malignant Neoplasms of Thyroid and Other Endocrine Glands|Anaplastic Thyroid Carcinoma|Poorly Differentiated Thyroid Cancer September 2017 Phase 2
    NCT01160185 GlaxoSmithKline Cervical Intraepithelial Neoplasia June 2009
    NCT02819518 Merck Sharp & Dohme Corp. Triple Negative Breast Cancer (TNBC) July 27, 2016 Phase 3
    NCT02830139 Wuhan University Malignant Neoplasm of Colorectum July 2016 Phase 2
    NCT00042835 National Cancer Institute (NCI) Adenocarcinoma of the Lung|Bronchoalveolar Cell Lung Cancer|Large Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer May 2002 Phase 1
    NCT00881166 Astex Pharmaceuticals Malignant Disease November 2007 Phase 1
    NCT00637897 Wake Forest University Health Sciences|National Cancer Institute (NCI) Breast Cancer March 2008 Phase 1
    NCT00559845 Hoffmann-La Roche Breast Cancer February 2008 Phase 2
    NCT01248949 MedImmune LLC Advanced Solid Tumors|Advanced Recurrent Ovarian Tumors October 2010 Phase 1
    NCT01959490 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer September 2013 Phase 2
    NCT02626520 Essentia Health Ductal Adenocarcinoma of Pancreas|Adenocarcinoma of Ampulla January 2016 Phase 2
    NCT02283489 Renmiao Zhang|West China Hospital|Chengdu Shi Endor Biological Engineering Technology Co., Ltd Head and Neck Neoplasms October 2014 Phase 2
    NCT00294762 OSI Pharmaceuticals|Astellas Pharma Inc Carcinoma, Non-Small-Cell Lung January 2006 Phase 2
    NCT02083679 EMD Serono Carcinoma, Non-Small-Cell Lung July 2014 Phase 1
    NCT02365805 Fundación Pública Andaluza para la gestión de la Investigación en Sevilla Breast Cancer April 2014 Phase 2
    NCT02429622 Chinese Academy of Medical Sciences Esophageal Neoplasms January 2015 Phase 1|Phase 2
    NCT02630823 Washington University School of Medicine|Merck Sharp & Dohme Corp. Endometrial Cancer|Endometrial Carcinoma|Neoplasms, Endometrial February 5, 2016 Phase 1
    NCT01817452 West German Study Group|Roche Pharma AG Breast Cancer March 2014 Phase 2
    NCT00228319 Jeanne Drisko, MD, CNS, FACN|Cancer Treatment Research Foundation|University of Kansas Medical Center Ovarian Cancer October 2002 Phase 1|Phase 2
    NCT00017017 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer February 2001 Phase 1|Phase 2
    NCT02565758 AbbVie Advanced Solid Tumor Cancer September 23, 2015 Phase 1
    NCT03044613 Sidney Kimmel Comprehensive Cancer Center|Bristol-Myers Squibb Gastric Cancer|Esophageal Cancer|GastroEsophageal Cancer June 2017 Phase 1
    NCT02903004 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Ovarian Neoplasms April 2016 Phase 3
    NCT02039791 Biotech Pharmaceutical Co., Ltd. Cervical Cancer January 2013 Phase 2
    NCT00006027 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|Gynecologic Oncology Group Endometrial Cancer August 2000 Phase 3
    NCT02913274 Rennes University Hospital Stenosis of Arteriovenous Dialysis Fistula March 20, 2017
    NCT00617409 H. Lee Moffitt Cancer Center and Research Institute Small Cell Lung Cancer October 2, 2007 Phase 2
    NCT00146549 Dana-Farber Cancer Institute|Massachusetts General Hospital|Brigham and Women's Hospital|North Shore Medical Center|GlaxoSmithKline Breast Cancer|Stage IV Breast Cancer August 2001 Phase 3
    NCT02124421 Mercy Medical Center Stage III Ovarian Cancer|Stage IV Ovarian Cancer|Epithelial Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Carcinoma|Ovarian Carcinoma|Fallopian Tube Carcinoma April 2014 Phase 2
    NCT02305654 Institute of Cancer Research, United Kingdom|ECOG-ACRIN Cancer Research Group|European Organisation for Research and Treatment of Cancer - EORTC Squamous Cell Carcinoma of the Penis, Usual Type April 2015 Phase 3
    NCT01783197 Canadian Cancer Trials Group|AstraZeneca Non Small Cell Lung Cancer January 30, 2013 Phase 1
    NCT01147016 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Breast Cancer July 2010 Phase 2
    NCT01333033 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Adenocarcinoma of the Gastroesophageal Junction|Esophageal Cancer July 2011 Phase 2
    NCT02568033 The Cooper Health System Non Small Cell Lung Cancer October 2013 Early Phase 1
    NCT00273507 Rigshospitalet, Denmark Non-small Cell Lung Cancer January 1998 Phase 3
    NCT03057366 Millennium Pharmaceuticals, Inc.|Takeda Advanced Solid Tumors, Neoplasms, Advanced Solid May 11, 2017 Phase 1
    NCT00198432 Intergroupe Francophone de Cancerologie Thoracique|Bristol-Myers Squibb|Pierre Fabre Laboratories|Ligue contre le cancer, France NSCLC Stage IIIB|Concomitant Radiochemotherapy March 2002 Phase 2
    NCT00186628 Stanford University|The Leukemia and Lymphoma Society Leukemia, Mast-Cell June 2005 Phase 2
    NCT01847001 Columbia University Locally Advanced Malignant Neoplasm|Breast Cancer October 2012 Phase 2
    NCT00779714 University of Wuerzburg|Hiege-Stiftung gegen Hautkrebs|medac GmbH|DCS Innovative Diagnostik Systeme Melanoma October 2008 Phase 3
    NCT00667251 Novartis Pharmaceuticals|NCIC Clinical Trials Group|Novartis Breast Cancer October 7, 2008 Phase 3
    NCT02446600 National Cancer Institute (NCI)|AstraZeneca Deleterious BRCA1 Gene Mutation|Deleterious BRCA2 Gene Mutation|Endometrial Undifferentiated Carcinoma|Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Tumor|Ovarian Seromucinous Carcinoma|Ovarian Serous Tumor|Ovarian Transitional Cell Carcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Undifferentiated Fallopian Tube Carcinoma|Undifferentiated Ova February 4, 2016 Phase 3
    NCT00795678 Case Comprehensive Cancer Center|United States Department of Defense|National Cancer Institute (NCI) Breast Cancer|Metastatic Cancer September 2008
    NCT02364713 Mayo Clinic|National Cancer Institute (NCI) Fallopian Tube Transitional Cell Carcinoma|Malignant Ovarian Clear Cell Tumor|Malignant Ovarian Endometrioid Tumor|Malignant Ovarian Serous Tumor|Ovarian Seromucinous Carcinoma|Ovarian Transitional Cell Carcinoma|Primary Peritoneal Serous Adenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Undifferentiated Fallopian Tube Carcinoma|Undifferentiated Ovarian Carcinoma March 2015 Phase 2
    NCT01308229 MINVASYS Coronary Disease December 2008
    NCT00231582 Assistance Publique - Hôpitaux de Paris|Ministry of Health, France|Amgen|Baxter Healthcare Corporation Testicular Neoplasms September 2004 Phase 2
    NCT02122185 University of Chicago|National Cancer Institute (NCI) Brenner Tumor|Malignant Ascites|Malignant Pleural Effusion|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mixed Epithelial Carcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Recurrent Fallopian Tube Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Ovarian Germ Cell Tumor|Recurrent Primary Peritoneal Cavity Cancer|Stage IIIA Fallopian Tube Cancer|Stage IIIA Ovarian Epithelial Cancer|Stage IIIA Ovarian Germ Cell Tumor|Stage II June 2014 Phase 2
    NCT02492867 University of Michigan Cancer Center Carcinoma, Non-Small-Cell Lung November 2015
    NCT00003696 Commissie Voor Klinisch Toegepast Onderzoek|National Cancer Institute (NCI) Lung Cancer October 1998 Phase 3
    NCT01779206 West German Study Group Breast Cancer May 2012 Phase 2|Phase 3
    NCT00550537 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Lung Cancer October 2007 Phase 2
    NCT00003930 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Bladder Cancer September 1999 Phase 1|Phase 2
    NCT02514681 Japan Breast Cancer Research Group|Chugai Pharmaceutical HER2-positive Locally Advanced or Metastatic Breast Cancer October 2015 Phase 3
    NCT00112086 Japan Clinical Oncology Group|Ministry of Health, Labour and Welfare, Japan Ovarian Neoplasms|Fallopian Tube Neoplasms|Peritoneal Neoplasms January 2003 Phase 2
    NCT02117024 Heat Biologics Non Small Cell Lung Cancer July 2014 Phase 2
    NCT01969578 European Organisation for Research and Treatment of Cancer - EORTC Salivary Gland Cancer February 2015 Phase 2
    NCT02419495 M.D. Anderson Cancer Center|Karyopharm Therapeutics Inc Advanced Cancers June 26, 2015 Phase 1
    NCT03143491 DFB Soria, LLC|US Biotest, Inc. Cervical Intraepithelial Neoplasia October 1, 2017 Phase 2
    NCT00043108 Fox Chase Cancer Center Lung Cancer July 2002 Phase 2
    NCT00976911 Hoffmann-La Roche Ovarian Cancer October 2009 Phase 3
    NCT00025480 University of Pennsylvania|National Cancer Institute (NCI) Lung Cancer August 2001 Phase 1
    NCT00513383 Massachusetts General Hospital|Brigham and Women's Hospital|Amgen Squamous Cell Carcinoma of the Head and Neck April 2006 Phase 1
    NCT02777788 Shanghai University of Traditional Chinese Medicine|Shanghai Chest Hospital|Shanghai Pulmonary Hospital, Shanghai, China Cancer September 2014 Phase 2|Phase 3
    NCT00107250 NCIC Clinical Trials Group|Canadian Cancer Trials Group Colorectal Cancer|Lung Cancer|Unspecified Adult Solid Tumor, Protocol Specific January 2005 Phase 1
    NCT01820858 Ding Ma|Shandong University|Huazhong University of Science and Technology|Zhejiang University Endometrial Neoplasms November 2012 Phase 3
    NCT00094861 Swedish Orphan Biovitrum|Amgen Dysphagia|Non-Small Cell Lung Cancer|Lung Cancer January 2005 Phase 2
    NCT02631876 ImmunoGen, Inc.|Gynecologic Oncology Group Epithelial Ovarian Cancer|Primary Peritoneal Carcinoma|Fallopian Tube Cancer|Ovarian Cancer November 2016 Phase 3
    NCT01121406 Boehringer Ingelheim Ovarian Neoplasms April 2010 Phase 2
    NCT02685059 German Breast Group|AstraZeneca|Celgene Corporation Breast Cancer March 2016 Phase 2
    NCT02857270 Eli Lilly and Company Advanced Cancer|Metastatic Melanoma|Metastatic Non-small Cell Lung Cancer|Metastatic Pancreatic Ductal Adenocarcinoma|Colorectal Cancer September 2016 Phase 1
    NCT00112294 Eli Lilly and Company|ImClone LLC Non-Small-Cell Lung Carcinoma December 2004 Phase 3
    NCT01133925 A.O. Ospedale Papa Giovanni XXIII|Case Western Reserve University|Medtronic Vascular Coronary Artery Disease May 2008 Phase 4
    NCT01304784 Merrimack Pharmaceuticals HER-2 Gene Amplification January 2011 Phase 1
    NCT02598687 Maastricht Radiation Oncology|Threshold Pharmaceuticals|Zuyderland Medical Centre Esophageal Cancer December 2015 Phase 1
    NCT02038621 The Second People's Hospital of Sichuan Advanced Gastric Cancer January 2014 Phase 2
    NCT00002679 Yale University Breast Cancer February 1994 Phase 2
    NCT01547741 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer April 2012 Phase 3
    NCT02931890 The Netherlands Cancer Institute Gastric Cancer October 2016 Phase 2
    NCT01369433 AVEO Pharmaceuticals, Inc. Solid Tumors June 2010
    NCT01779050 Washington University School of Medicine Breast Neoplasms December 19, 2013 Phase 2
    NCT01366183 Gynecologic Oncology Group|National Cancer Institute (NCI) Stage I Ovarian Cancer|Stage IA Fallopian Tube Cancer|Stage IB Fallopian Tube Cancer|Stage IC Fallopian Tube Cancer|Stage II Ovarian Cancer|Stage IIA Fallopian Tube Cancer|Stage IIB Fallopian Tube Cancer|Stage IIC Fallopian Tube Cancer|Stage III Ovarian Cancer|Stage III Primary Peritoneal Cancer|Stage IIIA Fallopian Tube Cancer|Stage IIIB Fallopian Tube Cancer|Stage IIIC Fallopian Tube Cancer|Stage IV Fallopian Tube Cancer|Stage IV Ovarian Cancer|Stage IV Primary Peritoneal Cancer August 2011
    NCT02489903 EpicentRx, Inc. Small Cell Lung Carcinoma|Carcinoma, Non-Small-Cell Lung|Neuroendocrine Tumors|Ovarian Epithelial Cancer June 2015 Phase 2
    NCT01137994 GlaxoSmithKline Neoplasms, Breast October 2011 Phase 2
    NCT00002854 City of Hope Medical Center|National Cancer Institute (NCI) Cancer December 1994 Phase 1
    NCT00048893 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Breast Neoplasms|Metastases, Neoplasm November 2002 Phase 1|Phase 2
    NCT00003399 University of Maryland Multiple Myeloma and Plasma Cell Neoplasm September 1998 Phase 2
    NCT03036488 Merck Sharp & Dohme Corp. Triple Negative Breast Neoplasms March 7, 2017 Phase 3
    NCT00003401 University of Maryland Multiple Myeloma and Plasma Cell Neoplasm January 1999 Phase 2
    NCT00091039 National Cancer Institute (NCI) Lung Cancer August 2004
    NCT01594177 German Breast Group|Boehringer Ingelheim Unilateral HER2 Positive Breast Cancer May 2012 Phase 2
    NCT00003402 University of Maryland|University of Maryland Greenebaum Cancer Center Leukemia|Lymphoma January 1999 Phase 2
    NCT02379585 Western Regional Medical Center Breast Cancer January 2013 Phase 1|Phase 2
    NCT01204996 Centocor, Inc. Cancer May 2010 Phase 1
    NCT02331251 Western Regional Medical Center Advanced Cancer|Breast Cancer|Sarcoma|Pancreatic Cancer|Small Cell Lung Cancer|Ovarian December 2014 Phase 1|Phase 2
    NCT02978495 Barretos Cancer Hospital BRCA1 Hereditary Breast and Ovarian Cancer Syndrome May 17, 2017 Phase 2
    NCT00580983 University of Michigan Cancer Center Head and Neck Cancer August 2003
    NCT01358877 Hoffmann-La Roche|Genentech, Inc.|Breast International Group Breast Cancer November 8, 2011 Phase 3
    NCT02122770 Millennium Pharmaceuticals, Inc.|Takeda Advanced Solid Tumors April 1, 2014 Phase 1
    NCT00508625 Amgen|Genentech, Inc. Non-Small Cell Lung Cancer June 2006 Phase 2
    NCT00022230 Roger Williams Medical Center Breast Cancer January 2000 Phase 1|Phase 2
    NCT02279134 Zefen Xiao|Chinese Academy of Medical Sciences Esophageal Neoplasms|Esophageal Cancer October 2014 Phase 2|Phase 3
    NCT00781612 Genentech, Inc.|F. Hoffmann-La Roche Breast Cancer October 31, 2008 Phase 2
    NCT02422563 Charite University, Berlin, Germany Cervical Cancer October 2015 Phase 3
    NCT00025298 European Organisation for Research and Treatment of Cancer - EORTC Drug/Agent Toxicity by Tissue/Organ|Head and Neck Cancer|Oral Complications|Radiation Toxicity July 2001 Phase 2
    NCT03088540 Regeneron Pharmaceuticals|Sanofi Carcinoma,Non-Small-Cell Lung|Lung Carcinomas, Non-Small-Cell|Non-small-cell Lung Carcinoma|Nonsmall Cell Lung Cancer May 30, 2017 Phase 3
    NCT00611286 Marco Valgimigli|Università degli Studi di Ferrara Coronary Artery Disease December 2006 Phase 4
    NCT00476827 Duke University|Genentech, Inc. Breast Cancer May 2007 Phase 2
    NCT02866370 NHS Greater Glasgow and Clyde|Boehringer Ingelheim|Cancer Research UK|European Organisation for Research and Treatment of Cancer - EORTC|Nordic Society for Gynaecologic Oncology|ARCAGY/ GINECO GROUP Ovarian Clear Cell Carcinoma|Endometrial Clear Cell Carcinoma April 2015 Phase 2
    NCT01822496 National Cancer Institute (NCI) Stage IIIA Non-Small Cell Lung Cancer AJCC v7|Stage IIIB Non-Small Cell Lung Cancer AJCC v7 November 4, 2013 Phase 2
    NCT01901146 Amgen|Actavis Inc. Breast Cancer April 29, 2013 Phase 3
    NCT00005838 National Cancer Institute (NCI)|Radiation Therapy Oncology Group|National Center for Complementary and Integrative Health (NCCIH) Adenocarcinoma of the Lung|Adenosquamous Cell Lung Cancer|Large Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer March 2000 Phase 3
    NCT03193190 Hoffmann-La Roche Pancreatic Adenocarcinoma July 5, 2017 Phase 1|Phase 2
    NCT01802749 National Cancer Institute, Naples|Mario Negri Institute for Pharmacological Research Recurrent Ovarian Cancer November 2013 Phase 3
    NCT02576574 EMD Serono Research & Development Institute, Inc.|Merck KGaA|EMD Serono First Line Non-Small Cell Lung Cancer October 29, 2015 Phase 3
    NCT02057380 Astellas Pharma Global Development, Inc.|Astellas Pharma Inc Advanced Solid Tumors April 2014 Phase 2
    NCT02009449 ARMO BioSciences Melanoma|Prostate Cancer|Ovarian Cancer|Renal Cell Carcinoma|Colorectal Carcinoma|Pancreatic Carcinoma|Non-small Cell Lung Carcinoma|Solid Tumors|Breast Cancer November 2013 Phase 1
    NCT02004093 Hoffmann-La Roche Ovarian Cancer December 2005 Phase 2
    NCT01507428 National Cancer Institute (NCI) Stage III Non-Small Cell Lung Cancer AJCC v7|Stage IIIA Non-Small Cell Lung Cancer AJCC v7|Stage IIIB Non-Small Cell Lung Cancer AJCC v7 February 22, 2012 Phase 2
    NCT02032277 AbbVie|US Oncology Research|NSABP Foundation Inc|Alliance for Clinical Trials in Oncology|German Breast Group|Grupo Español de Investigación del Cáncer de Mama Triple Negative Breast Cancer April 2, 2014 Phase 3
    NCT01970722 City of Hope Medical Center|National Cancer Institute (NCI) Recurrent Uterine Corpus Cancer|Recurrent Fallopian Tube Cancer|Recurrent Ovarian Cancer|Recurrent Primary Peritoneal Cancer|Stage IIIA Uterine Corpus Cancer|Stage IIIA Fallopian Tube Cancer|Stage IIIA Ovarian Cancer|Stage IIIA Primary Peritoneal Cavity Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIB Fallopian Tube Cancer|Stage IIIB Ovarian Cancer|Stage IIIB Primary Peritoneal Cavity Cancer|Stage IIIC Uterine Corpus Cancer|Stage IIIC Fallopian Tube Cancer|Stage IIIC Ovarian Cancer|Stage IIIC May 2014
    NCT00194792 University of Washington|National Cancer Institute (NCI) Estrogen Receptor-positive Breast Cancer|HER2-negative Breast Cancer|Progesterone Receptor-positive Breast Cancer|Stage I Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer August 2005 Phase 2
    NCT01964391 Hoffmann-La Roche Breast Cancer February 21, 2014 Phase 3
    NCT02940990 Shanghai Chest Hospital NSCLC|SBRT|GM-CSF November 2016 Phase 2
    NCT02822157 Universitaire Ziekenhuizen Leuven|AstraZeneca Ovarian Epithelial Cancer August 2016 Phase 2
    NCT01435018 AIDS Clinical Trials Group|National Institute of Allergy and Infectious Diseases (NIAID)|National Cancer Institute (NCI)|National Institute of Dental and Craniofacial Research (NIDCR) HIV-1 Infection August 2013 Phase 3
    NCT02013453 University of Michigan Cancer Center Cancer of Head and Neck December 2013 Phase 2
    NCT02909751 Vejle Hospital Breast Cancer September 2016 Phase 2
    NCT02784288 University of Michigan Cancer Center Oropharyngeal Squamous Cell Cancer September 2016 Phase 2
    NCT01973660 SOLTI Breast Cancer Research Group|Novartis Breast Cancer October 2013 Phase 2
    NCT01887704 Capital Medical University|Beijing Anzhen Hospital Coronary Artery Disease January 2010
    NCT02041533 Bristol-Myers Squibb|Ono Pharmaceutical Co. Ltd Stage IV or Recurrent Non-Small Cell Lung Cancer March 2014 Phase 3
    NCT02423239 e-Therapeutics PLC Hepatocellular Carcinoma|Pancreatic Cancer April 2015 Phase 1
    NCT01501487 Agendia|University of South Florida|University of Miami|Morton Plant Mease Health Care|Florida Hospital|Plano Cancer Center|Ohio State University Comprehensive Cancer Center|University of Oklahoma|University of South Alabama Breast Cancer October 2011 Phase 4
    NCT00148681 Dana-Farber Cancer Institute|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Brigham and Women's Hospital Breast Cancer|Stage II Breast Cancer|Stage III Breast Cancer May 2001 Phase 2
    NCT02579564 Xinqiao Hospital of Chongqing Malignant Hydrothorax|Non Small Cell Lung Cancer October 2016 Phase 3
    NCT01966471 Hoffmann-La Roche Breast Cancer January 31, 2014 Phase 3
    NCT01803282 Gilead Sciences Tumors|Pancreatic Cancer|Non-small Cell Lung Cancer|Esophagogastric Cancer|Colorectal Cancer|Breast Cancer March 29, 2013 Phase 1
    NCT01159236 M.D. Anderson Cancer Center Breast Cancer September 2010
    NCT03197584 NantCell, Inc. Ovarian Cancer September 2017 Phase 1|Phase 2
    NCT03169790 NantCell, Inc. Non Hodgkin Lymphoma August 2017 Phase 1|Phase 2
    NCT03175666 NantCell, Inc. Triple Negative Breast Cancer August 2017 Phase 1|Phase 2
    NCT03197571 NantCell, Inc. Urothelial Carcinoma August 2017 Phase 1|Phase 2
    NCT03169764 NantCell, Inc. Head and Neck Squamous Cell Carcinoma August 2017 Phase 1|Phase 2
    NCT02620865 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Metastatic Pancreatic Adenocarcinoma|Recurrent Pancreatic Carcinoma|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer December 2015 Phase 1|Phase 2
    NCT03169777 NantCell, Inc. Colorectal Cancer August 2017 Phase 1|Phase 2
    NCT03169738 NantCell, Inc. Non-small Cell Lung Cancer August 2017 Phase 1|Phase 2
    NCT02142738 Merck Sharp & Dohme Corp. Non-Small Cell Lung Carcinoma August 25, 2014 Phase 3
    NCT03136406 NantCell, Inc. Pancreatic Cancer May 2017 Phase 1|Phase 2
    NCT02915744 Nektar Therapeutics Metastasis|Breast Cancer November 2016 Phase 3
    NCT02287129 Technische Universität München Adenocarcinoma of the Esophagogastric Junction November 2014 Phase 2
    NCT03085914 Incyte Corporation Advanced or Metastatic Solid Tumors|Advanced or Metastatic Colorectal Cancer (CRC)|Pancreatic Ductal Adenocarcinoma (PDAC)|Non-Small Cell Lung Cancer (NSCLC; Squamous or Nonsquamous)|Advanced or Metastatic Solid Tumor That Progressed on Previous Therapy With a Programmed Cell Death Protein 1 (PD-1) Inhibitor|Advanced or Metastatic Solid Tumor That Progressed on Previous Therapy With a Programmed Cell Death Ligand 1 (PD-L1) Inhibitor May 2, 2017 Phase 1|Phase 2
    NCT03167164 NantCell, Inc. Merkel Cell Carcinoma August 2017 Phase 1|Phase 2
    NCT03167177 NantCell, Inc. Melanoma August 2017 Phase 1|Phase 2
    NCT00429299 GlaxoSmithKline Neoplasms, Breast August 2006 Phase 2
    NCT03053856 Samsung Medical Center Stage IIIA Non-small Cell Lung Cancer February 14, 2017 Phase 2
    NCT00422682 Sanofi Tumors January 2007 Phase 1
    NCT00020449 National Cancer Institute (NCI) Sarcoma January 2001 Phase 2
    NCT01593228 Sanofi Solid Tumors May 2012 Phase 3
    NCT00003589 European Organisation for Research and Treatment of Cancer - EORTC Lung Cancer August 1998 Phase 3
    NCT01534585 Taizhou Hospital Nasopharyngeal Carcinoma February 2012 Phase 1|Phase 2
    NCT02483247 Boston Biomedical, Inc Cancer September 2015 Phase 1|Phase 2
    NCT00104676 UNICANCER|National Cancer Institute (NCI) Extragonadal Germ Cell Tumor|Teratoma|Testicular Germ Cell Tumor November 2003 Phase 3
    NCT02509286 University Hospital Freiburg|Clinical Trials Unit Freiburg Esophageal Adenocarcinoma (UICC TNM7)|Adenocarcinoma of the Esophagogastric Junction January 2016 Phase 3
    NCT03064854 Novartis Pharmaceuticals|Novartis Non-small Cell Lung Cancer May 24, 2017 Phase 1
    NCT02988921 Chinese Academy of Medical Sciences Esophagus Cancer|Esophagogastric Junction Cancer October 2016
    NCT01505569 Masonic Cancer Center, University of Minnesota Ewing's Family Tumors|Renal Tumors|Hepatoblastoma|Rhabdomyosarcoma|Soft Tissue Sarcoma|Primary Malignant Brain Neoplasms|Retinoblastoma|Medulloblastoma|Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET)|Atypical Teratoid/Rhabdoid Tumor (AT/RT)|CNS Tumors|Germ Cell Tumors October 20, 2011
    NCT02622074 Merck Sharp & Dohme Corp. Triple Negative Breast Neoplasms January 27, 2016 Phase 1
    NCT00686959 Eli Lilly and Company Non Small Cell Lung Cancer September 2008 Phase 3
    NCT00570531 University of Michigan Cancer Center|Genentech, Inc. Loco-regional Esophageal Cancer June 2007 Phase 2
    NCT02039674 Merck Sharp & Dohme Corp. Non-small Cell Lung Carcinoma February 2014 Phase 1|Phase 2
    NCT00954512 Merck Sharp & Dohme Corp. Neoplasms September 25, 2009 Phase 1|Phase 2
    NCT03009058 Immodulon Therapeutics Ltd Metastatic Cancer May 24, 2017 Phase 1|Phase 2
    NCT02344472 Prof. W. Janni|Roche Pharma AG|DETECT study group|University of Ulm Metastatic Breast Cancer September 2015 Phase 3
    NCT02265510 Incyte Corporation Advanced Cancer August 2014 Phase 1|Phase 2
    NCT03184870 Bristol-Myers Squibb Colorectal Cancer|Pancreatic Cancer July 27, 2017 Phase 1|Phase 2
    NCT00230451 University of Michigan Cancer Center Esophageal Cancer November 1997 Phase 2
    NCT00014118 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer March 2001 Phase 2
    NCT03215706 Bristol-Myers Squibb Non-Small Cell Lung Cancer July 20, 2017 Phase 3
    NCT02383212 Regeneron Pharmaceuticals|Sanofi Advanced Cancer|Advanced Malignancies January 2015 Phase 1
    NCT02252796 West Virginia University Non-small Cell Lung Cancer July 2014 Phase 1
    NCT00028938 Wake Forest University Health Sciences|National Cancer Institute (NCI) Lung Cancer January 2002 Phase 3
    NCT00004865 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI)|ImClone LLC Head and Neck Cancer November 1999 Phase 2
    NCT01726452 Cancer Trials Ireland|Southampton Clinical Trials Unit|Region H Rigshospitalet|Centre Hospitalier Régional, Universitaire de Lille Adenocarcinoma of the Oesophagus|Adenocarcinoma of the Oesophago-gastric Junction|Oesophageal Tumours|Junctional Tumours|Oesophageal Cancer August 2012 Phase 3
    NCT02574078 Bristol-Myers Squibb Non-Small Cell Lung Cancer November 13, 2015 Phase 1|Phase 2
    NCT00611910 Deutsches Herzzentrum Muenchen Arteriosclerosis of Arterial Coronary Artery Bypass Graft November 2007 Phase 4
    NCT02502266 National Cancer Institute (NCI) Deleterious BRCA1 Gene Mutation|Deleterious BRCA2 Gene Mutation|Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Primary Peritoneal Serous Adenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|R February 5, 2016 Phase 2|Phase 3
    NCT01209520 University of Miami Lung Cancer|Non Small Cell Lung Carcinoma|Hypermethylation July 2009
    NCT01220128 GlaxoSmithKline Neoplasms, Breast April 1, 2011 Phase 2
    NCT00567554 German Breast Group|AGO Study Group Breast Cancer October 2007 Phase 3
    NCT01698281 AEterna Zentaris Breast Cancer December 2012 Phase 2
    NCT02658214 AstraZeneca Small Cell Lung Carcinoma|Carcinoma, Squamous Cell of Head and Neck|Stomach Neoplasms|Triple Negative Breast Neoplasms|Ovarian Neoplasms|Fallopian Tube Neoplasms|Peritoneal Neoplasms|Esophagogastric Junction Neoplasms April 28, 2016 Phase 1
    NCT00432094 Masonic Cancer Center, University of Minnesota Childhood Germ Cell Tumor|Ovarian Cancer|Teratoma December 19, 2006 Phase 2
    NCT00075712 Royal College of Obstetricians and Gynecologists|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer September 2003 Phase 2|Phase 3
    NCT00897026 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer July 2008
    NCT00146562 Harold J. Burstein, MD, PhD|Dana-Farber Cancer Institute|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Lowell General Hospital|Brigham and Women's Hospital|North Shore Medical Center Breast Cancer|Stage I Breast Cancer|Stage II Breast Cancer July 2003 Phase 2
    NCT00301730 National Cancer Institute (NCI) Breast Cancer|Metastatic Cancer October 2005 Phase 1
    NCT01376310 GlaxoSmithKline Cancer March 28, 2011 Phase 2
    NCT03141359 Carolinas Healthcare System Lung May 12, 2017 Phase 2
    NCT00004089 National Cancer Institute (NCI) Head and Neck Cancer August 1999 Phase 2
    NCT00828009 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Lung Cancer December 2010 Phase 2
    NCT00028860 Tulane University Health Sciences Center|National Cancer Institute (NCI) Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter October 2001 Phase 2
    NCT00003214 Swiss Group for Clinical Cancer Research Ovarian Cancer July 1996 Phase 3
    NCT03003962 AstraZeneca Non Small Cell Lung Carcinoma NSCLC January 2, 2017 Phase 3
    NCT02542293 AstraZeneca Non Small Cell Lung Carcinoma NSCLC November 3, 2015 Phase 3
    NCT00003899 Fred Hutchinson Cancer Research Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific January 1999 Phase 1
    NCT00003877 Roswell Park Cancer Institute|National Cancer Institute (NCI) Breast Cancer September 1998 Phase 1|Phase 2
    NCT00003862 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Gastric Cancer November 1999 Phase 2
    NCT00003111 Yale University|National Cancer Institute (NCI) Lung Cancer April 1997 Phase 2
    NCT00003064 Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer January 1997 Phase 1|Phase 2
    NCT00533936 Instituto Nacional de Cancerologia, Columbia|National Cancer Institute (NCI) Breast Cancer September 2006 Phase 2
    NCT00083083 American College of Radiology Imaging Network|National Cancer Institute (NCI)|Radiation Therapy Oncology Group Lung Cancer March 2005 Phase 2
    NCT00055887 Spectrum Pharmaceuticals, Inc Lung Cancer November 2002 Phase 3
    NCT00005612 H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI) Ovarian Cancer August 1999 Phase 1|Phase 2
    NCT00004921 EBMT Solid Tumors Working Party|National Cancer Institute (NCI) Ovarian Cancer September 1998 Phase 3
    NCT00003413 University of Maryland|University of Maryland Greenebaum Cancer Center Ovarian Cancer September 1998 Phase 2
    NCT00003392 UNC Lineberger Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer September 1997 Phase 2
    NCT00002931 City of Hope Medical Center|National Cancer Institute (NCI) Brain and Central Nervous System Tumors|Extragonadal Germ Cell Tumor|Ovarian Cancer|Teratoma|Testicular Germ Cell Tumor February 1997 Phase 2
    NCT00052351 National Cancer Institute (NCI) Breast Cancer September 2002 Phase 2
    NCT00003386 Gynecologic Oncology Group|National Cancer Institute (NCI) Ovarian Cancer July 1999 Phase 2
    NCT02477826 Bristol-Myers Squibb|Ono Pharmaceutical Co. Ltd Non-Small Cell Lung Cancer August 2015 Phase 3
    NCT02393833 International Breast Cancer Study Group Breast Cancer June 2002 Phase 3
    NCT00811993 Hoffmann-La Roche Neoplasms February 2009 Phase 1
    NCT00629278 Azienda Ospedaliera - Universitaria di Modena|National Cancer Institute (NCI) Breast Cancer December 2007 Phase 3
    NCT00311636 Gruppo Italiano Mammella (GIM)|National Cancer Institute (NCI) Breast Cancer September 2003 Phase 3
    NCT00030654 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group|Cancer and Leukemia Group B|Southwest Oncology Group|NRG Oncology Prostate Cancer October 2002 Phase 3
    NCT00027937 Fred Hutchinson Cancer Research Center|National Cancer Institute (NCI) Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific|Unspecified Childhood Solid Tumor, Protocol Specific August 2001 Phase 2
    NCT00014573 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Brain and Central Nervous System Tumors August 1998 Phase 2
    NCT00011921 EBMT Solid Tumors Working Party|National Cancer Institute (NCI) Lung Cancer September 1997 Phase 3
    NCT00003972 Fred Hutchinson Cancer Research Center|National Cancer Institute (NCI) Breast Cancer July 1998 Phase 3
    NCT00003957 Fox Chase Cancer Center|National Cancer Institute (NCI) Lymphoma December 1998 Phase 2
    NCT00003852 UNICANCER Childhood Germ Cell Tumor|Extragonadal Germ Cell Tumor|Ovarian Cancer|Testicular Germ Cell Tumor March 1998 Phase 2
    NCT00003397 University of Maryland|University of Maryland Greenebaum Cancer Center Lymphoma September 1998 Phase 2
    NCT00003159 Medical Research Council|European Organisation for Research and Treatment of Cancer - EORTC|National Cancer Institute (NCI) Lung Cancer August 1997 Phase 3
    NCT00003086 Feist-Weiller Cancer Center at Louisiana State University Health Sciences|National Cancer Institute (NCI) Breast Cancer March 1997 Phase 1|Phase 2
    NCT00003042 City of Hope Medical Center|National Cancer Institute (NCI) Breast Cancer May 1997 Phase 2
    NCT02453282 AstraZeneca Non-Small-Cell Lung Carcinoma NSCLC July 21, 2015 Phase 3
    NCT00572598 Virginia Commonwealth University Breast Cancer May 2005 Early Phase 1
    View MoreCollapse
    References
    Preparing Stock Solutions
    Concentration Volume (DMSO) Mass 1 mg 5 mg 10 mg
    1 mM 1.1711 mL 5.8554 mL 11.7108 mL
    5 mM 0.2342 mL 1.1711 mL 2.3422 mL
    10 mM 0.1171 mL 0.5855 mL 1.1711 mL
    Kinase Assay
    [1]

    To determine which caspases are involved in apoptosis induced by taxol, caspase-3 inhibitor (DEVD-CHO), caspase-6 inhibitor (Z-VEID-FMK), caspase-8 inhibitor (Z-IETD-FMK or IETD-CHO), caspase-9 inhibitors (Z-LEHD-FMK or LEHD-CHO), and caspase-10 inhibitor (Z-AEVD-FMK) are used. These caspase inhibitors are dissolved in dimethyl sulfoxide (Me2SO); the final concentration of Me2SO is 0.1%. Cells (5×105) are preincubated in the presence or absence of 100 μM each of these inhibitors for 3 h at 37°C then treated with or without 0.1, 0.5, and 1 μM Paclitaxel for 48 h and processed for annexin V binding assay. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Cell Assay
    [1]

    1×104 cells are plated in 100 μL of the growth medium in the presence or absence of increasing concentrations (0.1-1 μM) of taxol in 96-well plates and cultured at 37°C in 5% CO2 for 12-48 h. The cells are then incubated with 25 μL of MTT (5 mg/mL) at 37°C for 4 h. After dissolving the crystals with 0.04 N HCl in isopropanol, the plates are read in a microplate reader at 570 nm. The concentration of drug that inhibits cell survival by 50% (IC50) is determined from cell survival plots. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Administration
    [5]

    Paclitaxel is dissolved at 25 mg/mL in 1:1 Cremophor EL: ethanol and freshly diluted 1:12.5 in 0.9% sterile saline prior to injections.

    Adult (250-320 g) male Sprague-Dawley rats are used for all experiments. Rats are housed two per cage in a temperature and humidity controlled, on a 12 h:12 h light:dark schedule with food and water available ad libitum. One week following the DiI injection, rats are anesthetized with isofluorane and injected into the tail vein with 2 mg/kg paclitaxel or its vehicle (1:1:23, cremophor EL:ethanol:0.9% saline). The tail vein injection is repeated three more times every other day for a total of four injections. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    References
    Molecular Weight

    853.91

    Formula

    C₄₇H₅₁NO₁₄

    CAS No.

    33069-62-4

    Storage
    Powder -20°C 3 years
      4°C 2 years
    In solvent -80°C 6 months
      -20°C 1 month
    Shipping

    Room temperature in continental US; may vary elsewhere

    Solvent & Solubility

    DMSO: ≥ 31 mg/mL; H2O: < 0.1 mg/mL

    Paclitaxel is dissolved at 20 mg/mL in DMSO and freshly diluted (1:1-1:200) as a suspension with PBS.
    Paclitaxel is dissolved in DMSO, aliquoted and stored at -80°C until further use. The same volume of DMSO is used as the vehicle control[6].

    * "<1 mg/mL" means slightly soluble or insoluble. "≥" means soluble, but saturation unknown.

    References

    Purity: 99.60%

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product name

     

    Salutation

    Applicant name *

     

    Email address *

    Phone number

     

    Organization name *

    Country *

     

    Requested quantity *

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Paclitaxel
    Cat. No.:
    HY-B0015
    Quantity: